Annotation Detail for CDKN1A
Basic Information Top
| Gene Symbol: | CDKN1A ( CAP20,CDKN1,CIP1,MDA-6,P21,SDI1,WAF1,p21CIP1 ) |
|---|---|
| Gene Full Name: | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
| Band: | 6p21.2 |
| Quick Links | Entrez ID:1026; OMIM: 116899; Uniprot ID:CDN1A_HUMAN; ENSEMBL ID: ENSG00000124762; HGNC ID: 1784 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa05160 | Hepatitis C |
| hsa04012 | ErbB signaling pathway |
| hsa05219 | Bladder cancer |
| hsa04110 | Cell cycle |
| hsa04115 | p53 signaling pathway |
| hsa05220 | Chronic myeloid leukemia |
| hsa05218 | Melanoma |
| hsa05214 | Glioma |
| hsa05215 | Prostate cancer |
| hsa05200 | Pathways in cancer |
| Pathway ID | Pathway Name |
|---|---|
| Cell Cycle, Mitotic | |
| DNA Replication | |
| Signalling by NGF | |
| Cell Cycle Checkpoints |
| Pathway ID | Pathway Name |
|---|---|
| 200171 | Validated targets of C-MYC transcriptional repression |
| 200002 | Regulation of nuclear SMAD2/3 signaling |
| 200006 | Signaling events mediated by PRL |
| 200027 | E2F transcription factor network |
| 200130 | C-MYB transcription factor network |
| 200013 | Notch signaling pathway |
| 200020 | Signaling events mediated by HDAC Class III |
| 200066 | Angiopoietin receptor Tie2-mediated signaling |
| 200077 | Glucocorticoid receptor regulatory network |
| 200169 | Class I PI3K signaling events mediated by Akt |
| 200101 | Direct p53 effectors |
| 200191 | Regulation of retinoblastoma protein |
| Pathway ID | Pathway Name |
|---|---|
| P04398 | p53 pathway feedback loops 2 |
| P00059 | p53 pathway |
| P00036 | Interleukin signaling pathway |
| Pathway ID | Pathway Name |
|---|---|
| 501023 | Transcriptional activation of cell cycle inhibitor p21 |
| 500877 | Cyclin E associated events during G1/S transition |
| 500375 | Cyclin A:Cdk2-associated events at S phase entry |
| Desease ID | Desease Name |
|---|---|
| Cancers | |
| H00030 | Cervical cancer |
| Cancers of the breast and female genital organs |
| Desease ID | Desease Name |
|---|---|
| 1739 | Oral cancer |
| 1763 | Keratosis |
| 1781 | Rheumatoid arthritis |
| 1786 | Neck cancer |
| 1834 | Sarcoidosis |
| 1872 | Chronic simple glaucoma |
| 1901 | Endometriosis |
| 1934 | Cancer |
| 2025 | Polyarthritis |
| 2003 | Metaplastic polyp |
| 2052 | Infection |
| 2160 | Papillomavirus infection |
| 2174 | Chronic rejection of renal transplant |
| 1920 | Hyperparathyroidism |
| 2220 | Dermatitis |
| 2257 | Hemolytic-Uremic syndrome |
| Desease Name |
|---|
| Lupus Erythematosus, Systemic |
| oral cancer |
| prostate cancer |
| Lupus Nephritis |
| CANCER |
| stomach cancer |
| bladder cancer |
| breast cancer |
| overall effect |
| IMMUNE |
| head and neck cancer |
| Desease Name |
|---|
| Electrocardiographic traits |
| No data |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C492909 | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased expression of CDKN1A mRNA | increases expression | 15345676 |
| C492909 | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased expression of CDKN1A protein | increases expression | 15345676 |
| C492909 | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane | 2-chloro-5-nitrobenzanilide inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15345676 |
| C492909 | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane | SP1 protein affects the reaction [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased expression of CDKN1A protein] | affects reaction|increases expression | 15345676 |
| C492909 | 1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane | SP4 protein affects the reaction [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased expression of CDKN1A protein] | affects reaction|increases expression | 15345676 |
| C012277 | 1,2-diamino-4-nitrobenzene | 1,2-diamino-4-nitrobenzene results in decreased expression of CDKN1A mRNA | decreases expression | 17070881 |
| C074153 | 1,4-phenylenebis(methylene)selenocyanate | 1,4-phenylenebis(methylene)selenocyanate results in increased expression of CDKN1A mRNA | increases expression | 12844480 |
| C477941 | 1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate | 1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate results in increased expression of CDKN1A mRNA | increases expression | 12844480 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of CDKN1A protein | decreases expression | 15729575 |
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | 15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of CDKN1A | increases expression | 15254749 |
| C002029 | 17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol | 17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in increased expression of CDKN1A protein | increases expression | 16019103 |
| C095284 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one results in increased expression of CDKN1A protein | increases expression | 16288207 |
| C035314 | 1-nitropropane | 1-nitropropane results in decreased expression of CDKN1A mRNA | decreases expression | 17070881 |
| C110417 | 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol | 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15781256 |
| C404910 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of CDKN1A mRNA | increases expression | 20826375 |
| C044565 | 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide | 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide results in increased expression of CDKN1A protein | increases expression | 16857806 |
| C014211 | 2,3,7,8-tetrachlorodibenzofuran | 2,3,7,8-tetrachlorodibenzofuran affects the expression of CDKN1A mRNA | affects expression | 18343893 |
| C529061 | 2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone | TP53 protein mutant form affects the reaction [2-(4,5-dihydro-1,3-thiazol-2-ylthio)-1-(3,4-dihydroxyphenyl)ethanone results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 18424558 |
| C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in increased expression of CDKN1A mRNA | increases expression | 20713471 |
| C010914 | 2,4-diaminotoluene | 2,4-diaminotoluene results in increased expression of CDKN1A mRNA | increases expression | 17070881 |
| C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of CDKN1A mRNA | affects expression | 21346803 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1A protein | increases expression | 15695173 |
| C089946 | 2,4-thiazolidinedione | 2,4-thiazolidinedione results in increased expression of CDKN1A protein | increases expression | 15916743 |
| C025235 | 2,6-diaminotoluene | 2,6-diaminotoluene results in increased expression of CDKN1A mRNA | increases expression | 17070881 |
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of CDKN1A mRNA | affects expression | 21346803 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of CDKN1A protein | increases expression | 15635149 |
| C035208 | 2-amino-4,6-dinitrotoluene | 2-amino-4,6-dinitrotoluene affects the expression of CDKN1A mRNA | affects expression | 21346803 |
| C507359 | 2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone | 2-aziridin-1-yl-3-((2-((2-(3-aziridin-1-yl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)thio)ethoxy)ethyl)thio)naphthoquinone results in increased expression of CDKN1A protein | increases expression | 15642166 |
| C437043 | 2-butylamino-2-demethoxy-hypocrellin B | 2-butylamino-2-demethoxy-hypocrellin B results in increased expression of CDKN1A mRNA | increases expression | 17045927 |
| C437043 | 2-butylamino-2-demethoxy-hypocrellin B | 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide inhibits the reaction [2-butylamino-2-demethoxy-hypocrellin B results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17045927 |
| C437043 | 2-butylamino-2-demethoxy-hypocrellin B | Sodium Azide inhibits the reaction [2-butylamino-2-demethoxy-hypocrellin B results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17045927 |
| C457499 | 2-chloro-5-nitrobenzanilide | 2-chloro-5-nitrobenzanilide inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15345676 |
| C070279 | 2'-cyano-2'-deoxyarabinofuranosylcytosine | 2'-cyano-2'-deoxyarabinofuranosylcytosine results in increased expression of CDKN1A protein | increases expression | 16061671 |
| C518368 | (2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide | (2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide results in increased expression of CDKN1A mRNA | increases expression | 17352252 |
| C120275 | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone inhibits the reaction [Cisplatin results in increased expression of and affects the localization of CDKN1A protein] | affects localization|decreases reaction|increases expression | 12807743 |
| C120275 | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone inhibits the reaction [Dactinomycin results in increased expression of and affects the localization of CDKN1A protein] | affects localization|decreases reaction|increases expression | 12807743 |
| C120275 | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone results in decreased expression of CDKN1A protein | decreases expression | 12807743 |
| C120275 | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone results in increased expression of CDKN1A mRNA | increases expression | 12807743 11468187 12869419 |
| C120275 | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone | ferric ammonium citrate inhibits the reaction [2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 12807743 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [decitabine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18347191 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| C014706 | 2-nitro-4-phenylenediamine | 2-nitro-4-phenylenediamine results in decreased expression of CDKN1A mRNA | decreases expression | 17070881 |
| C019499 | 2-nitrofluorene | 2-nitrofluorene results in increased expression of CDKN1A mRNA | increases expression | 14600272 15890375 |
| C016617 | 2-nitropropane | 2-nitropropane results in increased expression of CDKN1A mRNA | increases expression | 17070881 |
| C029955 | 2-nitrotoluene | 2-nitrotoluene results in increased expression of CDKN1A mRNA | increases expression | 15618236 |
| C029955 | 2-nitrotoluene | 2-nitrotoluene results in decreased expression of CDKN1A mRNA | decreases expression | 16460773 |
| C079391 | 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide | 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide inhibits the reaction [2-butylamino-2-demethoxy-hypocrellin B results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17045927 |
| C016392 | 3,3'-diindolylmethane | 3,3'-diindolylmethane results in increased expression of CDKN1A mRNA | increases expression | 18025290 |
| C513485 | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester affects the expression of CDKN1A protein | affects expression | 16039525 |
| C513485 | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester analog results in decreased expression of CDKN1A protein | decreases expression | 16039525 |
| C034534 | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in increased expression of CDKN1A mRNA | increases expression | 15475462 16596235 |
| C034534 | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in increased expression of CDKN1A protein | increases expression | 15475462 |
| C034534 | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride promotes the reaction [3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 15475462 |
| C034534 | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride promotes the reaction [3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in increased expression of CDKN1A protein] | increases expression|increases reaction | 15475462 |
| C034534 | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in increased expression of CDKN1A mRNA | increases expression | 21071580 |
| C025160 | 3-aminobenzamide | 3-aminobenzamide results in increased expression of CDKN1A mRNA | increases expression | 15670817 |
| C028676 | 4-acetylaminofluorene | 4-acetylaminofluorene results in decreased expression of CDKN1A mRNA | decreases expression | 17070881 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [arsenic trioxide results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 15961274 |
| C108123 | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [arsenic trioxide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15961274 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased expression of CDKN1A protein | increases expression | 15607904 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CDKN1A protein | affects localization|increases expression | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | zinc protoporphyrin analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CDKN1A protein] | affects localization|decreases reaction|increases expression | 18508827 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A mRNA | increases expression | 15890375 14600272 |
| C507553 | 4'-O-methylalpinumisoflavone | 4'-O-methylalpinumisoflavone inhibits the reaction [Oxygen deficiency results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 19091749 |
| C494898 | 4-oxofenretinide | 4-oxofenretinide results in increased expression of CDKN1A protein | increases expression | 16540676 |
| C075773 | 4-phenylbutyric acid | [4-phenylbutyric acid co-treated with decitabine] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17210717 |
| C029728 | 4-phenylenediamine | 4-phenylenediamine results in increased expression of CDKN1A mRNA | increases expression | 16314067 |
| C439285 | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride promotes the reaction [3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 15475462 |
| C439285 | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride promotes the reaction [3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid results in increased expression of CDKN1A protein] | increases expression|increases reaction | 15475462 |
| C439285 | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride results in increased expression of CDKN1A mRNA | increases expression | 15475462 |
| C439285 | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride | (5-fluoro-2-methyl-1-(4-pyridyl)methylene-3-(N-benzyl)-indene)-acetamide hydrochloride results in increased expression of CDKN1A protein | increases expression | 15475462 |
| C471843 | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine results in increased expression of CDKN1A protein | increases expression | 15958644 |
| C054923 | 6-methyl-1,3,8-trichlorodibenzofuran | 6-methyl-1,3,8-trichlorodibenzofuran results in increased expression of CDKN1A protein | increases expression | 12203118 |
| C015008 | 8-azapurine | 8-azapurine analog results in increased expression of CDKN1A protein | increases expression | 15993080 |
| C111836 | 8-methyl-1,3,8-trichlorodibenzofuran | 8-methyl-1,3,8-trichlorodibenzofuran results in increased expression of CDKN1A protein | increases expression | 12203118 |
| C072876 | A 771726 | A 771726 results in increased expression of CDKN1A protein | increases expression | 12181422 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CDKN1A mRNA | affects expression | 11896290 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of CDKN1A mRNA | affects expression | 15606129 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of CDKN1A mRNA | increases expression | 11264010 18469330 19420014 12958197 |
| D000082 | Acetaminophen | SERPINE1 protein affects the reaction [Acetaminophen results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 18469330 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CDKN1A protein | decreases expression | 16330492 |
| D000082 | Acetaminophen | Chlormethiazole inhibits the reaction [Acetaminophen results in increased degradation of CDKN1A protein] | decreases reaction|increases degradation | 16330492 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of CDKN1A protein | decreases expression | 16330492 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [diaziquone results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 9343371 8943236 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [ethylenimine quinone results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 8943236 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15978937 |
| D000111 | Acetylcysteine | Acetylcysteine results in increased expression of CDKN1A protein | increases expression | 17602960 |
| D000111 | Acetylcysteine | Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 17602960 |
| D000181 | Acrylonitrile | Acrylonitrile results in increased expression of CDKN1A mRNA | increases expression | 10451498 |
| C096064 | actein | actein results in increased expression of CDKN1A protein | increases expression | 14758092 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of CDKN1A protein | affects expression | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of CDKN1A mRNA | increases expression | 15890375 14600272 |
| C103303 | alitretinoin | alitretinoin results in decreased expression of CDKN1A protein | decreases expression | 16340750 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone results in decreased expression of CDKN1A protein | decreases expression | 15322241 |
| C061133 | Am 80 | Am 80 results in increased expression of CDKN1A mRNA | increases expression | 17229644 |
| D009762 | o-Aminoazotoluene | o-Aminoazotoluene results in increased expression of CDKN1A mRNA | increases expression | 15346788 |
| D000499 | Allylamine | Allylamine results in increased expression of CDKN1A protein | increases expression | 15048878 |
| D000499 | Allylamine | pyrrolidine dithiocarbamic acid inhibits the reaction [Allylamine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15048878 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of CDKN1A mRNA | affects expression | 16483693 |
| D000643 | Ammonium Chloride | Ammonium Chloride results in increased expression of CDKN1A mRNA | increases expression | 12420312 |
| C054105 | ammonium trichloro(dioxoethylene-O,O'-)tellurate | ammonium trichloro(dioxoethylene-O,O'-)tellurate results in increased expression of CDKN1A protein | increases expression | 14656992 |
| C502471 | AN-7 phosphate cpd | AN-7 phosphate cpd results in increased expression of CDKN1A protein | increases expression | 16826403 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [arsenic trioxide results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 15961274 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [EGF protein results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 15961274 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of CDKN1A protein | increases expression | 16061660 |
| C432165 | anthra(1,9-cd)pyrazol-6(2H)-one | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Diethylnitrosamine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 19418558 |
| D000965 | Antimony | Antimony results in increased expression of CDKN1A mRNA | increases expression | 17547211 |
| D000966 | Antimony Potassium Tartrate | Antimony Potassium Tartrate results in increased expression of CDKN1A mRNA | increases expression | 17547211 |
| D047310 | Apigenin | Apigenin results in increased expression of CDKN1A mRNA | increases expression | 19397994 |
| D047310 | Apigenin | Apigenin results in increased expression of CDKN1A protein | increases expression | 19397994 16023288 11790449 |
| D047310 | Apigenin | TP53 protein affects the reaction [Apigenin results in increased expression of CDKN1A protein] | affects reaction|increases expression | 11790449 |
| D001151 | Arsenic | Arsenic results in increased expression of CDKN1A mRNA | increases expression | 11134558 |
| C006632 | arsenic trioxide | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [arsenic trioxide results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 15961274 |
| C006632 | arsenic trioxide | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [arsenic trioxide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15961274 |
| C006632 | arsenic trioxide | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [arsenic trioxide results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 15961274 |
| C006632 | arsenic trioxide | arsenic trioxide affects the expression of CDKN1A mRNA | affects expression | 18088464 12749819 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [CREBBP protein binds to CDKN1A promoter] | affects binding|increases reaction | 18822310 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [[CREBBP protein binds to CDKN1A promoter] which results in increased expression of CDKN1A mRNA] | affects binding|increases expression|increases reaction | 18822310 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [FOS protein binds to CDKN1A promoter] | affects binding|increases reaction | 18822310 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [[FOS protein binds to JUN promoter] which binds to CDKN1A promoter] | affects binding|increases reaction | 18822310 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [[FOS protein binds to JUN protein] which results in increased expression of CDKN1A mRNA] | affects binding|increases expression|increases reaction | 18822310 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [MAPK1 protein promotes the reaction [FOS protein binds to CDKN1A promoter]] | affects binding|increases reaction | 18822310 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [MAPK3 protein promotes the reaction [FOS protein binds to CDKN1A promoter]] | affects binding|increases reaction | 18822310 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [[TGIF1 protein co-treated with HDAC1 protein] binds to CDKN1A promoter] | affects binding|affects cotreatment|increases reaction | 18210215 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [[TGIF1 protein co-treated with HDAC1 protein] results in decreased expression of CDKN1A mRNA] | affects cotreatment|decreases expression|increases reaction | 18210215 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1A mRNA | increases expression | 15961274 19763917 20458559 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1A protein | increases expression | 19951532 15961274 20458559 |
| C006632 | arsenic trioxide | [arsenic trioxide results in increased phosphorylation of and results in increased activity of FOS protein] promotes the reaction [FOS protein binds to CDKN1A promoter] | affects binding|increases activity|increases phosphorylation|increases reaction | 18822310 |
| C006632 | arsenic trioxide | [arsenic trioxide results in increased phosphorylation of and results in increased activity of FOS protein] promotes the reaction [FOS protein results in increased expression of CDKN1A mRNA] | increases activity|increases expression|increases phosphorylation|increases reaction | 18822310 |
| C006632 | arsenic trioxide | [arsenic trioxide results in increased phosphorylation of and results in increased activity of JUN protein] which results in decreased expression of CDKN1A mRNA | decreases expression|increases activity|increases phosphorylation | 18822310 |
| C006632 | arsenic trioxide | [arsenic trioxide results in increased phosphorylation of JUN protein] which results in decreased expression of CDKN1A mRNA | decreases expression|increases phosphorylation | 18210215 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1A mRNA | increases expression | 15073043 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1A protein | increases expression | 15916724 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of CDKN1A mRNA | increases expression | 17487067 |
| C006632 | arsenic trioxide | pifithrin inhibits the reaction [arsenic trioxide results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17487067 |
| C015001 | arsenite | arsenite results in decreased expression of CDKN1A mRNA | decreases expression | 18191166 18929588 |
| C015001 | arsenite | arsenite results in decreased expression of CDKN1A protein | decreases expression | 16739126 |
| C015001 | arsenite | TRP53 protein affects the reaction [arsenite results in decreased expression of CDKN1A mRNA] | affects reaction|decreases expression | 18929588 |
| D001205 | Ascorbic Acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17917374 |
| D001241 | Aspirin | Aspirin results in decreased activity of CDKN1A protein | decreases activity | 15190207 |
| D001374 | Azacitidine | Azacitidine analog results in increased expression of CDKN1A protein | increases expression | 18324645 |
| D001374 | Azacitidine | Azacitidine results in increased expression of CDKN1A mRNA | increases expression | 15547111 |
| D001374 | Azacitidine | Azacitidine results in increased expression of CDKN1A protein | increases expression | 15547111 |
| D001374 | Azacitidine | [metacept-1 co-treated with Azacitidine] results in increased expression of CDKN1A | affects cotreatment|increases expression | 19148494 |
| D001374 | Azacitidine | pifithrin inhibits the reaction [Azacitidine results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 15547111 |
| D001374 | Azacitidine | pifithrin inhibits the reaction [Azacitidine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15547111 |
| D001374 | Azacitidine | [Azacitidine co-treated with N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 21224363 |
| D001374 | Azacitidine | Azacitidine results in increased expression of CDKN1A mRNA | increases expression | 21224363 |
| C517975 | AZD 6244 | AZD 6244 promotes the reaction [decitabine results in increased expression of CDKN1A] | increases expression|increases reaction | 19422044 |
| D001397 | Azoxymethane | [Azoxymethane co-treated with Sulindac] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 18644992 |
| D001554 | Benzene | Benzene results in increased expression of CDKN1A protein | increases expression | 20850422 |
| D001554 | Benzene | AHR protein affects the reaction [Benzene results in increased expression of CDKN1A protein] | affects reaction|increases expression | 12388843 |
| D001554 | Benzene | Benzene results in increased expression of CDKN1A mRNA | increases expression | 11896287 15935812 17157166 12857942 12615705 12655032 |
| D001554 | Benzene | Benzene results in increased expression of CDKN1A protein | increases expression | 12388843 17157166 18281070 11274754 |
| D001554 | Benzene | EPHX1 protein affects the reaction [Benzene results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 12655032 |
| D001554 | Benzene | TRP53 protein affects the reaction [Benzene results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 11896287 12857942 |
| D001554 | Benzene | TRP53 protein affects the reaction [Benzene results in increased expression of CDKN1A protein] | affects reaction|increases expression | 11274754 |
| D001554 | Benzene | TXN protein inhibits the reaction [Benzene results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17157166 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in decreased expression of CDKN1A mRNA | decreases expression | 19389873 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in decreased expression of CDKN1A protein | decreases expression | 19389873 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 18164116 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene affects the expression of CDKN1A mRNA | affects expression | 20624995 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased degradation of CDKN1A protein | decreases degradation | 15625077 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CDKN1A mRNA | increases expression | 19181443 20064835 15735009 18418871 20106945 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CDKN1A protein | increases expression | 11782367 15808406 15837074 20850422 |
| D001564 | Benzo(a)pyrene | Pravastatin inhibits the reaction [Benzo(a)pyrene results in decreased degradation of CDKN1A protein] | decreases degradation|decreases reaction | 15625077 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of CDKN1A protein | increases expression | 15459018 |
| D001564 | Benzo(a)pyrene | Tetrachlorodibenzodioxin inhibits the reaction [Benzo(a)pyrene results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15459018 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CDKN1A mRNA | increases expression | 20382639 17944540 19150397 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CDKN1A protein | increases expression | 11782367 18085531 |
| C004532 | benzoquinone | benzoquinone results in increased expression of CDKN1A mRNA | increases expression | 14976336 |
| C427308 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of CDKN1A protein] | decreases reaction|increases cleavage | 16777994 |
| D001599 | Berberine | Berberine results in increased expression of CDKN1A protein | increases expression | 16505103 |
| C020711 | beryllium sulfate | beryllium sulfate promotes the reaction [TP53 protein binds to CDKN1A promoter] | affects binding|increases reaction | 17395767 |
| C020711 | beryllium sulfate | beryllium sulfate results in increased expression of CDKN1A mRNA | increases expression | 17395767 |
| C020711 | beryllium sulfate | beryllium sulfate results in increased expression of CDKN1A protein | increases expression | 17395767 |
| C053541 | bicalutamide | bicalutamide results in increased expression of CDKN1A | increases expression | 11845989 |
| C053541 | bicalutamide | bicalutamide results in increased expression of CDKN1A mRNA | increases expression | 15638997 |
| C053541 | bicalutamide | bicalutamide results in increased expression of CDKN1A protein | increases expression | 15638997 |
| C004541 | biochanin A | biochanin A results in decreased expression of CDKN1A protein | decreases expression | 12111696 |
| C088060 | bisindolylmaleimide | bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15976015 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of CDKN1A mRNA | decreases expression | 16474171 |
| C006780 | bisphenol A | bisphenol A results in increased expression of CDKN1A mRNA | increases expression | 20826375 |
| C492810 | BL1521 | BL1521 results in increased expression of CDKN1A protein | increases expression | 15733867 |
| C400082 | bortezomib | [bortezomib co-treated with Butyrates] results in increased expression of and results in increased cleavage of CDKN1A protein | affects cotreatment|increases cleavage|increases expression | 12893773 |
| C400082 | bortezomib | [bortezomib co-treated with vorinostat] results in increased expression of and results in increased cleavage of CDKN1A protein | affects cotreatment|increases cleavage|increases expression | 12893773 |
| C400082 | bortezomib | bortezomib results in increased stability of CDKN1A protein | increases stability | 15543232 |
| C471992 | bosutinib | bosutinib results in increased expression of CDKN1A protein | increases expression | 17129604 |
| C099813 | bromochloroacetic acid | bromochloroacetic acid results in decreased expression of CDKN1A mRNA | decreases expression | 16460773 |
| D019819 | Budesonide | Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 12117777 |
| D019819 | Budesonide | Budesonide results in increased expression of CDKN1A mRNA | increases expression | 12117777 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 17602960 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 17602960 |
| D020122 | tert-Butylhydroperoxide | ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDKN1A protein] | affects expression|affects reaction | 15606011 |
| D020122 | tert-Butylhydroperoxide | Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 12782109 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of CDKN1A mRNA | increases expression | 15336504 12766906 12414654 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of CDKN1A protein | increases expression | 12782109 |
| C026105 | butylidenephthalide | butylidenephthalide results in increased expression of CDKN1A protein | increases expression | 16987298 |
| C026105 | butylidenephthalide | butylidenephthalide results in decreased expression of CDKN1A protein | decreases expression | 16987298 |
| D002087 | Butyrates | [bortezomib co-treated with Butyrates] results in increased expression of and results in increased cleavage of CDKN1A protein | affects cotreatment|increases cleavage|increases expression | 12893773 |
| D002087 | Butyrates | Butyrates results in increased expression of CDKN1A mRNA | increases expression | 16112107 16042588 17431121 |
| D002087 | Butyrates | Butyrates results in increased expression of CDKN1A protein | increases expression | 12893773 16007142 14707268 17431121 |
| D002087 | Butyrates | CDKN1A protein results in decreased susceptibility to Butyrates | decreases response to substance | 15942645 |
| D002087 | Butyrates | [Tretinoin co-treated with Butyrates] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 12130515 |
| D002087 | Butyrates | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 17431121 |
| D002087 | Butyrates | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1A protein] | increases expression|increases reaction | 17431121 |
| D002087 | Butyrates | Butyrates results in increased expression of CDKN1A mRNA | increases expression | 14674679 |
| D002087 | Butyrates | Butyrates results in increased expression of CDKN1A protein | increases expression | 15978324 |
| D020148 | Butyric Acid | Butyric Acid results in increased expression of CDKN1A protein | increases expression | 15715472 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in decreased expression of CDKN1A mRNA | decreases expression | 17481689 |
| D002104 | Cadmium | Cadmium results in increased expression of CDKN1A protein | increases expression | 14647439 |
| D002104 | Cadmium | PD 98059 inhibits the reaction [Cadmium results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 14647439 |
| D002104 | Cadmium | SB 203580 inhibits the reaction [Cadmium results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 14647439 |
| D002104 | Cadmium | Cadmium results in increased expression of CDKN1A protein | increases expression | 16730872 |
| D019256 | Cadmium Chloride | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 12634122 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of CDKN1A protein | increases expression | 16730872 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in increased expression of CDKN1A protein | increases expression | 16766008 |
| C055494 | caffeic acid phenethyl ester | Tretinoin promotes the reaction [caffeic acid phenethyl ester results in increased expression of CDKN1A protein] | increases expression|increases reaction | 16766008 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester results in increased expression of CDKN1A protein | increases expression | 15885897 |
| D002110 | Caffeine | Caffeine inhibits the reaction [Cytarabine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 17977830 |
| D002110 | Caffeine | Caffeine inhibits the reaction [decitabine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| D002110 | Caffeine | Caffeine inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18347191 |
| D002110 | Caffeine | Caffeine inhibits the reaction [N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| D002166 | Camptothecin | Camptothecin results in increased expression of CDKN1A protein | increases expression | 17555331 9673414 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CDKN1A mRNA | increases expression | 12759355 15056808 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of CDKN1A protein | increases expression | 12759355 |
| D002251 | Carbon Tetrachloride | CDKN1A protein affects the reaction [Carbon Tetrachloride affects the activity of CASP3 protein] | affects activity|affects reaction | 12759355 |
| D002251 | Carbon Tetrachloride | CDKN1A protein affects the reaction [Carbon Tetrachloride results in decreased expression of CYP2E1 mRNA] | affects reaction|decreases expression | 12759355 |
| D002251 | Carbon Tetrachloride | CDKN1A protein affects the reaction [Carbon Tetrachloride results in increased expression of CCNA2 mRNA] | affects reaction|increases expression | 12759355 |
| D002251 | Carbon Tetrachloride | CDKN1A protein affects the reaction [Carbon Tetrachloride results in increased phosphorylation of RB1 protein] | affects reaction|increases phosphorylation | 12759355 |
| D002251 | Carbon Tetrachloride | CDKN1B protein affects the reaction [Carbon Tetrachloride results in increased expression of CDKN1A protein] | affects reaction|increases expression | 12759355 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of CDKN1A mRNA | decreases expression | 17256749 |
| C111238 | carboxycinnamic acid bishydroxamide | carboxycinnamic acid bishydroxamide results in increased expression of CDKN1A protein | increases expression | 15897598 |
| D002330 | Carmustine | [Carmustine co-treated with O(6)-benzylguanine] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 15735757 |
| D002330 | Carmustine | Carmustine results in increased expression of CDKN1A protein | increases expression | 15735757 |
| C103436 | CB 1093 | CB 1093 results in decreased expression of CDKN1A protein | decreases expression | 12907249 |
| C105934 | celecoxib | celecoxib results in increased expression of CDKN1A protein | increases expression | 12960143 |
| C512273 | CGK 733 | CGK 733 inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18347191 |
| C006963 | chlamydocin | chlamydocin analog results in increased expression of CDKN1A protein | increases expression | 16439135 |
| D002699 | Chlorambucil | Chlorambucil results in increased expression of CDKN1A protein | increases expression | 16039525 |
| C023386 | chlorinated dibenzofurans | chlorinated dibenzofurans results in increased expression of CDKN1A protein | increases expression | 12203118 |
| D002713 | Chlorine | Chlorine results in increased expression of CDKN1A mRNA | increases expression | 18636392 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] affects the expression of CDKN1A mRNA | affects cotreatment|affects expression | 18636392 |
| D002719 | Chlormethiazole | Chlormethiazole inhibits the reaction [Acetaminophen results in increased degradation of CDKN1A protein] | decreases reaction|increases degradation | 16330492 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of CDKN1A mRNA | decreases expression | 17851650 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in increased expression of CDKN1A mRNA | increases expression | 16934159 |
| D002857 | Chromium | Chromium results in increased expression of CDKN1A mRNA | increases expression | 17547211 |
| C023600 | chromium oxide | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 12634122 |
| C017133 | chromous chloride | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 12634122 |
| C043561 | chrysin | chrysin results in increased expression of CDKN1A mRNA | increases expression | 19397994 |
| C043561 | chrysin | chrysin results in increased expression of CDKN1A protein | increases expression | 19397994 |
| D002939 | Ciprofloxacin | Ciprofloxacin results in decreased expression of CDKN1A | decreases expression | 12063570 |
| D002939 | Ciprofloxacin | Ciprofloxacin results in decreased expression of CDKN1A protein | decreases expression | 10741713 |
| D019343 | Citric Acid | [Citric Acid co-treated with zinc chloride] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 16624386 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of CDKN1A mRNA | increases expression | 16772336 |
| D003314 | Corn Oil | Corn Oil affects the expression of CDKN1A mRNA | affects expression | 16360708 |
| D003345 | Corticosterone | Corticosterone affects the expression of CDKN1A protein | affects expression | 12807724 |
| D003345 | Corticosterone | Corticosterone inhibits the reaction [CDKN1A protein binds to CDK4 protein] | affects binding|decreases reaction | 12807724 |
| D003345 | Corticosterone | Corticosterone promotes the reaction [CDKN1A protein binds to CDK2 protein] | affects binding|increases reaction | 12807724 |
| D003471 | Cuprizone | Cuprizone results in increased expression of CDKN1A mRNA | increases expression | 18550754 |
| D003474 | Curcumin | Curcumin results in decreased expression of CDKN1A protein | decreases expression | 17332326 17148446 18593936 |
| D003474 | Curcumin | [Curcumin results in decreased expression of MDM2 protein] which results in decreased expression of CDKN1A mRNA | decreases expression | 17332326 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1A mRNA | increases expression | 15713895 18316600 18161303 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1A protein | increases expression | 18316600 18161303 18156803 18226269 |
| D003474 | Curcumin | EGR1 protein affects the reaction [Curcumin results in increased expression of CDKN1A protein] | affects reaction|increases expression | 18316600 |
| D003474 | Curcumin | EGR1 protein promotes the reaction [Curcumin results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 18316600 |
| D003474 | Curcumin | MAPK1 protein affects the reaction [Curcumin results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 18316600 |
| D003474 | Curcumin | MAPK8 protein affects the reaction [Curcumin results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 18316600 |
| D003474 | Curcumin | TNFSF10 protein promotes the reaction [Curcumin results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18226269 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1A | increases expression | 15738001 |
| D003474 | Curcumin | Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 17602960 |
| D003474 | Curcumin | Curcumin results in increased expression of CDKN1A protein | increases expression | 17602960 18316600 |
| D003484 | Cyanamide | [Ethanol co-treated with Cyanamide] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 12003908 |
| C057862 | cyanoginosin LR | cyanoginosin LR results in increased expression of CDKN1A mRNA | increases expression | 17654400 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of CDKN1A mRNA | increases expression | 15331540 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of CDKN1A mRNA | increases expression | 20106945 |
| D003561 | Cytarabine | Caffeine inhibits the reaction [Cytarabine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 17977830 |
| D003561 | Cytarabine | Cytarabine results in increased expression of CDKN1A protein | increases expression | 17977830 |
| D018119 | Stavudine | Stavudine affects the expression of CDKN1A protein | affects expression | 18389896 |
| D003609 | Dactinomycin | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone inhibits the reaction [Dactinomycin results in increased expression of and affects the localization of CDKN1A protein] | affects localization|decreases reaction|increases expression | 12807743 |
| D003609 | Dactinomycin | Dactinomycin results in decreased expression of CDKN1A protein | decreases expression | 14601052 |
| D003609 | Dactinomycin | Dactinomycin results in increased expression of and affects the localization of CDKN1A protein | affects localization|increases expression | 12807743 |
| C004742 | daidzein | daidzein promotes the reaction [CDKN1A protein binds to CDK2 protein] | affects binding|increases reaction | 11322924 |
| C014347 | decitabine | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [decitabine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| C014347 | decitabine | [4-phenylbutyric acid co-treated with decitabine] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17210717 |
| C014347 | decitabine | AZD 6244 promotes the reaction [decitabine results in increased expression of CDKN1A] | increases expression|increases reaction | 19422044 |
| C014347 | decitabine | Caffeine inhibits the reaction [decitabine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| C014347 | decitabine | [decitabine affects the expression of DNMT3B protein] which affects the expression of CDKN1A mRNA | affects expression | 18544619 |
| C014347 | decitabine | [decitabine co-treated with trichostatin A] affects the expression of CDKN1A mRNA | affects cotreatment|affects expression | 17185465 |
| C014347 | decitabine | [decitabine co-treated with trichostatin A] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 17185465 |
| C014347 | decitabine | decitabine inhibits the reaction [HDAC1 protein binds to CDKN1A promoter] | affects binding|decreases reaction | 16043219 |
| C014347 | decitabine | decitabine promotes the reaction [TP53 protein modified form binds to CDKN1A promoter] | affects binding|increases reaction | 17977830 |
| C014347 | decitabine | decitabine results in decreased methylation of CDKN1A promoter | decreases methylation | 19234609 |
| C014347 | decitabine | decitabine results in increased expression of and affects the localization of CDKN1A protein | affects localization|increases expression | 17389721 |
| C014347 | decitabine | [decitabine results in increased expression of and affects the localization of CDKN1A protein] which results in increased activity of TP53 protein | affects localization|increases activity|increases expression | 17389721 |
| C014347 | decitabine | decitabine results in increased expression of CDKN1A | increases expression | 19422044 |
| C014347 | decitabine | decitabine results in increased expression of CDKN1A mRNA | increases expression | 16043219 18025290 17977830 18845559 |
| C014347 | decitabine | decitabine results in increased expression of CDKN1A protein | increases expression | 18223691 19234609 17417771 17977830 |
| C014347 | decitabine | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18223691 |
| C014347 | decitabine | Phenylbutyrates promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18223691 |
| C014347 | decitabine | pifithrin inhibits the reaction [decitabine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| C014347 | decitabine | PXD101 promotes the reaction [decitabine results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 19234609 |
| C014347 | decitabine | PXD101 promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 19234609 |
| C014347 | decitabine | TP53 protein affects the reaction [decitabine results in increased expression of CDKN1A protein] | affects reaction|increases expression | 18223691 |
| C014347 | decitabine | TP53 protein modified form affects the reaction [decitabine results in increased expression of CDKN1A protein] | affects reaction|increases expression | 17977830 |
| C014347 | decitabine | trichostatin A promotes the reaction [decitabine results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16043219 |
| C014347 | decitabine | trichostatin A promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18223691 |
| C014347 | decitabine | Valproic Acid promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18223691 |
| C014347 | decitabine | [decitabine co-treated with Valproic Acid] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 19155313 |
| D003676 | Deferoxamine | Deferoxamine results in decreased expression of CDKN1A protein | decreases expression | 12807743 |
| D003676 | Deferoxamine | Deferoxamine results in increased expression of CDKN1A mRNA | increases expression | 11468187 12807743 |
| C107676 | deguelin | deguelin metabolite results in decreased expression of CDKN1A protein | decreases expression | 19139008 |
| C107676 | deguelin | deguelin results in decreased expression of CDKN1A protein | decreases expression | 19139008 |
| D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in increased expression of CDKN1A mRNA | increases expression | 15752352 |
| D003687 | Dehydroepiandrosterone | Dehydroepiandrosterone results in increased expression of CDKN1A protein | increases expression | 16457693 |
| D013759 | Tetrahydrocannabinol | Tetrahydrocannabinol results in decreased expression of CDKN1A mRNA | decreases expression | 16039398 |
| C007262 | deoxynivalenol | deoxynivalenol results in decreased degradation of CDKN1A mRNA | decreases degradation | 18006205 |
| C007262 | deoxynivalenol | deoxynivalenol results in increased expression of CDKN1A protein | increases expression | 18006205 |
| C007262 | deoxynivalenol | U 0126 inhibits the reaction [deoxynivalenol results in decreased degradation of CDKN1A mRNA] | decreases degradation|decreases reaction | 18006205 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [CDK2 protein binds to CDKN1A protein] | affects binding|decreases reaction | 12800980 |
| D016190 | Carboplatin | Carboplatin results in increased expression of CDKN1A mRNA | increases expression | 18172885 |
| C038867 | diazene | diazene analog results in increased expression of CDKN1A | increases expression | 16061352 |
| C029108 | diaziquone | Acetylcysteine inhibits the reaction [diaziquone results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 9343371 8943236 |
| C029108 | diaziquone | diaziquone results in increased expression of CDKN1A mRNA | increases expression | 8943236 |
| C029108 | diaziquone | Dicumarol inhibits the reaction [diaziquone results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 9343371 |
| C029108 | diaziquone | [NQO1 protein results in increased metabolism of diaziquone] which results in increased expression of CDKN1A mRNA | increases expression|increases metabolic processing | 9343371 |
| C041517 | dibenzo(a,l)pyrene | dibenzo(a,l)pyrene results in increased expression of CDKN1A mRNA | increases expression | 15735009 |
| C061481 | dibenzoylmethane | dibenzoylmethane results in decreased expression of CDKN1A protein | decreases expression | 17942926 |
| D002945 | Cisplatin | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone inhibits the reaction [Cisplatin results in increased expression of and affects the localization of CDKN1A protein] | affects localization|decreases reaction|increases expression | 12807743 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of CDKN1A protein | decreases expression | 14601052 |
| D002945 | Cisplatin | Cisplatin results in increased expression of and affects the localization of CDKN1A protein | affects localization|increases expression | 12807743 |
| D002945 | Cisplatin | Cisplatin results in increased expression of CDKN1A mRNA | increases expression | 11099651 17355264 |
| D002945 | Cisplatin | Cisplatin results in increased expression of CDKN1A mRNA | increases expression | 18172885 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [diaziquone results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 9343371 |
| D001728 | Dicumarol | Dicumarol inhibits the reaction [RB1CC1 protein results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 16061648 |
| D019259 | Lamivudine | Lamivudine results in decreased expression of CDKN1A mRNA | decreases expression | 15784690 |
| D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 15784690 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of CDKN1A mRNA | decreases expression | 18042831 |
| C014476 | diethyl maleate | diethyl maleate results in increased expression of CDKN1A mRNA | increases expression | 11875189 |
| D004052 | Diethylnitrosamine | AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A mRNA] | decreases expression|decreases reaction | 19996281 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17917374 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of CDKN1A mRNA | decreases expression | 19996281 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CDKN1A mRNA | increases expression | 19100860 18282651 |
| D004052 | Diethylnitrosamine | RB1 protein promotes the reaction [Diethylnitrosamine results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 18282651 |
| D004052 | Diethylnitrosamine | 2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 17582756 |
| D004052 | Diethylnitrosamine | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [Diethylnitrosamine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 19418558 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of CDKN1A protein | affects cotreatment|affects expression|affects localization | 11003613 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 14633663 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 18164116 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 18544905 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of CDKN1A protein | decreases expression | 17582756 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of CDKN1A protein | increases expression | 19418558 19822196 |
| D004052 | Diethylnitrosamine | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 18253720 |
| D004052 | Diethylnitrosamine | IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA] | affects cotreatment|decreases expression|decreases reaction | 14633663 |
| D004052 | Diethylnitrosamine | pioglitazone inhibits the reaction [2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]] | decreases expression|decreases reaction | 17582756 |
| D004052 | Diethylnitrosamine | pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein] | decreases expression|increases reaction | 17582756 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CDKN1A mRNA | increases expression | 16636312 15545218 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of CDKN1A mRNA | increases expression | 15890375 |
| D002117 | Calcitriol | [Calcitriol co-treated with Genistein] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 15955619 |
| D002117 | Calcitriol | Calcitriol results in increased expression of CDKN1A mRNA | increases expression | 16434701 |
| D002117 | Calcitriol | Calcitriol results in increased expression of CDKN1A protein | increases expression | 16039115 |
| C444299 | diindolylmethane | diindolylmethane results in increased expression of CDKN1A protein | increases expression | 12203118 |
| C012920 | dimefox | dimefox results in decreased expression of CDKN1A mRNA | decreases expression | 18418871 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of CDKN1A mRNA | increases expression | 17547211 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in decreased expression of CDKN1A protein | decreases expression | 16155410 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of CDKN1A mRNA | increases expression | 14600272 15890375 |
| D004137 | Dinitrochlorobenzene | Dinitrochlorobenzene results in increased expression of CDKN1A mRNA | increases expression | 16314067 |
| C007517 | diphenyleneiodonium | diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15978937 |
| D004317 | Doxorubicin | 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15781256 |
| D004317 | Doxorubicin | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18347191 |
| D004317 | Doxorubicin | Caffeine inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18347191 |
| D004317 | Doxorubicin | CDC25C protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 19074854 |
| D004317 | Doxorubicin | CDKN1A affects the susceptibility to Doxorubicin | affects response to substance | 15492826 |
| D004317 | Doxorubicin | CDKN1A protein inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] | decreases reaction|increases activity | 16909308 |
| D004317 | Doxorubicin | CDKN1A protein results in decreased susceptibility to [Doxorubicin co-treated with TNF protein] | affects cotreatment|decreases response to substance | 15823547 |
| D004317 | Doxorubicin | CDKN1A protein results in increased susceptibility to Doxorubicin | increases response to substance | 15601469 |
| D004317 | Doxorubicin | CGK 733 inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18347191 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of CDKN1A protein | affects expression | 17893511 |
| D004317 | Doxorubicin | Doxorubicin affects the reaction [RELA protein binds to CDKN1A promoter] | affects binding|affects reaction | 18269916 |
| D004317 | Doxorubicin | Doxorubicin affects the reaction [RELA protein results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 18269916 |
| D004317 | Doxorubicin | [Doxorubicin co-treated with Paclitaxel] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 16168113 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [TP53 protein binds to CDKN1A promoter] | affects binding|increases reaction | 19351845 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of CDKN1A protein | decreases expression | 14601052 |
| D004317 | Doxorubicin | Doxorubicin results in increased activity of CDKN1A protein | increases activity | 15141020 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of CDKN1A mRNA | increases expression | 16439685 16705698 15205334 19351845 17653088 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of CDKN1A protein | increases expression | 15205334 15555623 17682292 18347191 16537896 19074854 15781256 17653088 15601469 14665630 17974990 |
| D004317 | Doxorubicin | FHL2 protein affects the reaction [Doxorubicin results in increased expression of CDKN1A protein] | affects reaction|increases expression | 17682292 |
| D004317 | Doxorubicin | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of CDKN1A protein] | affects cotreatment|increases expression|increases reaction | 16168113 |
| D004317 | Doxorubicin | [RELA protein affects the expression of CDKN1A protein] which affects the susceptibility to Doxorubicin | affects expression|affects response to substance | 18269916 |
| D004317 | Doxorubicin | RV 538 inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15781256 |
| D004317 | Doxorubicin | SPHK2 protein affects the reaction [Doxorubicin results in increased expression of CDKN1A protein] | affects reaction|increases expression | 17974990 |
| D004317 | Doxorubicin | tempol promotes the reaction [CDKN1A protein results in increased susceptibility to Doxorubicin] | increases reaction|increases response to substance | 15601469 |
| D004317 | Doxorubicin | TNF protein inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15823547 |
| D004317 | Doxorubicin | TP53 protein affects the reaction [Doxorubicin affects the reaction [RELA protein results in increased expression of CDKN1A mRNA]] | affects reaction|increases expression | 18269916 |
| D004317 | Doxorubicin | TP53 protein affects the reaction [Doxorubicin results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 17079232 |
| D004317 | Doxorubicin | TP53 protein affects the reaction [FHL2 protein affects the reaction [Doxorubicin results in increased expression of CDKN1A protein]] | affects reaction|increases expression | 17682292 |
| D004317 | Doxorubicin | TRIM28 protein modified form inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17079232 |
| D004317 | Doxorubicin | [Doxorubicin affects the reaction [TRP53 protein binds to HSPB1 protein]] which results in increased expression of CDKN1A protein | affects binding|affects reaction|increases expression | 18263706 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of CDKN1A mRNA | increases expression | 16432175 16013437 16949053 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of CDKN1A protein | increases expression | 16857806 |
| D004317 | Doxorubicin | TRP53 gene mutant form inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 16013437 |
| D004317 | Doxorubicin | [Doxorubicin affects the reaction [TP53 protein binds to HSPB1 protein]] which results in increased expression of CDKN1A protein | affects binding|affects reaction|increases expression | 18263706 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of CDKN1A protein | increases expression | 18031568 |
| C060327 | dracorhodin | dracorhodin analog results in increased expression of CDKN1A protein | increases expression | 15684474 |
| D004391 | Dust | Dust results in increased expression of CDKN1A mRNA | increases expression | 17805423 |
| C479799 | (E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide | (E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide results in increased expression of CDKN1A mRNA | increases expression | 15528975 |
| C045651 | epigallocatechin gallate | CDKN1A protein results in increased susceptibility to epigallocatechin gallate | increases response to substance | 15764647 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased expression of CDKN1A mRNA | decreases expression | 18851785 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of CDKN1A protein | increases expression | 15764647 |
| C045651 | epigallocatechin gallate | [Sulindac co-treated with epigallocatechin gallate] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 12628509 |
| D004958 | Estradiol | ESR2 protein affects the reaction [Estradiol results in decreased expression of CDKN1A mRNA] | affects reaction|decreases expression | 19434490 |
| D004958 | Estradiol | Estradiol affects the expression of CDKN1A mRNA | affects expression | 11896290 |
| D004958 | Estradiol | Estradiol promotes the reaction [ESR1 protein binds to CDKN1A promoter] | affects binding|increases reaction | 20696891 |
| D004958 | Estradiol | Estradiol promotes the reaction [NCOR1 protein binds to CDKN1A promoter] | affects binding|increases reaction | 20696891 |
| D004958 | Estradiol | Estradiol results in decreased expression of CDKN1A mRNA | decreases expression | 19434490 20696891 16474171 |
| D004958 | Estradiol | Estradiol results in decreased expression of CDKN1A protein | decreases expression | 12473173 15870704 |
| D004958 | Estradiol | Estradiol results in increased expression of CDKN1A mRNA | increases expression | 15757668 20106945 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 12473173 15870704 |
| D004958 | Estradiol | Tamoxifen inhibits the reaction [Estradiol results in decreased expression of CDKN1A mRNA] | decreases expression|decreases reaction | 19434490 |
| D004958 | Estradiol | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 12473173 |
| D004958 | Estradiol | Estradiol affects the expression of CDKN1A mRNA | affects expression | 15598610 |
| D004958 | Estradiol | Estradiol promotes the reaction [Lipopolysaccharides results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16977382 |
| D004958 | Estradiol | Estradiol results in increased expression of CDKN1A mRNA | increases expression | 17640349 20826375 |
| D000431 | Ethanol | [Ethanol co-treated with Cyanamide] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 12003908 |
| D000431 | Ethanol | Ethanol results in increased expression of CDKN1A mRNA | increases expression | 11181050 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of CDKN1A mRNA | affects expression | 14976129 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of CDKN1A mRNA | increases expression | 17555576 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17942748 |
| C009970 | ethylenimine quinone | Acetylcysteine inhibits the reaction [ethylenimine quinone results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 8943236 |
| C009970 | ethylenimine quinone | ethylenimine quinone results in increased expression of CDKN1A mRNA | increases expression | 8943236 9586815 9343371 |
| C009970 | ethylenimine quinone | ethylenimine quinone results in increased expression of CDKN1A protein | increases expression | 8943236 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased expression of CDKN1A mRNA | increases expression | 19100860 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased expression of CDKN1A mRNA | increases expression | 15954086 |
| D005047 | Etoposide | Etoposide results in increased expression of CDKN1A protein | increases expression | 14601052 |
| D011345 | Fenofibrate | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 18253720 |
| C013531 | ferric ammonium citrate | ferric ammonium citrate inhibits the reaction [2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 12807743 |
| C008169 | ferric oxide, saccharated | ferric oxide, saccharated results in increased expression of CDKN1A protein | increases expression | 16957011 |
| C004999 | ferulic acid | ferulic acid results in increased expression of CDKN1A protein | increases expression | 15486966 |
| C004999 | ferulic acid | ferulic acid results in increased expression of CDKN1A protein | increases expression | 15363954 |
| D005419 | Flavonoids | Flavonoids results in increased expression of CDKN1A mRNA | increases expression | 18035473 |
| C077990 | flavopiridol | [flavopiridol co-treated with gemcitabine] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 15770523 |
| C077990 | flavopiridol | flavopiridol results in increased expression of CDKN1A protein | increases expression | 15180955 |
| C024352 | fludarabine | fludarabine results in increased expression of CDKN1A mRNA | increases expression | 16439685 16439677 |
| D015073 | 2-Acetylaminofluorene | TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CDKN1A mRNA] | affects expression|affects reaction | 17317680 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 17582756 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of CDKN1A mRNA | increases expression | 17070881 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of CDKN1A protein | increases expression | 10708481 |
| D015073 | 2-Acetylaminofluorene | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of and affects the localization of CDKN1A protein | affects cotreatment|affects expression|affects localization | 11003613 |
| D015073 | 2-Acetylaminofluorene | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 14633663 |
| D015073 | 2-Acetylaminofluorene | IFNA1 protein inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CDKN1A mRNA] | affects cotreatment|decreases expression|decreases reaction | 14633663 |
| D015073 | 2-Acetylaminofluorene | pioglitazone inhibits the reaction [2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]] | decreases expression|decreases reaction | 17582756 |
| D005472 | Fluorouracil | CDKN1A affects the susceptibility to Fluorouracil | affects response to substance | 15067352 |
| D005472 | Fluorouracil | CDKN1A protein affects the susceptibility to Fluorouracil | affects response to substance | 15331170 |
| D005472 | Fluorouracil | CDKN1A protein results in decreased susceptibility to Fluorouracil | decreases response to substance | 16686938 |
| D005472 | Fluorouracil | CDKN1A protein results in increased susceptibility to Fluorouracil | increases response to substance | 15375580 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with Plant Extracts] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 18834353 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of CDKN1A protein] | affects cotreatment|increases expression|increases reaction | 16168113 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 15546879 |
| D005472 | Fluorouracil | Fluorouracil promotes the reaction [[TP53 protein binds to SP1 protein] which binds to CDKN1A promoter] | affects binding|increases reaction | 15489892 |
| D005472 | Fluorouracil | Fluorouracil results in decreased degradation of CDKN1A protein | decreases degradation | 15625077 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of CDKN1A mRNA | increases expression | 17355264 16434701 16584549 16557594 16709241 15331170 14665630 15205334 17039268 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of CDKN1A protein | increases expression | 14665630 19098008 16709241 17982676 15205334 15546879 17699798 15489892 |
| D005472 | Fluorouracil | [Leucovorin co-treated with Fluorouracil] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 15342418 |
| D005472 | Fluorouracil | mithramycin A inhibits the reaction [Fluorouracil results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15489892 |
| D005472 | Fluorouracil | Pravastatin inhibits the reaction [Fluorouracil results in decreased degradation of CDKN1A protein] | decreases degradation|decreases reaction | 15625077 |
| D005472 | Fluorouracil | Simvastatin inhibits the reaction [Fluorouracil results in decreased degradation of CDKN1A protein] | decreases degradation|decreases reaction | 15625077 |
| D005472 | Fluorouracil | TP53 protein affects the reaction [Fluorouracil results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 15016801 |
| D005472 | Fluorouracil | TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein]] | increases expression|increases reaction | 15546879 |
| D005472 | Fluorouracil | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16557594 |
| D005472 | Fluorouracil | TP53 protein promotes the reaction [Fluorouracil results in increased expression of CDKN1A protein] | increases expression|increases reaction | 17982676 15546879 17699798 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of CDKN1A mRNA | increases expression | 16949053 |
| D005492 | Folic Acid | Folic Acid affects the expression of CDKN1A mRNA | affects expression | 16361273 |
| D005492 | Folic Acid | Folic Acid affects the expression of CDKN1A protein | affects expression | 16361273 |
| D002955 | Leucovorin | [Leucovorin co-treated with Fluorouracil] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 15342418 |
| C096856 | FTI 277 | [Tamoxifen co-treated with FTI 277] promotes the reaction [CDKN1A protein binds to [CCNE1 protein binds to CDK2 protein]] | affects binding|affects cotreatment|increases reaction | 12866041 |
| C096856 | FTI 277 | [Tamoxifen co-treated with FTI 277] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 12866041 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [ESR1 protein binds to CDKN1A promoter] | affects binding|decreases reaction | 20696891 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 15870704 12473173 |
| C070081 | fulvestrant | fulvestrant results in increased expression of CDKN1A mRNA | increases expression | 20696891 |
| C056933 | fumonisin B1 | fumonisin B1 results in increased expression of CDKN1A mRNA | increases expression | 16221962 |
| C056507 | gemcitabine | [flavopiridol co-treated with gemcitabine] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 15770523 |
| C056507 | gemcitabine | gemcitabine results in increased expression of CDKN1A mRNA | increases expression | 17039268 |
| D019833 | Genistein | [Calcitriol co-treated with Genistein] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 15955619 |
| D019833 | Genistein | Genistein results in decreased expression of CDKN1A mRNA | decreases expression | 16474171 |
| D019833 | Genistein | Genistein results in decreased expression of CDKN1A protein | decreases expression | 17051425 |
| D019833 | Genistein | Genistein results in increased expression of CDKN1A mRNA | increases expression | 16865672 |
| D019833 | Genistein | Genistein results in increased expression of CDKN1A protein | increases expression | 11790449 16149052 11322924 12111696 |
| C035054 | ginsenoside Rg1 | ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDKN1A protein] | affects expression|affects reaction | 15606011 |
| D005938 | Glucocorticoids | Glucocorticoids results in increased expression of CDKN1A protein | increases expression | 15034294 |
| D019803 | Glutathione Disulfide | Glutathione Disulfide results in increased expression of CDKN1A protein | increases expression | 15993333 |
| D006427 | Hemin | Hemin results in increased expression of CDKN1A protein | increases expression | 14647439 |
| D006427 | Hemin | PD 98059 inhibits the reaction [Hemin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 14647439 |
| D006427 | Hemin | SB 203580 inhibits the reaction [Hemin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 14647439 |
| C014026 | hexamethylene bisacetamide | hexamethylene bisacetamide results in increased expression of CDKN1A mRNA | increases expression | 17349212 |
| C014026 | hexamethylene bisacetamide | [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 12130515 |
| D017313 | Fenretinide | Fenretinide results in increased expression of CDKN1A protein | increases expression | 16570282 16540676 |
| C403899 | HS 1030 | HS 1030 results in increased expression of CDKN1A protein | increases expression | 15202011 |
| C403900 | HS 1183 | HS 1183 promotes the reaction [CDKN1A protein binds to CDK2 protein] | affects binding|increases reaction | 12969788 |
| C403900 | HS 1183 | HS 1183 promotes the reaction [CDKN1A protein binds to PCNA protein] | affects binding|increases reaction | 12969788 |
| C403900 | HS 1183 | HS 1183 results in increased expression of CDKN1A mRNA | increases expression | 12969788 |
| C403900 | HS 1183 | HS 1183 results in increased expression of CDKN1A protein | increases expression | 15202011 12969788 |
| C503536 | HS-1199 | HS-1199 results in increased expression of CDKN1A protein | increases expression | 15202011 |
| C479128 | HS 1200 | HS 1200 promotes the reaction [CDKN1A protein binds to CDK2 protein] | affects binding|increases reaction | 12969788 |
| C479128 | HS 1200 | HS 1200 promotes the reaction [CDKN1A protein binds to PCNA protein] | affects binding|increases reaction | 12969788 |
| C479128 | HS 1200 | HS 1200 results in increased expression of CDKN1A mRNA | increases expression | 12969788 |
| C479128 | HS 1200 | HS 1200 results in increased expression of CDKN1A protein | increases expression | 15202011 12969788 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CDKN1A | increases expression | 18687144 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CDKN1A mRNA | increases expression | 17395767 12414654 8943236 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of CDKN1A protein | increases expression | 12479875 15242773 |
| D006861 | Hydrogen Peroxide | TP53 protein affects the reaction [Hydrogen Peroxide results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 8943236 |
| D006861 | Hydrogen Peroxide | SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 17108117 |
| D006918 | Hydroxyurea | Hydroxyurea results in increased expression of CDKN1A mRNA | increases expression | 16005713 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of CDKN1A mRNA | increases expression | 15099639 |
| D007052 | Ibuprofen | Ibuprofen results in increased expression of CDKN1A protein | increases expression | 15099639 |
| C016517 | indole-3-carbinol | indole-3-carbinol analog results in increased expression of CDKN1A protein | increases expression | 20570586 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of CDKN1A | increases expression | 16082211 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of CDKN1A mRNA | increases expression | 17311112 18025290 |
| D007213 | Indomethacin | Indomethacin promotes the reaction [CDKN1A protein results in decreased activity of CDK2 protein] | decreases activity|increases reaction | 14566837 |
| D007213 | Indomethacin | Indomethacin results in increased activity of CDKN1A protein | increases activity | 14566837 |
| D007213 | Indomethacin | Indomethacin results in increased expression of CDKN1A protein | increases expression | 15786552 |
| D007213 | Indomethacin | Indomethacin results in increased expression of CDKN1A protein | increases expression | 11170841 |
| C506002 | ircinin-1 | ircinin-1 results in increased expression of CDKN1A mRNA | increases expression | 16163705 |
| C506002 | ircinin-1 | ircinin-1 results in increased expression of CDKN1A protein | increases expression | 16163705 |
| C051890 | irinotecan | irinotecan affects the expression of CDKN1A protein | affects expression | 15132777 |
| D007501 | Iron | Iron results in increased expression of CDKN1A protein | increases expression | 16957011 |
| D007529 | Isoflavones | Isoflavones results in increased expression of CDKN1A mRNA | increases expression | 17374662 16365062 |
| D007529 | Isoflavones | Isoflavones results in increased expression of CDKN1A protein | increases expression | 17374662 |
| D007544 | Isopropyl Thiogalactoside | Isopropyl Thiogalactoside results in increased expression of CDKN1A protein | increases expression | 15190207 |
| C006552 | kaempferol | kaempferol results in increased expression of CDKN1A mRNA | increases expression | 19397994 |
| C006552 | kaempferol | kaempferol results in increased expression of CDKN1A protein | increases expression | 19397994 |
| D007654 | Ketoconazole | Ketoconazole results in increased expression of CDKN1A mRNA | increases expression | 16483768 |
| C074279 | KH 1060 | KH 1060 results in decreased expression of CDKN1A protein | decreases expression | 12907249 |
| C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17917374 |
| C011890 | kojic acid | [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 18544905 |
| C477361 | LAQ824 | [LAQ824 co-treated with Isotretinoin] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17237267 |
| C477361 | LAQ824 | [LAQ824 co-treated with Isotretinoin] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 17237267 |
| C477361 | LAQ824 | [LAQ824 co-treated with roscovitine] results in decreased expression of CDKN1A protein | affects cotreatment|decreases expression | 16275999 |
| C477361 | LAQ824 | LAQ824 results in increased expression of CDKN1A mRNA | increases expression | 17237267 |
| C477361 | LAQ824 | LAQ824 results in increased expression of CDKN1A protein | increases expression | 17237267 16189296 |
| C008261 | lead acetate | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 12634122 |
| D001556 | Lindane | Lindane results in increased expression of CDKN1A mRNA | increases expression | 14688026 |
| D001556 | Lindane | Lindane results in increased expression of CDKN1A protein | increases expression | 14688026 |
| D001556 | Lindane | Lindane results in increased expression of CDKN1A mRNA | increases expression | 17785943 |
| D008070 | Lipopolysaccharides | Estradiol promotes the reaction [Lipopolysaccharides results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16977382 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of CDKN1A mRNA | increases expression | 16977382 18550754 |
| D047311 | Luteolin | Luteolin results in increased expression of CDKN1A mRNA | increases expression | 19397994 |
| D047311 | Luteolin | Luteolin results in increased expression of CDKN1A protein | increases expression | 11790449 11322924 19397994 |
| C015329 | lycopene | lycopene inhibits the reaction [IGF1 protein results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 16565789 |
| C051883 | maxacalcitol | maxacalcitol results in increased expression of CDKN1A protein | increases expression | 16039115 |
| C527236 | metacept-1 | [metacept-1 co-treated with Azacitidine] results in increased expression of CDKN1A | affects cotreatment|increases expression | 19148494 |
| C527236 | metacept-1 | metacept-1 results in increased expression of CDKN1A | increases expression | 19148494 |
| D008701 | Methapyrilene | Methapyrilene results in increased expression of CDKN1A mRNA | increases expression | 15890375 |
| D008727 | Methotrexate | Methotrexate results in increased expression of CDKN1A protein | increases expression | 17637740 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of CDKN1A mRNA | increases expression | 15882963 |
| D008748 | Methylcholanthrene | SB 203580 inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 15882963 |
| C005223 | methyleugenol | methyleugenol results in increased expression of CDKN1A mRNA | increases expression | 15618236 |
| C008461 | methyl isocyanate | methyl isocyanate affects the expression of CDKN1A protein | affects expression | 19513903 |
| C020771 | methylmercury hydroxide | methylmercury hydroxide results in increased expression of CDKN1A mRNA | increases expression | 20493249 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate inhibits the reaction [TRIM28 protein binds to CDKN1A promoter] | affects binding|decreases reaction | 17079232 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate inhibits the reaction [ZNF350 protein binds to CDKN1A promoter] | affects binding|decreases reaction | 17079232 |
| D008741 | Methyl Methanesulfonate | TP53 protein affects the reaction [Methyl Methanesulfonate results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 17079232 |
| D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in decreased expression of CDKN1A mRNA | decreases expression | 12634122 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of CDKN1A mRNA | increases expression | 18593901 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in decreased expression of CDKN1A protein | decreases expression | 15581186 |
| C008480 | methylparaoxon | methylparaoxon results in increased expression of CDKN1A mRNA | increases expression | 18418871 |
| D008743 | Methyl Parathion | Methyl Parathion results in increased expression of CDKN1A mRNA | increases expression | 18418871 |
| C008493 | methylselenic acid | DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 16205645 |
| C008493 | methylselenic acid | DDIT3 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein] | affects reaction|increases expression | 16205645 |
| C008493 | methylselenic acid | HSPA5 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A protein] | affects reaction|increases expression | 16205645 |
| C008493 | methylselenic acid | KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 18314491 |
| C008493 | methylselenic acid | methylselenic acid affects the expression of CDKN1A mRNA | affects expression | 14617803 |
| C008493 | methylselenic acid | methylselenic acid promotes the reaction [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein] | affects binding|increases reaction | 17847021 |
| C008493 | methylselenic acid | methylselenic acid results in decreased activity of [CDKN1A protein binds to CDKN1B protein binds to CDK2 protein] | affects binding|decreases activity | 17847021 |
| C008493 | methylselenic acid | methylselenic acid results in increased expression of and results in decreased degradation of CDKN1A protein | decreases degradation|increases expression | 17847021 |
| C008493 | methylselenic acid | methylselenic acid results in increased expression of CDKN1A mRNA | increases expression | 18314491 12517777 |
| C008493 | methylselenic acid | methylselenic acid results in increased expression of CDKN1A protein | increases expression | 16205645 |
| C008493 | methylselenic acid | methylselenic acid affects the expression of CDKN1A protein | affects expression | 12017302 |
| C066851 | mithramycin A | mithramycin A inhibits the reaction [Fluorouracil results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15489892 |
| C066851 | mithramycin A | mithramycin A inhibits the reaction [SP1 protein binds to CDKN1A promoter] | affects binding|decreases reaction | 15489892 |
| C066851 | mithramycin A | mithramycin A inhibits the reaction [[TP53 protein binds to SP1 protein] which results in increased expression of CDKN1A mRNA] | affects binding|decreases reaction|increases expression | 15489892 |
| C020300 | monomethylarsonic acid | monomethylarsonic acid results in decreased expression of CDKN1A mRNA | decreases expression | 17481689 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of CDKN1A mRNA | increases expression | 15674843 |
| D009151 | Mustard Gas | Mustard Gas affects the expression of CDKN1A mRNA | affects expression | 15651846 |
| C040015 | myricetin | myricetin results in increased expression of CDKN1A mRNA | increases expression | 19397994 |
| C040015 | myricetin | myricetin results in increased expression of CDKN1A protein | increases expression | 19397994 |
| C514580 | N1-(2-aminophenyl)-N8-phenyloctanediamide | [N1-(2-aminophenyl)-N8-phenyloctanediamide co-treated with Tretinoin] results in increased expression of CDKN1A | affects cotreatment|increases expression | 17341627 |
| C514580 | N1-(2-aminophenyl)-N8-phenyloctanediamide | N1-(2-aminophenyl)-N8-phenyloctanediamide results in increased expression of CDKN1A protein | increases expression | 17341627 |
| C059685 | N(1),N(11)-diethylnorspermine | Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 15546879 |
| C059685 | N(1),N(11)-diethylnorspermine | N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein | increases expression | 15546879 |
| C059685 | N(1),N(11)-diethylnorspermine | TP53 protein promotes the reaction [Fluorouracil promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein]] | increases expression|increases reaction | 15546879 |
| C059685 | N(1),N(11)-diethylnorspermine | TP53 protein promotes the reaction [N(1),N(11)-diethylnorspermine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 15546879 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [TGFB1 protein results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 16361081 |
| C118739 | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| C118739 | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide | Caffeine inhibits the reaction [N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| C118739 | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18223691 |
| C118739 | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide results in increased expression of CDKN1A protein | increases expression | 18223691 |
| C118739 | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide | [Azacitidine co-treated with N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 21224363 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [CDKN1A protein results in decreased activity of CDK2 protein] | decreases activity|increases reaction | 14566837 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased activity of CDKN1A protein | increases activity | 14566837 |
| D019810 | Sodium Azide | Sodium Azide inhibits the reaction [2-butylamino-2-demethoxy-hypocrellin B results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17045927 |
| C115174 | netoglitazone | netoglitazone results in increased expression of CDKN1A protein | increases expression | 14977855 |
| C022838 | nickel chloride | nickel chloride results in increased expression of CDKN1A mRNA | increases expression | 17547211 |
| C022838 | nickel chloride | nickel chloride results in increased expression of CDKN1A mRNA | increases expression | 12839937 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of CDKN1A mRNA | increases expression | 16314067 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of CDKN1A mRNA | increases expression | 16100012 |
| D009538 | Nicotine | Nicotine results in increased expression of CDKN1A protein | increases expression | 16011614 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of CDKN1A mRNA | increases expression | 17616710 |
| C002741 | N-nitrosomorpholine | N-nitrosomorpholine results in increased expression of CDKN1A protein | increases expression | 10326863 |
| C482205 | nutlin 3 | nutlin 3 results in increased expression of CDKN1A mRNA | increases expression | 16439685 16439677 |
| C482205 | nutlin 3 | nutlin 3 results in increased expression of CDKN1A protein | increases expression | 16014563 19098008 16439685 |
| C482205 | nutlin 3 | TP53 protein affects the reaction [nutlin 3 results in increased expression of CDKN1A protein] | affects reaction|increases expression | 16439685 |
| C482205 | nutlin 3 | nutlin 3 results in increased expression of CDKN1A mRNA | increases expression | 16949053 |
| C064976 | O(6)-benzylguanine | [Carmustine co-treated with O(6)-benzylguanine] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 15735757 |
| C066515 | O-(chloroacetylcarbamoyl)fumagillol | O-(chloroacetylcarbamoyl)fumagillol results in increased expression of CDKN1A protein | increases expression | 15276080 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of CDKN1A mRNA | increases expression | 16251485 |
| D009828 | Oleanolic Acid | Oleanolic Acid results in increased expression of CDKN1A mRNA | increases expression | 18706400 |
| C475587 | olomoucine II | olomoucine II results in increased expression of CDKN1A protein | increases expression | 16003486 |
| C030110 | oxaliplatin | oxaliplatin results in increased expression of CDKN1A protein | increases expression | 16227409 |
| C030110 | oxaliplatin | TP53 protein promotes the reaction [oxaliplatin results in increased expression of CDKN1A protein] | increases expression|increases reaction | 16227409 |
| D010076 | Oxazepam | Oxazepam results in increased expression of CDKN1A mRNA | increases expression | 15618236 |
| D010100 | Oxygen | 4'-O-methylalpinumisoflavone inhibits the reaction [Oxygen deficiency results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 19091749 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of CDKN1A protein | increases expression | 10951577 |
| D010100 | Oxygen | Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 19091749 |
| D010126 | Ozone | Ozone results in increased expression of CDKN1A mRNA | increases expression | 17460151 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] affects the expression of CDKN1A mRNA | affects cotreatment|affects expression | 18636392 |
| D017239 | Paclitaxel | [Doxorubicin co-treated with Paclitaxel] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 16168113 |
| D017239 | Paclitaxel | Fluorouracil promotes the reaction [[Doxorubicin co-treated with Paclitaxel] results in increased expression of CDKN1A protein] | affects cotreatment|increases expression|increases reaction | 16168113 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of CDKN1A protein | increases expression | 18516295 |
| D017239 | Paclitaxel | [PD168393 co-treated with Paclitaxel] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 16413505 |
| D017239 | Paclitaxel | pifithrin inhibits the reaction [Paclitaxel results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18516295 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of CDKN1A mRNA | increases expression | 12929121 |
| C041786 | palm oil | palm oil results in decreased expression of CDKN1A mRNA | decreases expression | 18042831 |
| C055778 | panaxydol | panaxydol results in increased expression of CDKN1A mRNA | increases expression | 19450571 |
| C055778 | panaxydol | panaxydol results in increased expression of CDKN1A protein | increases expression | 19450571 |
| D010269 | Paraquat | Paraquat results in increased expression of CDKN1A mRNA | increases expression | 12595580 |
| D052638 | Particulate Matter | Particulate Matter results in increased activity of CDKN1A protein | increases activity | 20850422 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of CDKN1A protein | increases expression | 20850422 |
| C509204 | PD168393 | [PD168393 co-treated with Paclitaxel] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 16413505 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Cadmium results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 14647439 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Hemin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 14647439 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15978937 |
| C074968 | pentaacetyl geniposide | pentaacetyl geniposide results in increased expression of CDKN1A | increases expression | 15975050 |
| D010424 | Pentobarbital | Pentobarbital results in decreased expression of CDKN1A mRNA | decreases expression | 16978161 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of CDKN1A mRNA | increases expression | 18467677 |
| C023036 | perfluorooctanoic acid | PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 18467677 |
| D010634 | Phenobarbital | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CDKN1A mRNA] | affects reaction|increases expression | 19482888 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of CDKN1A mRNA | increases expression | 19482888 |
| D010654 | Phenylbutyrates | Phenylbutyrates promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18223691 |
| D010654 | Phenylbutyrates | Phenylbutyrates promotes the reaction [IFNG protein results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 10866311 |
| D010654 | Phenylbutyrates | Phenylbutyrates results in increased expression of CDKN1A mRNA | increases expression | 10866311 16875574 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of CDKN1A mRNA | increases expression | 10766810 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of CDKN1A protein | increases expression | 10766810 |
| D010656 | Phenylephrine | Phenylephrine results in increased stability of CDKN1A mRNA | increases stability | 10766810 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of CDKN1A | increases expression | 15603588 |
| D010672 | Phenytoin | Phenytoin results in decreased expression of CDKN1A mRNA | decreases expression | 14741686 |
| C121565 | pifithrin | pifithrin inhibits the reaction [Azacitidine results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 15547111 |
| C121565 | pifithrin | pifithrin inhibits the reaction [Azacitidine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15547111 |
| C121565 | pifithrin | pifithrin inhibits the reaction [decitabine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18223691 |
| C121565 | pifithrin | pifithrin inhibits the reaction [Paclitaxel results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18516295 |
| C121565 | pifithrin | pifithrin results in decreased expression of CDKN1A protein | decreases expression | 12893085 |
| C121565 | pifithrin | pifithrin inhibits the reaction [Vanadates results in increased activity of CDKN1A protein] | decreases reaction|increases activity | 11931974 |
| C121565 | pifithrin | pifithrin results in decreased expression of CDKN1A mRNA | decreases expression | 12413886 |
| C121565 | pifithrin | TRP53 protein affects the reaction [pifithrin results in decreased expression of CDKN1A mRNA] | affects reaction|decreases expression | 12413886 |
| C121565 | pifithrin | pifithrin inhibits the reaction [arsenic trioxide results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17487067 |
| C121565 | pifithrin | pifithrin inhibits the reaction [TP53 protein results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15144874 |
| C060836 | pioglitazone | pioglitazone results in decreased expression of CDKN1A protein | decreases expression | 15729575 |
| C060836 | pioglitazone | pioglitazone inhibits the reaction [2-Acetylaminofluorene inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein]] | decreases expression|decreases reaction | 17582756 |
| C060836 | pioglitazone | pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1A protein] | decreases expression|increases reaction | 17582756 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of CDKN1A mRNA | increases expression | 15890375 |
| C006253 | pirinixic acid | pirinixic acid affects the expression of CDKN1A mRNA | affects expression | 17950772 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of CDKN1A mRNA | increases expression | 18445702 16985257 20059764 18467677 18301758 |
| C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 18467677 20059764 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of CDKN1A mRNA | increases expression | 15890375 |
| D010936 | Plant Extracts | [Fluorouracil co-treated with Plant Extracts] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 18834353 |
| D010936 | Plant Extracts | Plant Extracts affects the expression of CDKN1A mRNA | affects expression | 12878215 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of CDKN1A protein | increases expression | 15327971 |
| D028321 | Plant Preparations | Plant Preparations affects the expression of CDKN1A mRNA | affects expression | 16046712 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in decreased expression of CDKN1A mRNA | decreases expression | 16474171 |
| D011084 | Polycyclic Hydrocarbons, Aromatic | Polycyclic Hydrocarbons, Aromatic results in increased expression of CDKN1A mRNA | increases expression | 16002475 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of CDKN1A mRNA | increases expression | 17547211 |
| D017035 | Pravastatin | Pravastatin inhibits the reaction [Benzo(a)pyrene results in decreased degradation of CDKN1A protein] | decreases degradation|decreases reaction | 15625077 |
| D017035 | Pravastatin | Pravastatin inhibits the reaction [Fluorouracil results in decreased degradation of CDKN1A protein] | decreases degradation|decreases reaction | 15625077 |
| D011241 | Prednisone | Prednisone results in increased expression of CDKN1A protein | increases expression | 15034294 |
| D011374 | Progesterone | Progesterone results in increased expression of CDKN1A protein | increases expression | 18045962 |
| C487081 | PXD101 | PXD101 promotes the reaction [decitabine results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 19234609 |
| C487081 | PXD101 | PXD101 promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 19234609 |
| C487081 | PXD101 | PXD101 results in increased expression of CDKN1A mRNA | increases expression | 19606018 |
| C487081 | PXD101 | PXD101 results in increased expression of CDKN1A protein | increases expression | 19234609 |
| C031280 | pyrazole | pyrazole results in increased expression of CDKN1A mRNA | increases expression | 17945193 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Allylamine results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15048878 |
| D011794 | Quercetin | Quercetin affects the expression of CDKN1A | affects expression | 16059641 |
| D011794 | Quercetin | [Quercetin co-treated with TNF protein] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 12589822 |
| D011794 | Quercetin | Quercetin metabolite results in increased expression of CDKN1A protein | increases expression | 16280456 |
| D011794 | Quercetin | Quercetin promotes the reaction [CDKN1A protein binds to CCNE1 protein] | affects binding|increases reaction | 12934110 |
| D011794 | Quercetin | Quercetin promotes the reaction [CDKN1A protein binds to CDK2 protein] | affects binding|increases reaction | 11322924 |
| D011794 | Quercetin | Quercetin results in increased expression of CDKN1A mRNA | increases expression | 12934110 19397994 18323654 14715546 |
| D011794 | Quercetin | Quercetin results in increased expression of CDKN1A protein | increases expression | 11322924 12934110 16049707 19009557 19397994 |
| D011794 | Quercetin | Quercetin results in increased stability of CDKN1A protein | increases stability | 12934110 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Streptozocin results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 19496084 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TRP53 protein results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 18813348 |
| D011794 | Quercetin | Quercetin results in increased expression of CDKN1A mRNA | increases expression | 14757127 |
| C037219 | quinoline | quinoline analog results in increased expression of CDKN1A protein | increases expression | 18645022 |
| C037219 | quinoline | [quinoline analog results in increased expression of TP53 protein] which results in increased expression of CDKN1A protein | increases expression | 18645022 |
| D020849 | Raloxifene | Raloxifene results in increased expression of CDKN1A mRNA | increases expression | 16497877 |
| D020849 | Raloxifene | Raloxifene results in increased expression of CDKN1A protein | increases expression | 16497877 |
| C059514 | resveratrol | resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK2 protein]] | affects binding|increases reaction | 16317118 |
| C059514 | resveratrol | resveratrol promotes the reaction [TNF promotes the reaction [CDKN1A protein binds to CDK4 protein]] | affects binding|increases reaction | 16317118 |
| C059514 | resveratrol | resveratrol promotes the reaction [TNF protein results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16317118 |
| C059514 | resveratrol | resveratrol promotes the reaction [TNF protein results in increased expression of CDKN1A protein] | increases expression|increases reaction | 16317118 |
| C059514 | resveratrol | resveratrol results in decreased expression of CDKN1A | decreases expression | 15583814 |
| C059514 | resveratrol | resveratrol results in increased expression of CDKN1A mRNA | increases expression | 17261084 16761963 17174366 17868649 16624241 |
| C059514 | resveratrol | resveratrol results in increased expression of CDKN1A protein | increases expression | 16761963 17804756 17050787 |
| C059514 | resveratrol | Thyroxine inhibits the reaction [resveratrol results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17174366 |
| C059514 | resveratrol | resveratrol affects the expression of CDKN1A protein | affects expression | 16369916 |
| C059514 | resveratrol | resveratrol results in increased expression of CDKN1A mRNA | increases expression | 16369916 |
| D015474 | Isotretinoin | Isotretinoin results in increased expression of CDKN1A protein | increases expression | 16575387 |
| D015474 | Isotretinoin | [LAQ824 co-treated with Isotretinoin] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17237267 |
| D015474 | Isotretinoin | [LAQ824 co-treated with Isotretinoin] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 17237267 |
| C087123 | romidepsin | romidepsin promotes the reaction [Tretinoin results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16223781 |
| C087123 | romidepsin | romidepsin results in increased expression of CDKN1A mRNA | increases expression | 16223781 |
| C087123 | romidepsin | romidepsin results in increased expression of CDKN1A protein | increases expression | 15849726 17230511 |
| C104586 | roscovitine | [LAQ824 co-treated with roscovitine] results in decreased expression of CDKN1A protein | affects cotreatment|decreases expression | 16275999 |
| C104586 | roscovitine | roscovitine promotes the reaction [CDKN1A protein results in increased susceptibility to ZD 9331] | increases reaction|increases response to substance | 15342418 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of CDKN1A protein | decreases expression | 15729575 |
| D012402 | Rotenone | Rotenone inhibits the reaction [Oxygen deficiency results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 19091749 |
| C085746 | rottlerin | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15976015 |
| C033110 | RV 538 | RV 538 inhibits the reaction [Doxorubicin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15781256 |
| C064116 | S-(1,1,2,2-tetrafluoroethyl)cysteine | S-(1,1,2,2-tetrafluoroethyl)cysteine results in increased expression of CDKN1A mRNA | increases expression | 16678137 |
| C005705 | sanguinarine | sanguinarine results in increased expression of CDKN1A protein | increases expression | 15981203 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Cadmium results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 14647439 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Hemin results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 14647439 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein] | affects cotreatment|decreases reaction|increases expression | 19082730 |
| C093642 | SB 203580 | [Selenium co-treated with SB 203580] results in decreased expression of CDKN1A protein | affects cotreatment|decreases expression | 18583539 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Hydrogen Peroxide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 17108117 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 15882963 |
| C417521 | SB 216763 | SB 216763 results in increased expression of CDKN1A protein | increases expression | 15958644 |
| D012643 | Selenium | [Selenium co-treated with SB 203580] results in decreased expression of CDKN1A protein | affects cotreatment|decreases expression | 18583539 |
| D012643 | Selenium | Selenium results in decreased expression of CDKN1A protein | decreases expression | 18583539 |
| C078903 | seocalcitol | seocalcitol results in decreased expression of CDKN1A protein | decreases expression | 12907249 |
| C078903 | seocalcitol | seocalcitol results in increased expression of CDKN1A protein | increases expression | 16340750 |
| C016101 | shikonin | shikonin results in increased expression of CDKN1A protein | increases expression | 16061028 |
| C440975 | silybin | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of CDKN1A protein] | decreases reaction|increases cleavage | 16777994 |
| C440975 | silybin | silybin results in increased cleavage of CDKN1A protein | increases cleavage | 16777994 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [Fluorouracil results in decreased degradation of CDKN1A protein] | decreases degradation|decreases reaction | 15625077 |
| C497103 | SK-7041 | SK-7041 results in increased expression of CDKN1A protein | increases expression | 16009488 |
| C118258 | SN50 peptide | SN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18508827 |
| C017947 | sodium arsenite | ATM gene mutant form inhibits the reaction [sodium arsenite results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 11507245 |
| C017947 | sodium arsenite | CDKN1A protein affects the susceptibility to sodium arsenite | affects response to substance | 20000476 |
| C017947 | sodium arsenite | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein] | affects cotreatment|decreases reaction|increases expression | 19082730 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 12634122 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 19082730 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CDKN1A mRNA | decreases expression | 20036271 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CDKN1A protein | decreases expression | 20036271 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CDKN1A mRNA | increases expression | 12377979 12760830 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CDKN1A protein | increases expression | 11813266 11507245 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of CDKN1A protein | increases expression | 18996350 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CDKN1A mRNA | decreases expression | 16876216 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of CDKN1A protein | decreases expression | 16876216 |
| D012980 | Sodium Salicylate | Sodium Salicylate results in decreased activity of CDKN1A protein | decreases activity | 15190207 |
| C530804 | S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea | S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea results in increased expression of CDKN1A protein | increases expression | 19497413 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15978937 |
| D013311 | Streptozocin | Quercetin inhibits the reaction [Streptozocin results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 19496084 |
| D013311 | Streptozocin | Streptozocin results in increased expression of CDKN1A mRNA | increases expression | 19496084 |
| C013690 | styrene oxide | styrene oxide affects the expression of CDKN1A mRNA | affects expression | 11230554 |
| C016766 | sulforafan | sulforafan results in increased expression of CDKN1A protein | increases expression | 15231455 |
| D013467 | Sulindac | CDKN1A protein promotes the reaction [Sulindac results in increased expression of and results in increased phosphorylation of MAPK8 protein] | increases expression|increases phosphorylation|increases reaction | 17292881 |
| D013467 | Sulindac | CSK protein affects the reaction [Sulindac results in increased expression of CDKN1A protein] | affects reaction|increases expression | 18644992 |
| D013467 | Sulindac | [Sulindac co-treated with epigallocatechin gallate] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 12628509 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of APP mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of CTSB mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GBA mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of GRN mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of IL32 mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of ITGB3 mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3BP mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SAA1 mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SHC1 mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of SOD2 mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of TGM2 mRNA] | decreases reaction|increases expression | 15190207 |
| D013467 | Sulindac | Sulindac promotes the reaction [CDKN1A protein results in decreased activity of CDK2 protein] | decreases activity|increases reaction | 14566837 |
| D013467 | Sulindac | Sulindac results in decreased activity of CDKN1A protein | decreases activity | 15190207 |
| D013467 | Sulindac | Sulindac results in increased activity of CDKN1A protein | increases activity | 14566837 |
| D013467 | Sulindac | Sulindac results in increased expression of CDKN1A mRNA | increases expression | 11507085 |
| D013467 | Sulindac | Sulindac results in increased expression of CDKN1A protein | increases expression | 17292881 18644992 18291362 |
| D013467 | Sulindac | CDKN1A protein results in increased susceptibility to Sulindac | increases response to substance | 15688007 11507085 |
| D013467 | Sulindac | Sulindac results in increased expression of CDKN1A mRNA | increases expression | 16230399 17292881 15688007 |
| D013467 | Sulindac | Sulindac results in increased expression of CDKN1A protein | increases expression | 15688007 |
| D013467 | Sulindac | [Azoxymethane co-treated with Sulindac] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 18644992 |
| C025462 | sulindac sulfide | PPARD protein inhibits the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 16091736 |
| C025462 | sulindac sulfide | PPARG protein promotes the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16091736 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased expression of CDKN1A mRNA | increases expression | 16184548 16091736 |
| C025462 | sulindac sulfide | sulindac sulfide results in increased expression of CDKN1A protein | increases expression | 15767558 |
| C025462 | sulindac sulfide | sulindac sulfide affects the activity of CDKN1A protein | affects activity | 15694660 |
| C025463 | sulindac sulfone | sulindac sulfone results in increased expression of CDKN1A mRNA | increases expression | 18593937 |
| C025463 | sulindac sulfone | sulindac sulfone results in increased expression of CDKN1A protein | increases expression | 18593937 |
| D014284 | Triiodothyronine | Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 14761676 |
| D014284 | Triiodothyronine | [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 14761676 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of CDKN1A mRNA | increases expression | 14761676 |
| D013974 | Thyroxine | Thyroxine inhibits the reaction [resveratrol results in increased expression of CDKN1A mRNA] | decreases reaction|increases expression | 17174366 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with FTI 277] promotes the reaction [CDKN1A protein binds to [CCNE1 protein binds to CDK2 protein]] | affects binding|affects cotreatment|increases reaction | 12866041 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with FTI 277] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 12866041 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [ESR1 protein binds to CDKN1A promoter] | affects binding|decreases reaction | 20696891 |
| D013629 | Tamoxifen | Tamoxifen inhibits the reaction [Estradiol results in decreased expression of CDKN1A mRNA] | decreases expression|decreases reaction | 19434490 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of CDKN1A mRNA | increases expression | 20696891 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of CDKN1A protein | increases expression | 20549698 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of CDKN1A mRNA | increases expression | 17555576 |
| C021751 | tanshinone | tanshinone results in increased expression of CDKN1A mRNA | increases expression | 15849732 |
| C508490 | TDP 521252 | TDP 521252 results in increased expression of CDKN1A mRNA | increases expression | 16432175 |
| C508490 | TDP 521252 | TDP 521252 results in increased expression of CDKN1A protein | increases expression | 16432175 |
| C508491 | TDP 665759 | TDP 665759 results in increased expression of CDKN1A mRNA | increases expression | 16432175 |
| C001803 | tempol | tempol promotes the reaction [CDKN1A protein results in increased susceptibility to Doxorubicin] | increases reaction|increases response to substance | 15601469 |
| C001803 | tempol | tempol results in increased expression of CDKN1A protein | increases expression | 15601469 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 12473173 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [Triiodothyronine results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 14761676 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CDKN1A mRNA | decreases expression | 16039398 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CDKN1A protein | decreases expression | 15322241 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CDKN1A mRNA | increases expression | 15056799 20106945 15345368 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CDKN1A protein | increases expression | 12203118 |
| D013749 | Tetrachlorodibenzodioxin | [Triiodothyronine co-treated with Tetrachlorodibenzodioxin] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 14761676 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of CDKN1A mRNA | affects expression | 18691609 18343893 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin binds to AHR protein] which binds to CDKN1A promoter | affects binding | 14718646 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of CDKN1A mRNA | decreases expression | 17586704 15667827 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of CDKN1A mRNA | increases expression | 15328365 14718646 17035482 17942748 12167310 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin inhibits the reaction [Benzo(a)pyrene results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15459018 |
| D013755 | Tetradecanoylphorbol Acetate | Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15978937 |
| D013755 | Tetradecanoylphorbol Acetate | bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15976015 |
| D013755 | Tetradecanoylphorbol Acetate | diphenyleneiodonium inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15978937 |
| D013755 | Tetradecanoylphorbol Acetate | PD 98059 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15978937 |
| D013755 | Tetradecanoylphorbol Acetate | rottlerin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15976015 |
| D013755 | Tetradecanoylphorbol Acetate | Staurosporine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 15978937 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate promotes the reaction [SP1 protein binds to CDKN1A promoter] | affects binding|increases reaction | 15978937 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CDKN1A mRNA | increases expression | 15978937 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of CDKN1A protein | increases expression | 18223691 15976015 15978937 |
| C026995 | thallium acetate | thallium acetate results in increased expression of CDKN1A protein | increases expression | 15965099 |
| D013876 | Thiophenes | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of CDKN1A protein] | increases expression|increases reaction | 16140954 |
| D014108 | Tosylphenylalanyl Chloromethyl Ketone | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of CDKN1A protein | increases expression | 12821135 |
| D014112 | Toxaphene | Toxaphene results in decreased expression of CDKN1A protein | decreases expression | 12473173 |
| C496197 | trans-10,cis-12-conjugated linoleic acid | trans-10,cis-12-conjugated linoleic acid results in increased expression of CDKN1A mRNA | increases expression | 17951470 |
| D014212 | Tretinoin | [N1-(2-aminophenyl)-N8-phenyloctanediamide co-treated with Tretinoin] results in increased expression of CDKN1A | affects cotreatment|increases expression | 17341627 |
| D014212 | Tretinoin | romidepsin promotes the reaction [Tretinoin results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16223781 |
| D014212 | Tretinoin | Thiophenes analog promotes the reaction [Tretinoin results in increased expression of CDKN1A protein] | increases expression|increases reaction | 16140954 |
| D014212 | Tretinoin | [Tretinoin binds to and affects the activity of RARA protein] which results in increased activity of CDKN1A protein | affects activity|affects binding|increases activity | 16765349 |
| D014212 | Tretinoin | [Tretinoin co-treated with Butyrates] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 12130515 |
| D014212 | Tretinoin | [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 12130515 |
| D014212 | Tretinoin | [Tretinoin co-treated with TGFB1 protein] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 16242776 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [Butyrates results in increased expression of CDKN1A protein] | increases expression|increases reaction | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [caffeic acid phenethyl ester results in increased expression of CDKN1A protein] | increases expression|increases reaction | 16766008 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1A protein] | increases expression|increases reaction | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [vorinostat results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 17431121 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [vorinostat results in increased expression of CDKN1A protein] | increases expression|increases reaction | 17431121 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CDKN1A mRNA | increases expression | 16223781 17138961 12130515 17349212 |
| D014212 | Tretinoin | Tretinoin results in increased expression of CDKN1A protein | increases expression | 16461808 16766008 16140954 15695403 17431121 16752155 16765349 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of CDKN1A protein | decreases expression | 15949692 |
| C012589 | trichostatin A | [decitabine co-treated with trichostatin A] affects the expression of CDKN1A mRNA | affects cotreatment|affects expression | 17185465 |
| C012589 | trichostatin A | [decitabine co-treated with trichostatin A] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 17185465 |
| C012589 | trichostatin A | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 17431121 |
| C012589 | trichostatin A | Tretinoin promotes the reaction [trichostatin A results in increased expression of CDKN1A protein] | increases expression|increases reaction | 17431121 |
| C012589 | trichostatin A | [trichostatin A affects the expression of DNMT3B protein] which affects the expression of CDKN1A mRNA | affects expression | 18544619 |
| C012589 | trichostatin A | trichostatin A promotes the reaction [decitabine results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 16043219 |
| C012589 | trichostatin A | trichostatin A promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18223691 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CDKN1A mRNA | increases expression | 17431121 19606018 16865256 |
| C012589 | trichostatin A | trichostatin A results in increased expression of CDKN1A protein | increases expression | 16051188 18223691 15179185 17230511 16009488 17431121 19234609 |
| C057693 | troglitazone | troglitazone results in decreased expression of CDKN1A protein | decreases expression | 15729575 |
| C102210 | TT 232 | TT 232 results in increased expression of CDKN1A | increases expression | 12556972 |
| C113580 | U 0126 | U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 18508827 |
| C113580 | U 0126 | U 0126 inhibits the reaction [deoxynivalenol results in decreased degradation of CDKN1A mRNA] | decreases degradation|decreases reaction | 18006205 |
| D014520 | Urethane | Urethane results in decreased expression of CDKN1A mRNA | decreases expression | 12117781 |
| D014635 | Valproic Acid | Valproic Acid promotes the reaction [decitabine results in increased expression of CDKN1A protein] | increases expression|increases reaction | 18223691 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of CDKN1A mRNA | increases expression | 19101580 |
| D014635 | Valproic Acid | [decitabine co-treated with Valproic Acid] results in increased expression of CDKN1A mRNA | affects cotreatment|increases expression | 19155313 |
| D014638 | Vanadates | pifithrin inhibits the reaction [Vanadates results in increased activity of CDKN1A protein] | decreases reaction|increases activity | 11931974 |
| D014638 | Vanadates | TRP53 protein affects the reaction [Vanadates results in increased expression of CDKN1A protein] | affects reaction|increases expression | 12435075 |
| D014638 | Vanadates | Vanadates results in increased expression of CDKN1A protein | increases expression | 12435075 11931974 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased expression of CDKN1A mRNA | increases expression | 19465080 |
| C025643 | vinclozolin | vinclozolin results in increased expression of CDKN1A mRNA | increases expression | 18940246 |
| C017963 | vinyl carbamate | Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1A protein] | decreases expression|decreases reaction | 12117777 |
| C017963 | vinyl carbamate | vinyl carbamate results in decreased expression of CDKN1A protein | decreases expression | 12117777 |
| D009536 | Niacinamide | Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein] | decreases reaction|increases expression | 12782109 |
| D009536 | Niacinamide | Niacinamide results in decreased expression of CDKN1A protein | decreases expression | 12782109 |
| D002762 | Cholecalciferol | Cholecalciferol results in decreased expression of CDKN1A protein | decreases expression | 12907249 |
| D024483 | Vitamin K 3 | SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein] | affects cotreatment|decreases reaction|increases expression | 19082730 |
| D024483 | Vitamin K 3 | [sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 19082730 |
| D024483 | Vitamin K 3 | Vitamin K 3 results in increased expression of CDKN1A mRNA | increases expression | 12414654 |
| C111237 | vorinostat | [bortezomib co-treated with vorinostat] results in increased expression of and results in increased cleavage of CDKN1A protein | affects cotreatment|increases cleavage|increases expression | 12893773 |
| C111237 | vorinostat | Tretinoin promotes the reaction [vorinostat results in increased expression of CDKN1A mRNA] | increases expression|increases reaction | 17431121 |
| C111237 | vorinostat | Tretinoin promotes the reaction [vorinostat results in increased expression of CDKN1A protein] | increases expression|increases reaction | 17431121 |
| C111237 | vorinostat | vorinostat results in increased expression of CDKN1A mRNA | increases expression | 17431121 |
| C111237 | vorinostat | vorinostat results in increased expression of CDKN1A protein | increases expression | 17218635 14707268 17431121 16144943 15897598 17417771 12893773 |
| C111237 | vorinostat | vorinostat inhibits the reaction [HDAC1 protein binds to CDKN1A promoter] | affects binding|decreases reaction | 16043219 |
| C111237 | vorinostat | vorinostat results in increased expression of CDKN1A mRNA | increases expression | 16043219 |
| C009687 | wortmannin | wortmannin results in increased expression of CDKN1A protein | increases expression | 15695173 17129604 |
| C451735 | WP 744 | WP 744 results in increased expression of CDKN1A protein | increases expression | 15555623 |
| C094299 | ZD 9331 | CDKN1A protein results in increased susceptibility to ZD 9331 | increases response to substance | 15342418 |
| C094299 | ZD 9331 | roscovitine promotes the reaction [CDKN1A protein results in increased susceptibility to ZD 9331] | increases reaction|increases response to substance | 15342418 |
| C094299 | ZD 9331 | ZD 9331 results in increased expression of CDKN1A mRNA | increases expression | 15342418 |
| C105427 | Zeocin | Zeocin results in increased expression of CDKN1A protein | increases expression | 11741290 |
| D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1A mRNA | affects cotreatment|decreases expression | 15784690 |
| D015215 | Zidovudine | Zidovudine results in decreased expression of CDKN1A mRNA | decreases expression | 15784690 |
| D015215 | Zidovudine | Zidovudine affects the expression of CDKN1A protein | affects expression | 18389896 |
| D015032 | Zinc | Zinc results in increased expression of CDKN1A mRNA | increases expression | 17074742 |
| C016837 | zinc chloride | [Citric Acid co-treated with zinc chloride] results in increased expression of CDKN1A protein | affects cotreatment|increases expression | 16624386 |
| C017803 | zinc protoporphyrin | zinc protoporphyrin analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CDKN1A protein] | affects localization|decreases reaction|increases expression | 18508827 |
| D019287 | Zinc Sulfate | Zinc Sulfate results in increased expression of CDKN1A mRNA | increases expression | 17074742 |
| C088658 | zoledronic acid | CYR61 protein affects the reaction [zoledronic acid results in increased expression of CDKN1A protein] | affects reaction|increases expression | 19530242 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of CDKN1A protein | increases expression | 19530242 |
| D015054 | Zymosan | Zymosan results in increased expression of CDKN1A mRNA | increases expression | 10451498 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 8.01 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 8.01 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | 2-amino-4,6-dinitrotoluene | 21.55 | 7525203 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 21.55 | 18926900 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 21.55 | 18769834 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Methotrexate | 21.55 | 12039119 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenobarbital | 21.55 | 6195326 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Phenytoin | 21.55 | 3425630 10563481 6195326 9677735 9118846 8986270 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 21.55 | 11752688 14514962 15322242 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 21.55 | 8875741 | |
| MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 5.81 | 18769834 | |
| MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 5.81 | 19490988 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 9.35 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 9.35 | 11192467 | |
| MESH:D000138 | Acidosis | Zinc Sulfate | 9.35 | 7265320 | |
| MESH:D000140 | Acidosis, Lactic | methyl isocyanate | 5.22 | 8440870 | |
| MESH:D017486 | Acneiform Eruptions | Isotretinoin | 4.76 | 16232082 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 7.00 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | Isotretinoin | 7.00 | 16185265 18769834 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 3.37 | 9612607 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.01 | 17694057 | |
| MESH:D000169 | Acrodermatitis | Zinc | 3.90 | 16889938 17190629 17202136 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 19.51 | 17670903 15814532 12690470 | |
| MESH:D058186 | Acute Kidney Injury | Folic Acid | 19.51 | 16316344 17003819 16595132 | |
| MESH:D058186 | Acute Kidney Injury | Ibuprofen | 19.51 | 6375363 | |
| MESH:D058186 | Acute Kidney Injury | pifithrin | 19.51 | 17670903 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 19.51 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 19.51 | 7897758 | |
| MESH:D058186 | Acute Kidney Injury | zoledronic acid | 19.51 | 19715164 | |
| MESH:D055371 | Acute Lung Injury | Chlorine | 17.64 | 20601635 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 17.64 | 18653653 11850527 | |
| MESH:D055371 | Acute Lung Injury | nickel sulfate | 17.64 | 11954676 16100012 19131640 12718980 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 17.64 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | Particulate Matter | 17.64 | 12396868 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 17.64 | 18653653 | |
| MESH:D000210 | Acute-Phase Reaction | zoledronic acid | 3.99 | 20200999 | |
| MESH:D000230 | Adenocarcinoma | 1,4-phenylenebis(methylene)selenocyanate | 45.15 | 12844480 | |
| MESH:D000230 | Adenocarcinoma | 1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate | 45.15 | 12844480 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 45.15 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 45.15 | 20464547 20127859 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 45.15 | 11798837 17638652 | |
| MESH:D000230 | Adenocarcinoma | daidzein | 45.15 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Dimethylnitrosamine | 45.15 | 16033868 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 45.15 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | dracorhodin | 45.15 | 15215653 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 45.15 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 45.15 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fenretinide | 45.15 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 45.15 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 45.15 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ibuprofen | 45.15 | 10697514 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 45.15 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 45.15 | 15688392 15113128 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 45.15 | 11910360 | |
| MESH:D000230 | Adenocarcinoma | Urethane | 45.15 | 18316556 | |
| MESH:D000230 | Adenocarcinoma | vinyl carbamate | 45.15 | 17363558 16247444 | |
| MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 4.19 | 15814487 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 35.03 | 10737359 | |
| MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 35.03 | 16176798 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 35.03 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 35.03 | 19389873 | |
| MESH:D000236 | Adenoma | Diethylnitrosamine | 35.03 | 6695378 10737359 | |
| MESH:D000236 | Adenoma | Dimethylnitrosamine | 35.03 | 19555203 | |
| MESH:D000236 | Adenoma | Ethylnitrosourea | 35.03 | 6695378 | |
| MESH:D000236 | Adenoma | Folic Acid | 35.03 | 16963246 | |
| MESH:D000236 | Adenoma | Indomethacin | 35.03 | 11497255 | |
| MESH:D000236 | Adenoma | Methylcholanthrene | 35.03 | 6695378 10545420 | |
| MESH:D000236 | Adenoma | resveratrol | 35.03 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 35.03 | 10223192 | |
| MESH:D000236 | Adenoma | Urethane | 35.03 | 11497255 16926031 17093202 6695378 17195641 10822126 10530776 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.48 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | Diethylnitrosamine | 17.31 | 19052882 16434500 17620307 18056438 19061943 17162532 | |
| MESH:D018248 | Adenoma, Liver Cell | Phenobarbital | 17.31 | 17620307 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 17.31 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 17.31 | 16835633 | |
| MESH:D018248 | Adenoma, Liver Cell | vinyl carbamate | 17.31 | 12371669 | |
| MESH:D011125 | Adenomatous Polyposis Coli | celecoxib | 15.94 | 19003578 16215675 | |
| MESH:D011125 | Adenomatous Polyposis Coli | dibenzoylmethane | 15.94 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulforafan | 15.94 | 17942926 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 15.94 | 11874996 12394442 15623613 16460482 19003578 17611924 11535846 | |
| MESH:D011125 | Adenomatous Polyposis Coli | sulindac sulfone | 15.94 | 16150858 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.18 | 15276417 | |
| MESH:D000309 | Adrenal Insufficiency | Dehydroepiandrosterone | 4.29 | 17302879 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 8.77 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 8.77 | 16712894 17306315 | |
| MESH:D000382 | Agricultural Workers' Diseases | Lindane | 6.36 | 12661182 | |
| MESH:D000382 | Agricultural Workers' Diseases | Paraquat | 6.36 | 11874814 | |
| MESH:D000382 | Agricultural Workers' Diseases | Toxaphene | 6.36 | 16132792 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 6.67 | 21441931 | |
| MESH:D000419 | Albuminuria | Raloxifene | 6.67 | 17308373 17451421 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 3.80 | 15451039 15451040 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.57 | 17887948 | |
| MESH:D000505 | Alopecia | Isoflavones | 5.26 | 17569567 | |
| MESH:D000505 | Alopecia | Tretinoin | 5.26 | 15955085 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.15 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 3.85 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 24.80 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Folic Acid | 24.80 | 17116317 | |
| MESH:D000544 | Alzheimer Disease | Ibuprofen | 24.80 | 18351690 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 24.80 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Iron | 24.80 | 16640825 16563566 | |
| MESH:D000544 | Alzheimer Disease | Nicotine | 24.80 | 16627626 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 24.80 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Particulate Matter | 24.80 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 24.80 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 24.80 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 24.80 | 16162502 16183991 | |
| MESH:D000544 | Alzheimer Disease | rosiglitazone | 24.80 | 19621015 | |
| MESH:D000544 | Alzheimer Disease | sulindac sulfide | 24.80 | 18759972 | |
| MESH:D000544 | Alzheimer Disease | Zinc | 24.80 | 16410023 16580781 17119284 16325427 | |
| MESH:D000550 | Amblyopia | Valproic Acid | 3.71 | 17688650 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 3.04 | 15469931 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 4.91 | 10965797 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | Tetrahydrocannabinol | 4.91 | 15204022 | |
| MESH:D000707 | Anaphylaxis | Ibuprofen | 3.78 | 9532969 | |
| MESH:D000740 | Anemia | Fluorouracil | 10.21 | 16511603 17963324 15504547 | |
| MESH:D000740 | Anemia | Iron | 10.21 | 16566752 16434484 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 10.21 | 11748828 | |
| MESH:D000740 | Anemia | Zymosan | 10.21 | 18664788 | |
| MESH:D000741 | Anemia, Aplastic | Benzene | 3.09 | 11369114 17661222 14761424 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 2.86 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 3.30 | 17147795 17162259 17375513 16569441 17163184 | |
| MESH:D000755 | Anemia, Sickle Cell | Zinc | 3.46 | 16916123 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 3.43 | 16910769 | |
| MESH:D000799 | Angioedema | Acetaminophen | 2.34 | 10982225 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.35 | 15513904 | |
| MESH:D000860 | Anoxia | Oxygen | 6.60 | 20872349 | |
| MESH:D000860 | Anoxia | Zinc Sulfate | 6.60 | 7265320 | |
| MESH:D000881 | Anthrax | Ciprofloxacin | 5.19 | 20385868 | |
| MESH:D016736 | Antiphospholipid Syndrome | Ciprofloxacin | 5.19 | 9485080 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 10.61 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Pentobarbital | 10.61 | 18313124 11141031 | |
| MESH:D001008 | Anxiety Disorders | Valproic Acid | 10.61 | 17497229 | |
| MESH:D001008 | Anxiety Disorders | vinclozolin | 10.61 | 19015723 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 3.40 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 6.85 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 6.85 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 4.89 | 16604332 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 4.89 | 17460149 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.24 | 18414634 16251483 12569548 16835338 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 8.70 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Dietary Fats | 8.70 | 15238619 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 8.70 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.65 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 17.26 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 17.26 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 17.26 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 17.26 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Tosylphenylalanyl Chloromethyl Ketone | 17.26 | 18706406 | |
| MESH:D001169 | Arthritis, Experimental | Tretinoin | 17.26 | 16412693 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 17.26 | 15142272 15944321 17659584 16872482 15188379 | |
| MESH:D001172 | Arthritis, Rheumatoid | Am 80 | 8.38 | 16819260 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 8.38 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 8.38 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Methotrexate | 8.38 | 17286800 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 8.38 | 15570426 | |
| MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 8.38 | 16292516 | |
| MESH:D001249 | Asthma | Budesonide | 8.34 | 15572850 10893010 15136378 18489783 20004779 12604023 12113382 | |
| MESH:D001249 | Asthma | epigallocatechin gallate | 8.34 | 16516891 | |
| MESH:D001249 | Asthma | Mustard Gas | 8.34 | 10378619 | |
| MESH:D001249 | Asthma | Ozone | 8.34 | 17854713 16373670 | |
| MESH:D001249 | Asthma | Tretinoin | 8.34 | 16456186 | |
| MESH:D001249 | Asthma | Zinc | 8.34 | 17085522 | |
| MESH:D055963 | Asthma, Aspirin-Induced | Aspirin | 3.38 | 12372130 20485159 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 8.16 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 8.16 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Am 80 | 23.15 | 16484594 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 23.15 | 19371607 12928151 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 23.15 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 23.15 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 23.15 | 16632123 16640825 | |
| MESH:D050197 | Atherosclerosis | Methylcholanthrene | 23.15 | 11922910 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 23.15 | 16391483 | |
| MESH:D050197 | Atherosclerosis | Phenytoin | 23.15 | 15136057 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 23.15 | 16873680 17967414 | |
| MESH:D050197 | Atherosclerosis | Tetrahydrocannabinol | 23.15 | 15815632 | |
| MESH:D001284 | Atrophy | fulvestrant | 3.42 | 11514358 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 2.09 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Folic Acid | 2.09 | 21388746 | |
| MESH:D001321 | Autistic Disorder | Glutathione Disulfide | 2.09 | 19056591 | |
| MESH:D001321 | Autistic Disorder | Iron | 2.09 | 17352947 | |
| MESH:D001321 | Autistic Disorder | pioglitazone | 2.09 | 17207275 | |
| MESH:D001321 | Autistic Disorder | Valproic Acid | 2.09 | 17507914 17688650 15238991 16609825 20603192 18985861 18316065 18940202 18177632 18558336 19232924 17157402 18775368 19460635 18396377 | |
| MESH:D001327 | Autoimmune Diseases | Cholecalciferol | 18.63 | 16142846 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 18.63 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 18.63 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 18.63 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | sulforafan | 18.63 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Ciprofloxacin | 7.62 | 11505790 | |
| MESH:D001424 | Bacterial Infections | Iron | 7.62 | 16640825 | |
| MESH:D001471 | Barrett Esophagus | Tretinoin | 2.95 | 16935849 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 3.51 | 10684365 | |
| MESH:D001607 | Berylliosis | Prednisone | 4.26 | 18757698 | |
| MESH:D001714 | Bipolar Disorder | Valproic Acid | 2.10 | 17594078 20046352 | |
| MESH:D001768 | Blister | Mustard Gas | 3.66 | 19167455 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 10.73 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 10.73 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 10.73 | 12125929 | |
| MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 10.73 | 16206674 16197459 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.28 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 4.13 | 15746008 | |
| MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 4.13 | 8888407 | |
| MESH:D001855 | Bone Marrow Diseases | Benzene | 3.72 | 16183116 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 17.11 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 17.11 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 17.11 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 17.11 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 6.15 | 15867366 | |
| MESH:D001859 | Bone Neoplasms | zoledronic acid | 6.15 | 11697798 19442620 15867366 16778634 16121404 17312309 | |
| MESH:D001862 | Bone Resorption | Berberine | 8.20 | 9881647 | |
| MESH:D001862 | Bone Resorption | bisphenol A | 8.20 | 11985600 | |
| MESH:D001862 | Bone Resorption | zoledronic acid | 8.20 | 16769263 18404659 15845617 11869084 18496637 8053405 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 3.84 | 11207687 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 3.08 | 15306635 | |
| MESH:D001927 | Brain Diseases | Ethylnitrosourea | 3.51 | 14991843 | |
| MESH:D001929 | Brain Edema | Indomethacin | 3.51 | 11481608 | |
| MESH:D020201 | Brain Hemorrhage, Traumatic | Progesterone | 3.81 | 17868700 | |
| MESH:D001930 | Brain Injuries | Progesterone | 10.06 | 15665606 15845082 15380490 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 10.06 | 16580743 | |
| MESH:D001930 | Brain Injuries | Zinc | 10.06 | 17109824 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 16.36 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Ibuprofen | 16.36 | 15837124 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 16.36 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 16.36 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 16.36 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Acrylonitrile | 20.45 | 12562636 | |
| MESH:D001932 | Brain Neoplasms | Aspirin | 20.45 | 15481559 | |
| MESH:D001932 | Brain Neoplasms | Carmustine | 20.45 | 16187019 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 20.45 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 20.45 | 17150277 | |
| MESH:D001932 | Brain Neoplasms | Ethylnitrosourea | 20.45 | 16357521 16651633 15144691 18412241 16436596 | |
| MESH:D001932 | Brain Neoplasms | Fenretinide | 20.45 | 16187019 | |
| MESH:D001943 | Breast Neoplasms | 2,4-diaminotoluene | 77.68 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 77.68 | 20146248 | |
| MESH:D001943 | Breast Neoplasms | 4-oxofenretinide | 77.68 | 16540676 | |
| MESH:D001943 | Breast Neoplasms | alitretinoin | 77.68 | 16344269 | |
| MESH:D001943 | Breast Neoplasms | AN-7 phosphate cpd | 77.68 | 16826403 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 77.68 | 17132221 16541309 | |
| MESH:D001943 | Breast Neoplasms | Ascorbic Acid | 77.68 | 16443354 | |
| MESH:D001943 | Breast Neoplasms | Aspirin | 77.68 | 15161893 | |
| MESH:D001943 | Breast Neoplasms | Benzene | 77.68 | 17162533 11921183 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 77.68 | 20146248 17474063 | |
| MESH:D001943 | Breast Neoplasms | bisphenol A | 77.68 | 17123778 | |
| MESH:D001943 | Breast Neoplasms | Cacodylic Acid | 77.68 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Calcitriol | 77.68 | 11237771 | |
| MESH:D001943 | Breast Neoplasms | Chromium | 77.68 | 15986119 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 77.68 | 18382427 19526202 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 77.68 | 18462866 19250217 16243823 18593918 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 77.68 | 18323546 11325840 17388661 16978400 18234424 17020986 15093573 15136595 12006526 | |
| MESH:D001943 | Breast Neoplasms | decitabine | 77.68 | 18320071 19208741 | |
| MESH:D001943 | Breast Neoplasms | Deferoxamine | 77.68 | 15993339 | |
| MESH:D001943 | Breast Neoplasms | deguelin | 77.68 | 17035597 18593368 | |
| MESH:D001943 | Breast Neoplasms | Dietary Fats | 77.68 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Diethylnitrosamine | 77.68 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 77.68 | 15324884 17129689 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 77.68 | 16115903 15993339 17369602 15692762 16595493 16826403 18234424 16322301 17983394 15136595 15567936 15994142 15634643 16264153 16935488 16096432 18382427 15939500 17426702 18628466 15668708 19526202 11325840 18695136 | |
| MESH:D001943 | Breast Neoplasms | (E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide | 77.68 | 15528975 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 77.68 | 17261762 17018787 17289903 18497071 19861407 14630087 12948864 16675129 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 77.68 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fenretinide | 77.68 | 16601279 | |
| MESH:D001943 | Breast Neoplasms | flavopiridol | 77.68 | 12517783 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 77.68 | 16595493 18357371 16557594 19217205 18608205 16110121 15136595 | |
| MESH:D001943 | Breast Neoplasms | Folic Acid | 77.68 | 16777985 | |
| MESH:D001943 | Breast Neoplasms | fulvestrant | 77.68 | 18984771 | |
| MESH:D001943 | Breast Neoplasms | gemcitabine | 77.68 | 18382427 17039268 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 77.68 | 16541309 16873071 17200150 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 77.68 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 77.68 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 77.68 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | Lindane | 77.68 | 14688026 | |
| MESH:D001943 | Breast Neoplasms | Methotrexate | 77.68 | 16978400 | |
| MESH:D001943 | Breast Neoplasms | Methylcholanthrene | 77.68 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | methyleugenol | 77.68 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 77.68 | 16253758 14633655 11306469 | |
| MESH:D001943 | Breast Neoplasms | ochratoxin A | 77.68 | 11921183 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 77.68 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 77.68 | 18223236 18323546 18234424 15136595 16115903 16244791 11325840 16273361 | |
| MESH:D001943 | Breast Neoplasms | Plant Preparations | 77.68 | 17398067 | |
| MESH:D001943 | Breast Neoplasms | Progesterone | 77.68 | 15562024 17614352 16175315 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 77.68 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 77.68 | 17952589 15758505 17595753 15572757 17261762 17893378 17049068 17242785 16837676 16912660 17440819 15775269 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 77.68 | 17651959 17534123 16393696 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 77.68 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 77.68 | 20859285 18629630 17049068 18425577 20390343 18821012 19289846 18855134 20005174 17242785 16873071 18997820 19115204 16818667 21138602 20065188 19410462 16273361 18984771 19066611 15668708 19059307 15565566 19244106 17261762 19084267 21152245 16202921 19487384 19189210 17440819 19189212 19103187 19142967 19288272 20135344 19200415 18351453 19155303 19221464 17893378 18815881 20544844 19011961 11161223 | |
| MESH:D001943 | Breast Neoplasms | tanshinone | 77.68 | 19885617 15849732 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 77.68 | 20435547 | |
| MESH:D001943 | Breast Neoplasms | Tretinoin | 77.68 | 16873071 16166294 16443354 | |
| MESH:D001943 | Breast Neoplasms | vorinostat | 77.68 | 16144943 | |
| MESH:D001943 | Breast Neoplasms | zoledronic acid | 77.68 | 18695136 16096432 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 2.44 | 15516495 17626835 16777450 14754758 18417511 19059883 18315731 | |
| MESH:D001989 | Bronchiolitis Obliterans | Mustard Gas | 3.66 | 15286001 | |
| MESH:D001991 | Bronchitis | Antimony | 4.61 | 8768112 | |
| MESH:D029481 | Bronchitis, Chronic | Mustard Gas | 3.46 | 10378619 17687719 | |
| MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.09 | 16813970 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 2.91 | 11589617 | |
| MESH:D002056 | Burns | Ethanol | 6.53 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 6.53 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 3.82 | 9625245 | |
| MESH:D002100 | Cachexia | Ibuprofen | 12.59 | 15141370 | |
| MESH:D002100 | Cachexia | Indomethacin | 12.59 | 11239499 16537180 15141370 15625704 | |
| MESH:D002100 | Cachexia | Ozone | 12.59 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.02 | 16962696 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 2.97 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 8.92 | 16050911 15721981 16097048 15700767 16124888 16227642 16192424 15673190 10355542 18705752 16011737 3786805 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | ferulic acid | 8.92 | 16011737 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Oleanolic Acid | 8.92 | 10355542 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 12.57 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 12.57 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Streptozocin | 12.57 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 12.64 | 18593918 | |
| MESH:D002277 | Carcinoma | Dimethylnitrosamine | 12.64 | 19555203 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 12.64 | 17121937 | |
| MESH:D002277 | Carcinoma | Methylcholanthrene | 12.64 | 10545420 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 12.64 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.53 | 17687452 15504454 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.03 | 19066611 | |
| MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 3.64 | 16168501 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 73.79 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 73.79 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 73.79 | 3581430 6705139 17761372 10737359 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 73.79 | 17270033 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 73.79 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Aflatoxin B1 | 73.79 | 12907637 12619106 21507988 | |
| MESH:D006528 | Carcinoma, Hepatocellular | anthra(1,9-cd)pyrazol-6(2H)-one | 73.79 | 19418558 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 73.79 | 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 73.79 | 16217749 15553829 14691202 11135700 15073043 | |
| MESH:D006528 | Carcinoma, Hepatocellular | AZD 6244 | 73.79 | 17876044 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 73.79 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 73.79 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 73.79 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | deguelin | 73.79 | 18575727 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylnitrosamine | 73.79 | 20935162 16698587 19171122 20084675 17428255 18978308 16288022 3581430 17978847 19335982 20524982 19394651 18506893 18785209 11831363 20007298 17173139 19822196 19701751 16807293 19539802 21159647 17138121 16540662 18788625 16830150 18665156 16779866 16502159 19519916 19107877 19052882 19919837 16681979 18393292 20727157 10737359 17761372 18971187 17162532 20514400 3084413 20101231 20512989 19418558 10672840 18494052 19383236 16935385 18691550 16569478 16328049 16878318 20214788 19208518 18056438 20432363 18210153 17055752 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 73.79 | 16924424 15948411 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 73.79 | 16234567 17876044 16023760 18059187 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 73.79 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 73.79 | 15289165 15763234 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fenretinide | 73.79 | 16270382 17159502 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 73.79 | 17971768 16799960 17045692 17088986 16332177 18930000 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 73.79 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 73.79 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | N-nitrosomorpholine | 73.79 | 8364915 15543204 16935385 15010824 1967229 9029167 10629087 11509945 9311599 19335982 9466558 1917145 19383236 2885971 1701930 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 73.79 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | panaxydol | 73.79 | 19450571 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Phenobarbital | 73.79 | 6705139 1701930 20935162 20007298 17173139 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 73.79 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 73.79 | 19519916 12508355 | |
| MESH:D006528 | Carcinoma, Hepatocellular | quinoline | 73.79 | 598648 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 73.79 | 16227395 19321006 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 73.79 | 17306315 16507464 15276417 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 73.79 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 73.79 | 1917145 | |
| MESH:D006528 | Carcinoma, Hepatocellular | vinyl carbamate | 73.79 | 12371669 | |
| MESH:D002278 | Carcinoma in Situ | bisphenol A | 3.49 | 17123778 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 10.57 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 10.57 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 10.57 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 3.85 | 14736730 11352223 18791128 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bortezomib | 17.60 | 16052434 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Carboplatin | 17.60 | 16685392 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 17.60 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 17.60 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | S,S'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea | 17.60 | 19497413 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfide | 17.60 | 12391285 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | sulindac sulfone | 17.60 | 18758305 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | vinyl carbamate | 17.60 | 16247446 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | zoledronic acid | 17.60 | 19233551 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.48 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.36 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | celecoxib | 15.21 | 16369983 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 15.21 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 15.21 | 1485588 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 15.21 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 15.21 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | N-nitrosomorpholine | 15.21 | 1429202 7921415 | |
| MESH:D002292 | Carcinoma, Renal Cell | zoledronic acid | 15.21 | 18507039 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 2.74 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | therapeutic | 15375580 | ||
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 42.98 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 42.98 | 17687452 15504454 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 42.98 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 42.98 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 42.98 | 6189445 17066447 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 42.98 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | decitabine | 42.98 | 19215824 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Dimethylnitrosamine | 42.98 | 16033868 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 42.98 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fenretinide | 42.98 | 16274795 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 42.98 | 17066447 16280240 16757204 18986760 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 42.98 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 42.98 | 11237771 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Plant Preparations | 42.98 | 17418620 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 42.98 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 42.98 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 42.98 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 42.98 | 16051514 16096774 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 42.98 | 16543248 | |
| MESH:D002295 | Carcinoma, Transitional Cell | marker/mechanism | 18640142 | ||
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 15.49 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Ciprofloxacin | 15.49 | 15028437 10741713 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 15.49 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | romidepsin | 15.49 | 17230511 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 15.49 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Ethanol | 12.83 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 12.83 | 15728586 17287366 17124262 11179087 11754973 16170337 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 12.83 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 12.83 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 12.83 | 18670907 18850075 16120746 | |
| MESH:D006332 | Cardiomegaly | Thyroxine | 12.83 | 18093424 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 4.28 | 16269455 15476868 15792986 16651473 16952015 17308081 16109756 16364871 17351982 16731534 17007740 17131338 17382496 17519947 17974986 17329180 17928571 16612575 16278810 17924179 16455267 15505089 15811867 18627295 16242529 | |
| MESH:D009202 | Cardiomyopathies | Iron | 4.28 | 16640825 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Antimony | 4.83 | 10334427 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 4.83 | 17334414 16243910 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 4.83 | 16604332 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 33.39 | 15738583 17938729 19152805 | |
| MESH:D002318 | Cardiovascular Diseases | daidzein | 33.39 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Folic Acid | 33.39 | 16755160 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 33.39 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 33.39 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | Isoflavones | 33.39 | 17689850 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 33.39 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | Particulate Matter | 33.39 | 12396868 | |
| MESH:D002318 | Cardiovascular Diseases | Plant Preparations | 33.39 | 16862667 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 33.39 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 33.39 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Zinc | 33.39 | 16936243 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 2.96 | 16973168 18022660 | |
| MESH:D016893 | Carotid Stenosis | Plant Preparations | 4.64 | 15158307 | |
| MESH:D002375 | Catalepsy | Tetrahydrocannabinol | 4.25 | 10318961 | |
| MESH:D002386 | Cataract | Acetaminophen | 8.58 | 10977129 | |
| MESH:D002386 | Cataract | Methylnitrosourea | 8.58 | 12484553 | |
| MESH:D002386 | Cataract | Simvastatin | 8.58 | 12518039 | |
| MESH:D002386 | Cataract | Tretinoin | 8.58 | 17460283 | |
| MESH:D002418 | Cattle Diseases | Citric Acid | 4.76 | 1108409 | |
| MESH:D002430 | Cecal Neoplasms | 2-nitrotoluene | 4.28 | 14688030 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 36.27 | 6135515 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 36.27 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 36.27 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Azoxymethane | 36.27 | 18075178 15705887 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 36.27 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 36.27 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cytarabine | 36.27 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Diethylnitrosamine | 36.27 | 2727394 21159647 7505956 17174075 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 36.27 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Ethylnitrosourea | 36.27 | 16003739 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylcholanthrene | 36.27 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitronitrosoguanidine | 36.27 | 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 36.27 | 7505956 2727394 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 36.27 | 19524636 20056578 | |
| MESH:D002493 | Central Nervous System Diseases | Phenobarbital | 6.81 | 4080065 | |
| MESH:D002493 | Central Nervous System Diseases | Phenytoin | 6.81 | 4080065 | |
| MESH:D016543 | Central Nervous System Neoplasms | Ethylnitrosourea | 4.46 | 17160924 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Fenretinide | 8.03 | 16154183 | |
| MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 8.03 | 16129372 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 1.95 | 20734317 | |
| MESH:D018281 | Cholangiocarcinoma | Diethylnitrosamine | 4.87 | 19052882 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 4.87 | 16835633 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.65 | 11181007 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 6.14 | 19486331 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 6.14 | 16919318 17333356 16105132 17110522 15861022 11677210 17681005 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 6.14 | 19176532 | |
| OMIM:601042 | CHOREOATHETOSIS/SPASTICITY, EPISODIC | Phenytoin | 4.37 | 11748493 | |
| MESH:D002822 | Choriocarcinoma | Tretinoin | 3.64 | 16461808 | |
| MESH:D002971 | Cleft Lip | Ethanol | 6.46 | 15513904 | |
| MESH:D002971 | Cleft Lip | Folic Acid | 6.46 | 21254359 | |
| MESH:D002971 | Cleft Lip | Phenytoin | 6.46 | 2227380 | |
| MESH:D002972 | Cleft Palate | Ethanol | 11.04 | 15513904 | |
| MESH:D002972 | Cleft Palate | Folic Acid | 11.04 | 8946559 21254359 | |
| MESH:D002972 | Cleft Palate | Phenytoin | 11.04 | 6862529 2227380 3877104 10789828 1687470 6856622 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 11.04 | 12621046 8697196 16354765 15340226 15668235 | |
| MESH:D002972 | Cleft Palate | Tretinoin | 11.04 | 9407595 | |
| MESH:D002972 | Cleft Palate | Urethane | 11.04 | 12810352 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 3.16 | 15800139 | |
| MESH:D003092 | Colitis | Curcumin | 11.09 | 16782535 16804969 18200517 | |
| MESH:D003092 | Colitis | resveratrol | 11.09 | 16474422 | |
| MESH:D003092 | Colitis | Selenium | 11.09 | 17936198 | |
| MESH:D003092 | Colitis | Tretinoin | 11.09 | 17035595 | |
| MESH:D003093 | Colitis, Ulcerative | Dinitrochlorobenzene | 3.13 | 17373747 19159591 | |
| MESH:D003103 | Coloboma | Curcumin | 6.69 | 18809619 | |
| MESH:D003103 | Coloboma | Phenytoin | 6.69 | 9212184 | |
| MESH:D003110 | Colonic Neoplasms | 1,4-phenylenebis(methylene)selenocyanate | 38.52 | 10753194 | |
| MESH:D003110 | Colonic Neoplasms | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 38.52 | 16596235 | |
| MESH:D003110 | Colonic Neoplasms | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine | 38.52 | 15958644 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 38.52 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Aspirin | 38.52 | 12411196 | |
| MESH:D003110 | Colonic Neoplasms | Azoxymethane | 38.52 | 19056647 15824018 16293270 15705887 12189186 16818512 14668109 | |
| MESH:D003110 | Colonic Neoplasms | Butyrates | 38.52 | 15936596 | |
| MESH:D003110 | Colonic Neoplasms | celecoxib | 38.52 | 16004971 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 38.52 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | decitabine | 38.52 | 17616700 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 38.52 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 38.52 | 17169374 15001691 17287894 17725105 18772588 16510598 16340194 17172411 17016597 17018589 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 38.52 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 38.52 | 11260862 15936596 15963497 15625704 15637740 15786552 | |
| MESH:D003110 | Colonic Neoplasms | irinotecan | 38.52 | 17287894 17725105 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 38.52 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | oxaliplatin | 38.52 | 16510598 16004971 16024531 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 38.52 | 17148506 19056647 19440933 17191121 16640504 11134977 15741050 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 38.52 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 38.52 | 12902858 12458338 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 31.20 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Aspirin | 31.20 | 17047198 | |
| MESH:D015179 | Colorectal Neoplasms | Azacitidine | 31.20 | 19934284 | |
| MESH:D015179 | Colorectal Neoplasms | Azoxymethane | 31.20 | 11076880 10416599 | |
| MESH:D015179 | Colorectal Neoplasms | celecoxib | 31.20 | 11197048 18349538 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 31.20 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | decitabine | 31.20 | 18981723 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 31.20 | 18259882 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Fenretinide | 31.20 | 17273769 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 31.20 | 18288408 16282729 18949393 20501625 16391804 18802399 18448328 18509181 15289873 16524972 14970324 17454858 16331619 16303861 17094418 18383874 17255274 17695437 17016601 15148649 17401013 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Folic Acid | 31.20 | 17087956 17245555 16963246 16985020 17116713 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 31.20 | 11197048 12606626 18059344 17054584 | |
| MESH:D015179 | Colorectal Neoplasms | irinotecan | 31.20 | 17454858 16391804 16303861 18259882 18509181 17159606 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | Isoflavones | 31.20 | 17116718 | |
| MESH:D015179 | Colorectal Neoplasms | Leucovorin | 31.20 | 16303861 17454858 17401013 17594712 20501625 17255274 | |
| MESH:D015179 | Colorectal Neoplasms | oxaliplatin | 31.20 | 18448328 17594712 17401013 17255274 17695437 18509181 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 31.20 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Polychlorinated Biphenyls | 31.20 | 15531428 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 31.20 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 31.20 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 31.20 | 11076880 10666051 18059344 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | sulindac sulfone | 31.20 | 10416599 11197048 10666051 18059344 | |
| MESH:D003139 | Common Cold | Ascorbic Acid | 3.96 | 17323712 | |
| MESH:D000013 | Congenital Abnormalities | 2-amino-4,6-dinitrotoluene | 8.06 | 15095906 | |
| MESH:D000013 | Congenital Abnormalities | Phenytoin | 8.06 | 10627286 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 8.06 | 14669216 17141729 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 3.42 | 18497527 | |
| MESH:D003324 | Coronary Artery Disease | Plant Preparations | 3.23 | 15158307 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.61 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 2.75 | 12609071 | |
| MESH:D003328 | Coronary Thrombosis | methyleugenol | 6.43 | 16048847 | |
| MESH:D003328 | Coronary Thrombosis | Oxazepam | 6.43 | 16048847 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.19 | 17302372 | |
| MESH:D003371 | Cough | Citric Acid | 4.70 | 9413022 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 18.35 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Benzene | 18.35 | 15643154 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 18.35 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 18.35 | 10194807 15451039 15513904 19302082 15451040 11198716 11873399 | |
| MESH:D019465 | Craniofacial Abnormalities | Glucocorticoids | 18.35 | 18281261 | |
| MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 18.35 | 9879862 18769834 | |
| MESH:D019465 | Craniofacial Abnormalities | lead acetate | 18.35 | 19769572 | |
| MESH:D019465 | Craniofacial Abnormalities | Leucovorin | 18.35 | 16925845 | |
| MESH:D019465 | Craniofacial Abnormalities | Methotrexate | 18.35 | 9562676 12039119 | |
| MESH:D019465 | Craniofacial Abnormalities | ochratoxin A | 18.35 | 20036863 | |
| MESH:D019465 | Craniofacial Abnormalities | Phenytoin | 18.35 | 19952982 9212184 8986270 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 18.35 | 20055451 15322242 10048152 | |
| MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 18.35 | 9224671 17551590 9211117 10589399 16925845 9125849 9664655 8800419 14991402 9142499 | |
| MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 18.35 | 8888407 17688650 16575769 | |
| MESH:D019465 | Craniofacial Abnormalities | Zinc | 18.35 | 19302082 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 6.58 | 16002989 12952375 | |
| MESH:D003456 | Cryptorchidism | vinclozolin | 6.58 | 14966744 | |
| MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 6.04 | 18551238 | |
| MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 6.04 | 18551238 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 12.57 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Ciprofloxacin | 12.57 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Methotrexate | 12.57 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | pioglitazone | 12.57 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Simvastatin | 12.57 | 19747007 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 3.48 | 15276878 18295254 18093676 12388444 10498854 16989017 16614059 11948286 12161096 10700343 16651033 16413132 18433785 18483878 18710439 17979934 15643279 18372110 17010015 12913760 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.30 | 16733453 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 2.68 | 15213294 | |
| MESH:D003704 | Dementia | Polychlorinated Biphenyls | 3.33 | 16140633 | |
| MESH:D003711 | Demyelinating Diseases | Cuprizone | 7.98 | 18550754 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 7.98 | 19031437 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 2.83 | 17474826 | |
| MESH:D003872 | Dermatitis | Benzene | 3.31 | 15902427 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4-phenylenediamine | 9.32 | 11906362 18759875 16823706 16533241 19470301 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cobaltous chloride | 9.32 | 15059100 16823706 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 9.32 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dinitrochlorobenzene | 9.32 | 15491423 | |
| MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 9.32 | 16823706 16780908 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Potassium Dichromate | 9.32 | 16823706 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.51 | 18249437 | |
| MESH:D003877 | Dermatitis, Contact | 4-phenylenediamine | 3.97 | 11531941 | |
| MESH:D003882 | Dermatomyositis | Methotrexate | 3.68 | 20191521 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 11.16 | 16640825 16604332 | |
| MESH:D003920 | Diabetes Mellitus | rosiglitazone | 11.16 | 17446233 | |
| MESH:D003920 | Diabetes Mellitus | Streptozocin | 11.16 | 16285004 | |
| MESH:D003920 | Diabetes Mellitus | Zinc | 11.16 | 16479319 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 9.26 | 11751995 15331540 10990075 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 9.26 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 9.26 | 16873680 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 9.26 | 15862027 19586609 7637645 12093613 16286809 11055810 12446591 17442507 19496084 12083368 19960420 11260395 18603373 1374869 6379147 2177838 16684804 15831366 19298542 17874149 15298345 18715473 8740154 12644472 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 6.13 | 18772604 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Dehydroepiandrosterone | 6.13 | 16616286 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 6.13 | 16506275 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 6.13 | 18603373 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Ascorbic Acid | 27.41 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 27.41 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | daidzein | 27.41 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Diethylnitrosamine | 27.41 | 20387270 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 27.41 | 16988119 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Folic Acid | 27.41 | 16886840 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 27.41 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 27.41 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Niacinamide | 27.41 | 19647726 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | pioglitazone | 27.41 | 12642470 16023994 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 27.41 | 12642470 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 27.41 | 19647726 19586609 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 27.41 | 17107852 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | troglitazone | 27.41 | 16023994 | |
| MESH:D003925 | Diabetic Angiopathies | troglitazone | 4.17 | 12601628 | |
| MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.23 | 16025228 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 21.97 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 21.97 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 21.97 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 21.97 | 15920148 17308373 17451421 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 21.97 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Streptozocin | 21.97 | 19682444 19960420 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 21.97 | 19279558 | |
| MESH:D003929 | Diabetic Neuropathies | Progesterone | 3.03 | 17187935 | |
| MESH:D003930 | Diabetic Retinopathy | Streptozocin | 7.47 | 17662242 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 7.47 | 17621415 12861449 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 5.53 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 5.53 | 7907874 7237001 | |
| MESH:D003967 | Diarrhea | vorinostat | 5.53 | 20479100 | |
| MESH:D004283 | Dog Diseases | Antimony | 4.17 | 12019027 | |
| OMIM:607208 | DRAVET SYNDROME | Phenytoin | 3.92 | 11748493 | |
| MESH:D003875 | Drug Eruptions | Phenytoin | 4.03 | 15024534 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 35.66 | 18551238 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 35.66 | 18551238 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2-amino-4,6-dinitrotoluene | 35.66 | 21346803 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2-nitropropane | 35.66 | 15804453 16445897 20517888 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 35.66 | 19420014 19416960 19923254 14550746 11421492 11461765 19164858 18713872 15619225 11743745 17522070 10774834 12594235 16393943 2444490 18071297 15968718 19370779 16081117 12540782 11287661 12705907 19739265 17562736 12958197 12153990 10915739 16485898 16227642 11739529 16109766 10663392 11834606 14725611 17906064 11529661 16177239 16781746 14986274 12392966 19085960 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 35.66 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 35.66 | 15998439 10915739 15968718 16227642 6623471 2869522 19085960 9327722 3786805 4309450 19336974 17522070 7120509 10092053 7440962 6884620 3732212 21278145 11566570 15027814 16177239 7179309 | |
| MESH:D056486 | Drug-Induced Liver Injury | Chlorodiphenyl (54% Chlorine) | 35.66 | 17851650 | |
| MESH:D056486 | Drug-Induced Liver Injury | cyanoginosin LR | 35.66 | 17654400 | |
| MESH:D056486 | Drug-Induced Liver Injury | Diethylnitrosamine | 35.66 | 19107877 | |
| MESH:D056486 | Drug-Induced Liver Injury | Dimethylnitrosamine | 35.66 | 8172417 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 35.66 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 35.66 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | fumonisin B1 | 35.66 | 16221962 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ketoconazole | 35.66 | 18289764 | |
| MESH:D056486 | Drug-Induced Liver Injury | pyrazole | 35.66 | 12499123 | |
| MESH:D056486 | Drug-Induced Liver Injury | Selenium | 35.66 | 15131321 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 35.66 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | troglitazone | 35.66 | 14986274 | |
| MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 35.66 | 1733752 19641884 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.58 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 19.70 | 12649298 15033597 19839026 12231392 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 19.70 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Lamivudine | 19.70 | 15040536 | |
| MESH:D004362 | Drug Toxicity | Plant Preparations | 19.70 | 11033412 | |
| MESH:D004362 | Drug Toxicity | Stavudine | 19.70 | 15040536 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 19.70 | 11462148 | |
| MESH:D004362 | Drug Toxicity | Zidovudine | 19.70 | 15040536 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 8.28 | 16133044 18446180 18450898 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 8.28 | 18043480 18446180 17190690 16326151 16133044 12774134 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 4.74 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 4.74 | 16699067 11535926 11595415 17151854 10671773 17351913 17045617 17329845 17202747 11991626 11595431 | |
| MESH:D050171 | Dyslipidemias | Dietary Fats | 4.84 | 18367378 | |
| MESH:D050171 | Dyslipidemias | Fenofibrate | 4.84 | 16707586 | |
| MESH:D004417 | Dyspnea | Budesonide | 8.89 | 20016425 | |
| MESH:D004417 | Dyspnea | Chlorine | 8.89 | 20016425 | |
| MESH:D004417 | Dyspnea | Oxygen | 8.89 | 20016425 | |
| MESH:D004421 | Dystonia | Phenobarbital | 5.74 | 1851702 | |
| MESH:D004421 | Dystonia | Valproic Acid | 5.74 | 1851702 | |
| MESH:D020821 | Dystonic Disorders | Nicotine | 4.43 | 17881519 | |
| MESH:C538011 | Eales disease | Ascorbic Acid | 3.96 | 9068938 | |
| MESH:D004476 | Ectodermal Dysplasia | Ethylnitrosourea | 4.46 | 18357618 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.03 | 12438553 | |
| MESH:D004487 | Edema | Aspirin | 36.57 | 17259670 | |
| MESH:D004487 | Edema | Dexamethasone | 36.57 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 36.57 | 7990266 16100529 8273558 7907874 19703484 10653021 8985016 | |
| MESH:D004487 | Edema | Mustard Gas | 36.57 | 11402378 9260866 11428631 11428647 | |
| MESH:D004487 | Edema | perfluorooctanoic acid | 36.57 | 12083418 17259670 | |
| MESH:D004487 | Edema | pirinixic acid | 36.57 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 36.57 | 12787963 | |
| MESH:D004487 | Edema | Raloxifene | 36.57 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 36.57 | 8985016 | |
| MESH:D004487 | Edema | rosiglitazone | 36.57 | 12083418 | |
| MESH:D004487 | Edema | Sodium Salicylate | 36.57 | 10653021 | |
| MESH:D004487 | Edema | Staurosporine | 36.57 | 8273558 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 36.57 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 36.57 | 15177302 8273558 11698051 9599246 7812673 8113982 16716910 | |
| MESH:D004487 | Edema | Zymosan | 36.57 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 6.94 | 16714409 15322242 18230668 | |
| MESH:D004489 | Edema, Cardiac | Tretinoin | 6.94 | 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 30.21 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Am 80 | 30.21 | 16819260 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 30.21 | 15138306 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 30.21 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Phenytoin | 30.21 | 17654737 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Progesterone | 30.21 | 17692515 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 30.21 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 30.21 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 30.21 | 19031437 | |
| MESH:D004701 | Endocrine Gland Neoplasms | decitabine | 9.01 | 19294695 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 9.01 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 6.96 | 16402032 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 6.96 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | daidzein | 24.31 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 24.31 | 16804899 15700306 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 24.31 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 24.31 | 11473722 18566989 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Fenofibrate | 24.31 | 16569247 | |
| MESH:D016889 | Endometrial Neoplasms | Folic Acid | 24.31 | 17301261 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 24.31 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 24.31 | 16202921 20544844 17893378 19155303 | |
| MESH:D016889 | Endometrial Neoplasms | Tretinoin | 24.31 | 16569247 | |
| MESH:D004715 | Endometriosis | celecoxib | 18.32 | 15652904 | |
| MESH:D004715 | Endometriosis | Ibuprofen | 18.32 | 15652904 | |
| MESH:D004715 | Endometriosis | Indomethacin | 18.32 | 15652904 | |
| MESH:D004715 | Endometriosis | Progesterone | 18.32 | 16134523 | |
| MESH:D004715 | Endometriosis | Sulindac | 18.32 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 18.32 | 9294722 10568697 | |
| MESH:D004716 | Endometritis | Citric Acid | 5.23 | 1108409 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 9.04 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 9.04 | 15268973 | |
| MESH:D019446 | Endotoxemia | Ibuprofen | 9.20 | 11545620 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 9.20 | 18509659 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 9.20 | 15328337 15821434 17637181 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.25 | 17763956 10567023 16328016 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 7.50 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 7.50 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 6.90 | 11006010 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 6.90 | 11298111 | |
| MESH:D004802 | Eosinophilia | Prednisone | 6.90 | 16111148 | |
| MESH:D004816 | Epidermal Necrolysis, Toxic | Phenytoin | 3.76 | 20235791 | |
| MESH:D004820 | Epidermolysis Bullosa | Phenytoin | 4.71 | 1399206 6251365 | |
| MESH:D004831 | Epilepsies, Myoclonic | Phenobarbital | 5.95 | 3659116 | |
| MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 5.95 | 17275665 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Phenobarbital | 8.38 | 3922381 11558140 | |
| MESH:D004828 | Epilepsies, Partial | Phenytoin | 8.38 | 17116037 11558140 | |
| MESH:D004828 | Epilepsies, Partial | Valproic Acid | 8.38 | 3922381 16628512 | |
| MESH:D004827 | Epilepsy | Phenobarbital | 9.69 | 20417680 | |
| MESH:D004827 | Epilepsy | Phenytoin | 9.69 | 20417680 11434505 821787 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 9.69 | 19700373 19439326 | |
| MESH:D004827 | Epilepsy | Tetrahydrocannabinol | 9.69 | 821787 | |
| MESH:D004827 | Epilepsy | Valproic Acid | 9.69 | 18234410 20417680 | |
| MESH:D004832 | Epilepsy, Absence | Phenobarbital | 4.46 | 6401628 | |
| MESH:D004832 | Epilepsy, Absence | Valproic Acid | 4.46 | 6426943 7562514 6254150 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenobarbital | 11.00 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Phenytoin | 11.00 | 7750514 | |
| MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 11.00 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenobarbital | 9.37 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Phenytoin | 9.37 | 3659116 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 9.37 | 3659116 | |
| MESH:D007172 | Erectile Dysfunction | daidzein | 3.60 | 14972507 | |
| MESH:D004890 | Erythema | Mustard Gas | 3.66 | 9357497 | |
| MESH:D004931 | Esophageal Achalasia | Diethylnitrosamine | 3.59 | 16302075 | |
| MESH:D004938 | Esophageal Neoplasms | therapeutic | 15375580 | ||
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 24.68 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 24.68 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 24.68 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 24.68 | 16785472 16481741 17638652 15464296 15173087 | |
| MESH:D004938 | Esophageal Neoplasms | Dimethylnitrosamine | 24.68 | 17016578 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 24.68 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 24.68 | 16337965 17638652 15173087 16481741 16785472 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 24.68 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | nitrosobenzylmethylamine | 24.68 | 15264214 16805852 15547721 15547733 15878914 15623463 16510608 16704527 15150132 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 24.68 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Plant Preparations | 24.68 | 16510608 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 24.68 | 12235107 | |
| MESH:D004938 | Esophageal Neoplasms | Zinc | 24.68 | 16543248 | |
| MESH:D017889 | Exfoliation Syndrome | Folic Acid | 4.00 | 16504073 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 4.64 | 11564622 | |
| MESH:D005124 | Eye Abnormalities | Tretinoin | 4.64 | 9664655 16938888 | |
| MESH:D005221 | Fatigue | vorinostat | 4.11 | 20479100 | |
| MESH:D005234 | Fatty Liver | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 64.36 | 21071580 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 64.36 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 64.36 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 64.36 | 12631006 16239168 61145 16045604 12795759 15959796 19224547 17595544 | |
| MESH:D005234 | Fatty Liver | Curcumin | 64.36 | 19297423 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 64.36 | 19224547 | |
| MESH:D005234 | Fatty Liver | Dietary Fats | 64.36 | 17967931 19004024 18296743 19551842 | |
| MESH:D005234 | Fatty Liver | Diethylnitrosamine | 64.36 | 21071580 20387270 | |
| MESH:D005234 | Fatty Liver | Ethanol | 64.36 | 19236843 16409862 18620774 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 64.36 | 15345470 | |
| MESH:D005234 | Fatty Liver | Iron | 64.36 | 16640825 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 64.36 | 20131406 19236843 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 64.36 | 15975614 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 64.36 | 17473493 | |
| MESH:D005234 | Fatty Liver | rosiglitazone | 64.36 | 19196556 | |
| MESH:D005234 | Fatty Liver | Stavudine | 64.36 | 18299183 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 64.36 | 19224547 14986274 | |
| MESH:D005234 | Fatty Liver | Valproic Acid | 64.36 | 14986274 19224547 | |
| MESH:D005234 | Fatty Liver | Zidovudine | 64.36 | 18299183 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.14 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 4.41 | 16611131 15751030 16534752 16513791 16002989 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 4.41 | 16709447 | |
| MESH:D005264 | Femoral Fractures | zoledronic acid | 4.33 | 16234978 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 3.80 | 15513904 10194807 15451040 16946407 | |
| MESH:D005313 | Fetal Death | Phenytoin | 5.90 | 10627286 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 5.90 | 11858732 | |
| MESH:D005315 | Fetal Diseases | Valproic Acid | 3.37 | 16575769 | |
| MESH:D005317 | Fetal Growth Retardation | lead acetate | 6.42 | 19769572 | |
| MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 6.42 | 8888407 18558336 | |
| MESH:D005334 | Fever | Ibuprofen | 7.58 | 16997862 | |
| MESH:D005334 | Fever | Indomethacin | 7.58 | 10431976 11852909 17627676 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 7.58 | 9205823 11852909 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 8.00 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 8.00 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 11.01 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 11.01 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 11.01 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 11.76 | 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylcholanthrene | 11.76 | 14633661 10962813 | |
| MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 11.76 | 11555667 | |
| MESH:D005355 | Fibrosis | arsenite | 27.79 | 18296743 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 27.79 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 27.79 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 27.79 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Dietary Fats | 27.79 | 18296743 | |
| MESH:D005355 | Fibrosis | Indomethacin | 27.79 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 27.79 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 27.79 | 20067830 | |
| MESH:D005355 | Fibrosis | Tretinoin | 27.79 | 17994277 | |
| MESH:D005499 | Folliculitis | Indomethacin | 3.65 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 4.04 | 6392382 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 3.95 | 16640825 16604332 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 2.82 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Budesonide | 11.31 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Chlorine | 11.31 | 20016425 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 11.31 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 20.37 | 16983495 | |
| MESH:D005756 | Gastritis | Ethanol | 20.37 | 15046732 | |
| MESH:D005756 | Gastritis | Folic Acid | 20.37 | 17171786 | |
| MESH:D005756 | Gastritis | Indomethacin | 20.37 | 15046732 | |
| MESH:D005756 | Gastritis | Zinc | 20.37 | 17241300 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.57 | 11910360 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.23 | 18462866 | |
| MESH:D030342 | Genetic Diseases, Inborn | vinclozolin | 3.43 | 16973722 | |
| MESH:D005832 | Genital Diseases, Male | vinclozolin | 3.78 | 16417039 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 7.86 | 16452187 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 7.86 | 16452187 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 7.96 | 8708960 | |
| MESH:D005885 | Gingival Hyperplasia | Phenytoin | 7.96 | 9029455 | |
| MESH:D019214 | Gingival Overgrowth | Phenytoin | 4.71 | 14659971 16390469 | |
| MESH:D005901 | Glaucoma | Folic Acid | 3.66 | 16504073 | |
| MESH:D005909 | Glioblastoma | Aspirin | 40.76 | 12870263 | |
| MESH:D005909 | Glioblastoma | biochanin A | 40.76 | 16598420 | |
| MESH:D005909 | Glioblastoma | butylidenephthalide | 40.76 | 16987298 | |
| MESH:D005909 | Glioblastoma | Carmustine | 40.76 | 16187019 | |
| MESH:D005909 | Glioblastoma | Curcumin | 40.76 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 40.76 | 17150277 | |
| MESH:D005909 | Glioblastoma | Ethylnitrosourea | 40.76 | 16436596 | |
| MESH:D005909 | Glioblastoma | Fenretinide | 40.76 | 16187019 | |
| MESH:D005909 | Glioblastoma | Genistein | 40.76 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 40.76 | 12870263 | |
| MESH:D005909 | Glioblastoma | myricetin | 40.76 | 19804834 | |
| MESH:D005909 | Glioblastoma | Quercetin | 40.76 | 19804834 | |
| MESH:D005909 | Glioblastoma | Tretinoin | 40.76 | 17312396 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 40.76 | 18801729 | |
| MESH:D005910 | Glioma | Ethylnitrosourea | 11.33 | 18412241 16357521 16651633 | |
| MESH:D005910 | Glioma | Fluorouracil | 11.33 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 11.33 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Methylnitrosourea | 11.33 | 9825942 | |
| MESH:D005910 | Glioma | Quercetin | 11.33 | 17643826 | |
| MESH:D005910 | Glioma | tanshinone | 11.33 | 16955220 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 4.01 | 11389073 | |
| MESH:D005911 | Gliosis | Paraquat | 3.64 | 11124998 | |
| MESH:D005922 | Glomerulonephritis, IGA | deoxynivalenol | 3.73 | 16524712 15173396 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 5.98 | 11849393 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | pioglitazone | 5.98 | 16687628 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.07 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 3.85 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 7.30 | 15172196 16376943 11014644 | |
| MESH:D006086 | Graft vs Host Disease | Methotrexate | 7.30 | 16518429 | |
| MESH:D006130 | Growth Disorders | Zinc | 2.82 | 17217573 | |
| MESH:D006261 | Headache | Aspirin | 3.48 | 15240983 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 18.25 | 15102660 15464296 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 18.25 | 18462866 18829502 | |
| MESH:D006258 | Head and Neck Neoplasms | decitabine | 18.25 | 19215824 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 18.25 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 18.25 | 15102660 18337622 15162350 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 18.25 | 15482327 | |
| MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 18.25 | 16096774 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 2.97 | 19898482 | |
| MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 3.64 | 16084493 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.09 | 15464296 | |
| MESH:D006330 | Heart Defects, Congenital | 2,3,7,8-tetrachlorodibenzofuran | 12.65 | 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Ascorbic Acid | 12.65 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 12.65 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | Folic Acid | 12.65 | 17286298 16524890 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 12.65 | 10048152 11294989 | |
| MESH:D006330 | Heart Defects, Congenital | Tretinoin | 12.65 | 9664655 14991402 | |
| MESH:D006331 | Heart Diseases | Ciprofloxacin | 14.11 | 11505790 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 14.11 | 18006777 16330681 12587719 16879835 17888722 16707910 16495754 18674790 16244371 16244372 16144979 17875725 14766674 | |
| MESH:D006331 | Heart Diseases | pifithrin | 14.11 | 14766674 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 14.11 | 11110106 | |
| MESH:D006331 | Heart Diseases | Streptozocin | 14.11 | 12093613 | |
| MESH:D006331 | Heart Diseases | Urethane | 14.11 | 16046796 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 10.19 | 17481944 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 10.19 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 10.19 | 18097624 | |
| MESH:D006333 | Heart Failure | Selenium | 10.19 | 17162251 | |
| MESH:D006333 | Heart Failure | Zinc | 10.19 | 17162251 | |
| MESH:D006335 | Heart Injuries | Zinc | 4.25 | 17074742 | |
| MESH:D016481 | Helicobacter Infections | Ciprofloxacin | 6.33 | 17643012 | |
| MESH:D016481 | Helicobacter Infections | Zinc | 6.33 | 17241300 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 7.99 | 6705139 | |
| MESH:D006390 | Hemangioendothelioma | quinoline | 7.99 | 598648 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 10.55 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | 2-nitrotoluene | 10.55 | 13678655 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 10.55 | 15692506 | |
| MESH:D006394 | Hemangiosarcoma | quinoline | 10.55 | 598648 | |
| MESH:D006402 | Hematologic Diseases | Benzene | 6.38 | 16183116 | |
| MESH:D006402 | Hematologic Diseases | Zidovudine | 6.38 | 12579204 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.25 | 16640825 17053826 16574947 17236123 17255318 16604332 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 2.92 | 15720958 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.02 | 16366002 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 3.81 | 11918545 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 1.95 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 3.71 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.18 | 15633222 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 4.01 | 14986274 | |
| MESH:D006505 | Hepatitis | Caffeine | 7.79 | 11394713 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 7.79 | 19900420 19110552 | |
| MESH:D006505 | Hepatitis | Zymosan | 7.79 | 19110552 | |
| MESH:D006509 | Hepatitis B | Lamivudine | 3.70 | 17703166 | |
| MESH:D019694 | Hepatitis B, Chronic | Lamivudine | 3.70 | 15309715 15631357 15274664 16476009 12044531 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.24 | 15135802 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 3.95 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 10.22 | 17182432 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc | 10.22 | 17276780 | |
| MESH:D006527 | Hepatolenticular Degeneration | Zinc Sulfate | 10.22 | 17063115 | |
| MESH:D006529 | Hepatomegaly | fumonisin B1 | 15.46 | 16221962 | |
| MESH:D006529 | Hepatomegaly | Iron | 15.46 | 16890145 | |
| MESH:D006529 | Hepatomegaly | perfluorooctanoic acid | 15.46 | 3609246 | |
| MESH:D006529 | Hepatomegaly | Phenobarbital | 15.46 | 16109766 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 15.46 | 18467677 19772884 16221962 19176532 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 15.46 | 15340226 16120746 12621046 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.56 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Ascorbic Acid | 3.48 | 16863852 16490937 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 3.48 | 7520565 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.51 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 8.11 | 10809021 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 8.11 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 8.11 | 16876885 | |
| MESH:D015658 | HIV Infections | marker/mechanism | 12878215 | ||
| MESH:D015658 | HIV Infections | 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone | 11.66 | 17631934 | |
| MESH:D015658 | HIV Infections | Iron | 11.66 | 16597321 | |
| MESH:D015658 | HIV Infections | Lamivudine | 11.66 | 17530837 20032539 11141242 9296927 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 11.66 | 12878215 | |
| MESH:D015658 | HIV Infections | Stavudine | 11.66 | 11141242 | |
| MESH:D015658 | HIV Infections | Zidovudine | 11.66 | 17358032 11698656 11363243 20032539 11141242 | |
| MESH:D006679 | HIV Seropositivity | Folic Acid | 4.00 | 17209195 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 14.68 | 16200630 16170182 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 14.68 | 16135485 17606976 | |
| MESH:D006689 | Hodgkin Disease | Cytarabine | 14.68 | 16200630 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 14.68 | 15147373 18501091 17606976 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 14.68 | 18180244 15147373 16135485 16200630 17606976 | |
| MESH:D006689 | Hodgkin Disease | Prednisone | 14.68 | 17606976 16135485 16794504 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 14.68 | 12676792 | |
| MESH:D019584 | Hot Flashes | Estradiol | 8.69 | 17088409 | |
| MESH:D019584 | Hot Flashes | Isoflavones | 8.69 | 17290160 14716179 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 8.69 | 16566672 17454163 14716179 | |
| MESH:D006849 | Hydrocephalus | Valproic Acid | 3.37 | 17688650 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.53 | 15340226 16354765 8697196 18606429 16959395 | |
| MESH:D012001 | Hyperacusis | Aspirin | 4.24 | 15240983 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 20.85 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 20.85 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 20.85 | 12727271 | |
| MESH:D006930 | Hyperalgesia | oxaliplatin | 20.85 | 17418472 | |
| MESH:D006930 | Hyperalgesia | perfluorooctanoic acid | 20.85 | 12083418 | |
| MESH:D006930 | Hyperalgesia | rosiglitazone | 20.85 | 12083418 | |
| MESH:D006930 | Hyperalgesia | Tretinoin | 20.85 | 16870215 | |
| MESH:D006930 | Hyperalgesia | zoledronic acid | 20.85 | 16769263 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.19 | 17883296 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.04 | 16899240 | |
| MESH:D006934 | Hypercalcemia | bortezomib | 6.81 | 18089816 | |
| MESH:D006934 | Hypercalcemia | zoledronic acid | 6.81 | 18089816 19622757 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 10.69 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | Dietary Fats | 10.69 | 21332399 | |
| MESH:D006937 | Hypercholesterolemia | Pravastatin | 10.69 | 17188708 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 10.69 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 3.51 | 12524144 | |
| MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.09 | 16778211 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 11.42 | 18262572 | |
| MESH:D006943 | Hyperglycemia | methyl isocyanate | 11.42 | 8440870 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 11.42 | 20558911 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 11.42 | 11834736 18262572 | |
| MESH:D020138 | Hyperhomocysteinemia | Folic Acid | 8.00 | 16865747 16397167 16755160 16433478 16395265 | |
| MESH:D020138 | Hyperhomocysteinemia | Phenytoin | 8.00 | 10459572 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 8.00 | 16484555 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.08 | 17050553 | |
| MESH:D006949 | Hyperlipidemias | Dietary Fats | 14.20 | 21332399 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 14.20 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | Oleanolic Acid | 14.20 | 8847885 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 14.20 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 14.20 | 16873680 | |
| MESH:D006938 | Hyperlipoproteinemia Type II | Simvastatin | 3.93 | 16238680 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 2.98 | 12960047 14722030 | |
| MESH:D006968 | Hypersensitivity, Delayed | Corn Oil | 4.30 | 11484837 | |
| MESH:D006973 | Hypertension | Arsenic | 16.21 | 11953799 9931084 16076760 | |
| MESH:D006973 | Hypertension | Benzene | 16.21 | 17940673 | |
| MESH:D006973 | Hypertension | Cyclosporine | 16.21 | 10903974 | |
| MESH:D006973 | Hypertension | daidzein | 16.21 | 17169123 | |
| MESH:D006973 | Hypertension | Dexamethasone | 16.21 | 17042910 | |
| MESH:D006973 | Hypertension | Phenylephrine | 16.21 | 8949925 12717712 | |
| MESH:D006973 | Hypertension | Quercetin | 16.21 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 16.21 | 15787275 17577099 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 16.21 | 18670907 18850075 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 2.63 | 15338365 | |
| MESH:D006984 | Hypertrophy | Ibuprofen | 6.30 | 16672835 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 6.30 | 12791704 18502941 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 6.18 | 17488730 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | tanshinone | 6.18 | 19662366 | |
| MESH:D006987 | Hypesthesia | Arsenic | 4.04 | 16093927 | |
| MESH:D006996 | Hypocalcemia | zoledronic acid | 4.67 | 12669777 | |
| MESH:D007006 | Hypogonadism | Iron | 3.19 | 16640825 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 6.38 | 16002989 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 6.38 | 16569931 16945680 | |
| MESH:D007022 | Hypotension | Zinc Sulfate | 3.12 | 7265320 | |
| MESH:D007035 | Hypothermia | Tetrahydrocannabinol | 4.47 | 10318961 | |
| MESH:D007037 | Hypothyroidism | Iron | 3.62 | 16640825 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.51 | 10574470 18306037 | |
| MESH:D007079 | Ileitis | Indomethacin | 3.85 | 10647630 16133968 10651667 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 3.82 | 16076520 | |
| MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 9.18 | 16133044 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 9.18 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | pifithrin | 11.12 | 19475672 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | Progesterone | 11.12 | 15869954 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 11.12 | 17600658 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 2.93 | 15036965 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.06 | 12013081 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 16.89 | 16517039 7193160 | |
| MESH:D007248 | Infertility, Male | decitabine | 16.89 | 17581917 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 16.89 | 17937319 | |
| MESH:D007248 | Infertility, Male | fulvestrant | 16.89 | 11514358 | |
| MESH:D007248 | Infertility, Male | Methylnitrosourea | 16.89 | 7193160 | |
| MESH:D007248 | Infertility, Male | Paraquat | 16.89 | 4850670 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 16.89 | 12646999 15346721 | |
| MESH:D007248 | Infertility, Male | vinclozolin | 16.89 | 16467254 | |
| MESH:D007249 | Inflammation | Curcumin | 48.38 | 18403477 16956363 17151092 | |
| MESH:D007249 | Inflammation | Dexamethasone | 48.38 | 11099482 8960868 | |
| MESH:D007249 | Inflammation | Dietary Fats | 48.38 | 20412841 | |
| MESH:D007249 | Inflammation | Diethylnitrosamine | 48.38 | 18785209 | |
| MESH:D007249 | Inflammation | Flavonoids | 48.38 | 17296493 | |
| MESH:D007249 | Inflammation | Ibuprofen | 48.38 | 3291741 | |
| MESH:D007249 | Inflammation | Indomethacin | 48.38 | 3291741 12568917 7812673 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 48.38 | 17963957 9205823 17237260 12878042 17255318 | |
| MESH:D007249 | Inflammation | Mustard Gas | 48.38 | 8975870 9260866 9357497 11428620 17524151 11428647 11428631 11402378 16001271 | |
| MESH:D007249 | Inflammation | Oleanolic Acid | 48.38 | 8847885 | |
| MESH:D007249 | Inflammation | perfluorooctanoic acid | 48.38 | 12083418 | |
| MESH:D007249 | Inflammation | pioglitazone | 48.38 | 16908763 | |
| MESH:D007249 | Inflammation | Plant Extracts | 48.38 | 12787963 16366677 15997105 19332304 | |
| MESH:D007249 | Inflammation | Prednisone | 48.38 | 16111148 | |
| MESH:D007249 | Inflammation | Progesterone | 48.38 | 15869954 | |
| MESH:D007249 | Inflammation | resveratrol | 48.38 | 16366677 | |
| MESH:D007249 | Inflammation | rosiglitazone | 48.38 | 12083418 | |
| MESH:D007249 | Inflammation | Sulindac | 48.38 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 48.38 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 48.38 | 12878042 12200463 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 48.38 | 8273558 15177302 11698051 7562506 7812673 | |
| MESH:D007249 | Inflammation | Zymosan | 48.38 | 8014878 11289658 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 2.39 | 18596194 18200517 | |
| MESH:D007251 | Influenza, Human | pyrrolidine dithiocarbamic acid | 14.54 | 18473937 | |
| MESH:D007251 | Influenza, Human | Quercetin | 14.54 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 14.54 | 16624496 | |
| MESH:D007251 | Influenza, Human | Selenium | 14.54 | 16624496 | |
| MESH:D007333 | Insulin Resistance | Berberine | 13.87 | 18563319 | |
| MESH:D007333 | Insulin Resistance | bisphenol A | 13.87 | 16393666 | |
| MESH:D007333 | Insulin Resistance | Dietary Fats | 13.87 | 18457598 11836018 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 13.87 | 16627594 16393666 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 13.87 | 16306350 | |
| MESH:D007333 | Insulin Resistance | rosiglitazone | 13.87 | 16306350 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 5.09 | 17329856 10210152 15831440 17994277 11855677 18236018 11686837 11713966 15610444 | |
| MESH:D007410 | Intestinal Diseases | Tretinoin | 5.09 | 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | marker/mechanism|therapeutic | 11535846 12468628 | ||
| MESH:D007414 | Intestinal Neoplasms | 1,4-phenylenebis(methylene)selenocyanate | 16.32 | 10753194 | |
| MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 16.32 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 16.32 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 16.32 | 12628509 12351151 12584176 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 16.32 | 10213222 12663524 12351151 10223192 12628509 12584176 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 3.57 | 12394442 11245490 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 3.85 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 6.88 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 6.88 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.34 | 17553498 | |
| MESH:D007511 | Ischemia | Zinc | 3.18 | 16584753 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 9.17 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 9.17 | 16580747 | |
| MESH:D007569 | Jaw Abnormalities | Tretinoin | 9.17 | 15992940 17551590 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.51 | 16133968 10574470 18306037 | |
| MESH:D007627 | Keloid | Quercetin | 3.48 | 17086741 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 2.92 | 15604871 | |
| MESH:D007642 | Keratosis | Arsenic | 3.49 | 12749816 16930632 | |
| MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.14 | 16144296 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.63 | 15464296 | |
| MESH:D007674 | Kidney Diseases | marker/mechanism | 16968891 | ||
| MESH:D007674 | Kidney Diseases | Acetaminophen | 43.21 | 15629191 12587719 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 43.21 | 16226777 16962696 16322080 | |
| MESH:D007674 | Kidney Diseases | Cadmium Chloride | 43.21 | 16962696 | |
| MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 43.21 | 15369732 | |
| MESH:D007674 | Kidney Diseases | Chromium | 43.21 | 17934191 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 43.21 | 18289764 12231392 12649298 19839026 15190930 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 43.21 | 8314463 10903974 18776723 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 43.21 | 15369732 16775033 15699352 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 43.21 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 43.21 | 17190690 | |
| MESH:D007674 | Kidney Diseases | ochratoxin A | 43.21 | 11409539 | |
| MESH:D007674 | Kidney Diseases | Potassium Dichromate | 43.21 | 19665454 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 43.21 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 43.21 | 20008137 | |
| MESH:D007674 | Kidney Diseases | Streptozocin | 43.21 | 12093613 | |
| MESH:D007674 | Kidney Diseases | tempol | 43.21 | 17640563 | |
| MESH:D007674 | Kidney Diseases | Zinc | 43.21 | 16960431 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 12.57 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 12.57 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Selenium | 12.57 | 16518626 | |
| MESH:D007676 | Kidney Failure, Chronic | Zinc | 12.57 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 25.39 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 25.39 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 25.39 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 25.39 | 15003126 16762066 14681315 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 25.39 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Ethylnitrosourea | 25.39 | 17379185 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 25.39 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | ochratoxin A | 25.39 | 16251485 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 25.39 | 18625569 | |
| MESH:D007680 | Kidney Neoplasms | Zidovudine | 25.39 | 12579204 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.29 | 11231351 | |
| MESH:D007805 | Language Development Disorders | Methotrexate | 3.68 | 9562676 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 5.01 | 17184923 | |
| MESH:D007859 | Learning Disorders | Ethanol | 5.01 | 15451040 | |
| MESH:D007889 | Leiomyoma | Curcumin | 6.45 | 18555241 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 6.45 | 16973256 | |
| MESH:D007896 | Leishmaniasis | Antimony | 3.52 | 15220340 21063981 12019027 10953559 21182181 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Antimony | 9.33 | 19141829 8889330 11475954 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 9.33 | 11703811 12228301 10320625 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Ketoconazole | 9.33 | 1311351 19744259 8889330 2166429 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Zinc Sulfate | 9.33 | 15237267 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Antimony | 4.01 | 11370249 10881086 10651420 7854095 9643325 | |
| MESH:D007898 | Leishmaniasis, Visceral | Antimony | 6.26 | 1899875 11105143 20495762 7854095 7554475 8142506 7875148 | |
| MESH:D007898 | Leishmaniasis, Visceral | Antimony Potassium Tartrate | 6.26 | 12707265 | |
| MESH:D007898 | Leishmaniasis, Visceral | Ketoconazole | 6.26 | 11332679 | |
| MESH:D007938 | Leukemia | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 44.49 | 12970779 | |
| MESH:D007938 | Leukemia | (2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide | 44.49 | 17352252 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 44.49 | 15070760 | |
| MESH:D007938 | Leukemia | Azacitidine | 44.49 | 19148494 | |
| MESH:D007938 | Leukemia | Benzene | 44.49 | 14694614 18335105 15935818 17119257 | |
| MESH:D007938 | Leukemia | Curcumin | 44.49 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 44.49 | 10602166 | |
| MESH:D007938 | Leukemia | decitabine | 44.49 | 18980019 19235587 | |
| MESH:D007938 | Leukemia | Genistein | 44.49 | 18980019 17468513 | |
| MESH:D007938 | Leukemia | kaempferol | 44.49 | 17468513 | |
| MESH:D007938 | Leukemia | LAQ824 | 44.49 | 16275999 | |
| MESH:D007938 | Leukemia | metacept-1 | 44.49 | 19148494 | |
| MESH:D007938 | Leukemia | Quercetin | 44.49 | 17468513 | |
| MESH:D007938 | Leukemia | roscovitine | 44.49 | 16275999 | |
| MESH:D007938 | Leukemia | SN50 peptide | 44.49 | 12970779 | |
| MESH:D007938 | Leukemia | Tretinoin | 44.49 | 17143497 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 9.21 | 16085563 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | troglitazone | 9.21 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 4.16 | 17802794 17296974 18172266 17008537 17658394 18587576 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | fludarabine | 4.16 | 18172266 18587576 17802794 17296974 17658394 | |
| MESH:D007945 | Leukemia, Lymphoid | Toxaphene | 4.79 | 16132792 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 15.88 | 17077332 12560223 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | bortezomib | 15.88 | 18089816 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 15.88 | 16106398 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 15.88 | 20370541 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | zoledronic acid | 15.88 | 18089816 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | anthra(1,9-cd)pyrazol-6(2H)-one | 16.06 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 16.06 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 16.06 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 16.06 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 6.92 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 6.92 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 6.92 | 10785260 16572323 15631656 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 19.61 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Azacitidine | 19.61 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Benzene | 19.61 | 17506065 | |
| MESH:D007951 | Leukemia, Myeloid | decitabine | 19.61 | 17236224 19117987 18454857 | |
| MESH:D007951 | Leukemia, Myeloid | Hydroxyurea | 19.61 | 16532439 | |
| MESH:D007951 | Leukemia, Myeloid | Tretinoin | 19.61 | 16482212 19285840 16932348 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 14.79 | 19850784 17050201 16467208 20471514 16968895 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 14.79 | 17596541 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 14.79 | 19478238 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | bortezomib | 14.79 | 20471514 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | decitabine | 14.79 | 18460780 19010910 17679729 19387464 18206229 18704418 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Deferoxamine | 14.79 | 20368581 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 14.79 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 14.79 | 16294345 17596541 19850784 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 14.79 | 18206229 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 14.79 | 16294345 17596541 | |
| MESH:D015477 | Leukemia, Myelomonocytic, Chronic | decitabine | 3.94 | 18055864 | |
| MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 3.77 | 19299654 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Am 80 | 25.24 | 16819260 16531727 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Antimony Potassium Tartrate | 25.24 | 9834237 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 25.24 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 25.24 | 17712046 17107899 9834237 17217047 15213294 19642359 16891316 12018890 19035177 17869043 17649720 15622746 16112521 19225113 12712474 16966277 16823087 16330433 11468182 15748426 19075265 12679006 15336539 16331271 11161223 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 25.24 | 16766008 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | dracorhodin | 25.24 | 16864444 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 25.24 | 16087638 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Thiophenes | 25.24 | 16140955 16140954 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 25.24 | 17339181 15748426 19075265 17368321 16788101 19642359 9834237 16766008 17107899 16331271 19035177 17712046 17506722 17294898 16935935 17649720 16823087 17301526 19225113 12679006 16891316 17361223 19029980 17217047 16140955 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 6.92 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 6.92 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 3.85 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.19 | 17980183 | |
| MESH:D007970 | Leukopenia | Ciprofloxacin | 11.22 | 17846019 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 11.22 | 10052129 11830472 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 11.22 | 15821434 | |
| MESH:D007972 | Leukoplakia, Oral | Fenretinide | 4.52 | 16707609 | |
| MESH:D020961 | Lewy Body Disease | Iron | 3.95 | 16563566 | |
| MESH:D007984 | Leydig Cell Tumor | perfluorooctanoic acid | 7.99 | 8812269 | |
| MESH:D007984 | Leydig Cell Tumor | vinclozolin | 7.99 | 16417039 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 6.70 | 17676605 | |
| MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 6.70 | 15526292 | |
| MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 6.70 | 9224671 | |
| MESH:D008064 | Lipidoses | Ketoconazole | 4.27 | 17567588 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 4.27 | 15342952 17567588 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.40 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.19 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 21.04 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 21.04 | 17174718 11408273 17157831 16943688 17334410 11903743 21278145 16239168 16221502 | |
| MESH:D008103 | Liver Cirrhosis | Dietary Fats | 21.04 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Diethylnitrosamine | 21.04 | 18665156 19638242 18407596 20032147 18522880 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 21.04 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 21.04 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Methotrexate | 21.04 | 14986274 | |
| MESH:D008103 | Liver Cirrhosis | Phenobarbital | 21.04 | 21047994 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 21.04 | 17157831 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 3.60 | 18295389 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 3.09 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 36.19 | 18420326 18279442 16116963 15925388 18705752 14716496 15057751 15818738 16192424 18395914 12632512 10355542 17631135 18251166 12609069 12389079 18395095 17640975 17565644 17557913 15123356 15876570 18166357 12445421 17766677 12666154 18481824 14620537 18339082 18418968 18187930 17721639 15362042 12445418 16027843 18412020 16097048 17823541 11481614 15730626 20821823 18054572 12586293 12898905 17900296 12667390 14716833 16248980 14724832 18156304 12741479 17708605 16033810 18205269 15996030 17761835 12958196 16015684 18317297 17805973 17944888 12546737 16011737 17525996 15959796 17698563 18263696 18376398 16136751 15673190 15650968 12632514 15052691 15370692 17976157 18006644 14748882 15338365 15893842 13678700 18277467 17714472 18472332 18429990 18472094 18210741 12649538 14512876 17922224 15931870 17481882 17869086 16638106 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 36.19 | 17355460 18705752 18006644 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 36.19 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dimethylnitrosamine | 36.19 | 15138612 16603200 17348192 15571005 12925901 15369754 17465448 14643895 18239293 14726149 17881167 17203207 16042886 15383259 17036385 16570917 17666798 17201889 15577212 17724770 16544323 16009107 17198567 16169303 15067225 15723089 16627068 15161499 15492853 14568256 15298665 15591649 15763062 18567088 18095165 12918455 15864749 18371158 17719030 15339415 15081153 15086199 15942678 17640959 15479170 17196135 18364076 15733078 18672772 15504291 14659978 18210741 14709902 15366600 17432682 15744066 15099470 18237412 15842777 18629640 17534399 15798949 18637143 16270385 15793283 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 36.19 | 16439617 16595196 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 36.19 | 17481882 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 36.19 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 36.19 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Fenofibrate | 36.19 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | ferulic acid | 36.19 | 16011737 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 36.19 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 36.19 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 36.19 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Oleanolic Acid | 36.19 | 10355542 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pioglitazone | 36.19 | 15052691 16484506 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 36.19 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 36.19 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Preparations | 36.19 | 17724770 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pyrrolidine dithiocarbamic acid | 36.19 | 15078482 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 36.19 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 36.19 | 15980055 17347453 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | silybin | 36.19 | 16169303 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 36.19 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 36.19 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 36.19 | 16248980 18397230 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 21.01 | 16611625 12587719 19784758 19014921 12969438 11587558 19460945 16610002 | |
| MESH:D008107 | Liver Diseases | Arsenic | 21.01 | 11134558 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 21.01 | 15720792 16964402 15830285 17285989 16246199 | |
| MESH:D008107 | Liver Diseases | Curcumin | 21.01 | 16956363 | |
| MESH:D008107 | Liver Diseases | Diethylnitrosamine | 21.01 | 17034775 | |
| MESH:D008107 | Liver Diseases | Folic Acid | 21.01 | 16877991 | |
| MESH:D008107 | Liver Diseases | Hemin | 21.01 | 17173083 | |
| MESH:D008107 | Liver Diseases | Lindane | 21.01 | 1715830 | |
| MESH:D008107 | Liver Diseases | Oleanolic Acid | 21.01 | 15720792 8847885 | |
| MESH:D008107 | Liver Diseases | Phenobarbital | 21.01 | 19363144 | |
| MESH:D008107 | Liver Diseases | Phenytoin | 21.01 | 14986274 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 21.01 | 17034775 | |
| MESH:D008107 | Liver Diseases | Sulindac | 21.01 | 16867024 14986274 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Chlormethiazole | 10.85 | 16054987 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 10.85 | 17207112 17347304 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 10.85 | 17207112 16737972 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 6.98 | 15123358 | |
| MESH:D017093 | Liver Failure | Stavudine | 6.98 | 18299183 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 8.40 | 17185352 16871587 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 8.40 | 16899240 14706259 | |
| MESH:D017114 | Liver Failure, Acute | Dimethylnitrosamine | 8.40 | 17457977 | |
| MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 74.23 | 7678174 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 74.23 | 16273603 10737359 14678523 10672840 11376686 18001218 | |
| MESH:D008113 | Liver Neoplasms | 2-nitrofluorene | 74.23 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid | 74.23 | 21071580 | |
| MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 74.23 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | Aflatoxin B1 | 74.23 | 9163691 2125692 15890375 18177683 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 74.23 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 74.23 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 74.23 | 21137059 20195826 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 74.23 | 19389873 21295105 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 74.23 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Dehydroepiandrosterone | 74.23 | 18709148 | |
| MESH:D008113 | Liver Neoplasms | Diethylnitrosamine | 74.23 | 20492335 20118626 10737359 19850985 2862719 20452335 19642983 20501860 21047994 19812893 21167192 19254457 21071580 18644402 2422723 18978307 16942905 18977376 19833225 20434301 19996281 15885732 19255062 19090486 20583210 19551842 19073162 20101389 19427195 19294768 12112319 18754104 19638242 18648771 19690152 15175105 20405173 9163691 12771043 21278145 20137499 19499222 19256749 19426721 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 74.23 | 15890375 16712894 | |
| MESH:D008113 | Liver Neoplasms | Dimethylnitrosamine | 74.23 | 15890375 3113478 | |
| MESH:D008113 | Liver Neoplasms | Fenofibrate | 74.23 | 18978307 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 74.23 | 15113037 18383874 16603448 17045692 | |
| MESH:D008113 | Liver Neoplasms | Iron | 74.23 | 20302851 16640825 | |
| MESH:D008113 | Liver Neoplasms | Methapyrilene | 74.23 | 15890375 | |
| MESH:D008113 | Liver Neoplasms | perfluorooctanoic acid | 74.23 | 18709148 14757943 | |
| MESH:D008113 | Liver Neoplasms | Phenobarbital | 74.23 | 19073162 8742319 21047994 19812893 19482888 15975961 | |
| MESH:D008113 | Liver Neoplasms | Piperonyl Butoxide | 74.23 | 18648771 15890375 19690152 20101389 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 74.23 | 15890375 20007298 16377806 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 74.23 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 74.23 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 74.23 | 19073162 19321006 20405173 19812893 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 74.23 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 74.23 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 74.23 | 16984957 | |
| MESH:D008113 | Liver Neoplasms | Urethane | 74.23 | 17093202 16391232 17559639 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 54.14 | 2876786 6135515 2876784 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 54.14 | 534488 1399818 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Aflatoxin B1 | 54.14 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 54.14 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Ascorbic Acid | 54.14 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 54.14 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 54.14 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 54.14 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dehydroepiandrosterone | 54.14 | 8603461 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Diethylnitrosamine | 54.14 | 17942915 21159647 16842330 17854601 9362446 16267830 18308698 19004024 3124819 17174075 19519916 19009564 19126423 2563599 18093689 18544905 18282651 18079962 18775883 19539802 18164116 18253720 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Dimethylnitrosamine | 54.14 | 1848544 15603536 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 54.14 | 17085340 16842330 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Fenofibrate | 54.14 | 18253720 18775883 | |
| MESH:D008114 | Liver Neoplasms, Experimental | kojic acid | 54.14 | 18544905 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Methylcholanthrene | 54.14 | 598648 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | o-Aminoazotoluene | 54.14 | 15346788 10887293 16267830 12882633 11398193 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Phenobarbital | 54.14 | 2563599 17172636 1399818 18308698 6150874 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Polychlorinated Biphenyls | 54.14 | 1423854 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 54.14 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | styrene oxide | 54.14 | 12562636 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 54.14 | 12151625 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 2.15 | 15213294 | |
| MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 3.99 | 16080182 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 13.57 | 12815614 | |
| MESH:D008171 | Lung Diseases | Ascorbic Acid | 13.57 | 16863852 | |
| MESH:D008171 | Lung Diseases | methyl isocyanate | 13.57 | 1396463 | |
| MESH:D008171 | Lung Diseases | Mustard Gas | 13.57 | 18161513 18702808 | |
| MESH:D008171 | Lung Diseases | Ozone | 13.57 | 19066396 8266340 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 13.57 | 19095001 | |
| MESH:D017563 | Lung Diseases, Interstitial | Benzene | 10.55 | 14698565 | |
| MESH:D017563 | Lung Diseases, Interstitial | Methotrexate | 10.55 | 18516814 | |
| MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 10.55 | 17228818 | |
| MESH:D055370 | Lung Injury | Ciprofloxacin | 13.23 | 18197910 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 13.23 | 21114838 | |
| MESH:D055370 | Lung Injury | Oxygen | 13.23 | 18339021 | |
| MESH:D055370 | Lung Injury | Ozone | 13.23 | 20417186 | |
| MESH:D055370 | Lung Injury | pyrrolidine dithiocarbamic acid | 13.23 | 16129981 | |
| MESH:D008175 | Lung Neoplasms | marker/mechanism | 18508827 12466968 | ||
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 92.58 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 92.58 | 15893417 16401635 19931552 17139156 18508827 12438228 14755239 15172992 16061637 9255578 18813816 | |
| MESH:D008175 | Lung Neoplasms | Acrylonitrile | 92.58 | 17372256 | |
| MESH:D008175 | Lung Neoplasms | Aflatoxin B1 | 92.58 | 14755239 | |
| MESH:D008175 | Lung Neoplasms | alitretinoin | 92.58 | 16413115 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 92.58 | 19168569 17306315 17976673 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 92.58 | 19825857 11798837 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 92.58 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Ascorbic Acid | 92.58 | 16401635 | |
| MESH:D008175 | Lung Neoplasms | Azacitidine | 92.58 | 21224363 | |
| MESH:D008175 | Lung Neoplasms | Azoxymethane | 92.58 | 15824018 | |
| MESH:D008175 | Lung Neoplasms | Benzene | 92.58 | 12562636 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 92.58 | 20064080 18520028 20135361 17053015 18569708 20464547 6695378 18816296 20869020 | |
| MESH:D008175 | Lung Neoplasms | Budesonide | 92.58 | 17163412 16885199 12117777 | |
| MESH:D008175 | Lung Neoplasms | Ciprofloxacin | 92.58 | 20211752 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 92.58 | 17225452 11798837 6189445 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 92.58 | 16243823 19359593 18462866 | |
| MESH:D008175 | Lung Neoplasms | deguelin | 92.58 | 19336726 16288123 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 92.58 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Diethylnitrosamine | 92.58 | 20970405 6695378 21163286 20512841 | |
| MESH:D008175 | Lung Neoplasms | Dimethylnitrosamine | 92.58 | 16061637 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 92.58 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | (E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide | 92.58 | 15528975 | |
| MESH:D008175 | Lung Neoplasms | Ethylnitrosourea | 92.58 | 6695378 17703301 16019985 16271038 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 92.58 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 92.58 | 11053908 11497255 16537180 | |
| MESH:D008175 | Lung Neoplasms | Iron | 92.58 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | Isotretinoin | 92.58 | 15899809 | |
| MESH:D008175 | Lung Neoplasms | Methylcholanthrene | 92.58 | 20970405 16337739 9230183 15390079 1399818 16271038 17909032 20512841 21163286 10545420 11893704 7750092 6695378 | |
| MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 92.58 | 18062963 | |
| MESH:D008175 | Lung Neoplasms | Mustard Gas | 92.58 | 8781369 3148597 | |
| MESH:D008175 | Lung Neoplasms | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide | 92.58 | 21224363 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 92.58 | 7614698 8597069 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 92.58 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Polycyclic Hydrocarbons, Aromatic | 92.58 | 10814675 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 92.58 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | silybin | 92.58 | 16788158 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 92.58 | 16712894 19931552 17077188 15276417 17306315 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 92.58 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 92.58 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 92.58 | 11884234 19555203 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 92.58 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Urethane | 92.58 | 11307925 11807781 11074608 17093202 7750092 16204055 11552296 17195641 11062179 16926031 14587096 11323394 16007126 10530776 16337739 10997738 11246140 12117781 16391232 16788158 15136453 12957351 11893704 11497255 15166089 16289808 12466968 11544531 12765245 15902970 6695378 17255336 10779650 10822126 11992545 | |
| MESH:D008175 | Lung Neoplasms | Vehicle Emissions | 92.58 | 9255578 | |
| MESH:D008175 | Lung Neoplasms | vinyl carbamate | 92.58 | 12117777 12438228 15824018 16885199 17361011 15172992 11134547 16247444 17163412 17363558 14755239 12765245 11195469 | |
| MESH:D008175 | Lung Neoplasms | Zidovudine | 92.58 | 18800350 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 3.30 | 15086387 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Folic Acid | 2.73 | 17718048 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 3.65 | 15166399 | |
| MESH:D008223 | Lymphoma | Benzene | 38.85 | 17119257 17584886 | |
| MESH:D008223 | Lymphoma | bortezomib | 38.85 | 16098063 | |
| MESH:D008223 | Lymphoma | Chlorambucil | 38.85 | 10745627 | |
| MESH:D008223 | Lymphoma | Curcumin | 38.85 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 38.85 | 12854902 | |
| MESH:D008223 | Lymphoma | decitabine | 38.85 | 19470736 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 38.85 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 38.85 | 16098063 | |
| MESH:D008223 | Lymphoma | Ethylnitrosourea | 38.85 | 15790496 | |
| MESH:D008223 | Lymphoma | Etoposide | 38.85 | 12556972 12854902 | |
| MESH:D008223 | Lymphoma | Methotrexate | 38.85 | 17352296 | |
| MESH:D008223 | Lymphoma | Methylnitrosourea | 38.85 | 11418001 16257854 | |
| MESH:D008223 | Lymphoma | TT 232 | 38.85 | 12556972 | |
| MESH:D016393 | Lymphoma, B-Cell | bortezomib | 13.07 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 13.07 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 13.07 | 14633661 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 13.07 | 17088997 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 10.04 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 10.04 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 10.04 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 10.04 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 11.06 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 11.06 | 15621674 | |
| MESH:D016399 | Lymphoma, T-Cell | Ethylnitrosourea | 11.06 | 15375218 | |
| MESH:D016410 | Lymphoma, T-Cell, Cutaneous | vorinostat | 4.21 | 20479100 | |
| MESH:D008268 | Macular Degeneration | Iron | 2.94 | 16640825 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 3.99 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Acrylonitrile | 12.02 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 12.02 | 12562636 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 12.02 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 12.02 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 1,4-phenylenebis(methylene)selenocyanate | 65.38 | 12844480 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 1,4-phenylenebis(methylene)selenocyanate, glutathione conjugate | 65.38 | 12844480 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 2,4-diaminotoluene | 65.38 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 65.38 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | celecoxib | 65.38 | 19196722 12104042 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Corticosterone | 65.38 | 12807724 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Dehydroepiandrosterone | 65.38 | 16457693 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 65.38 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 65.38 | 17203775 11408345 16891317 11807958 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ethylnitrosourea | 65.38 | 18041768 10838139 10767621 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Fenretinide | 65.38 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 65.38 | 12929590 14578162 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 65.38 | 10697514 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | methyleugenol | 65.38 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 65.38 | 15688392 15113128 17020996 14999141 17131329 11807958 16944150 11751437 10838139 15313902 16051031 16619500 10767621 16827153 19196723 14633655 12931682 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | ochratoxin A | 65.38 | 11921183 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Progesterone | 65.38 | 17203775 11408345 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 65.38 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 65.38 | 16827153 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 65.38 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 65.38 | 19196722 16827153 19196723 14580682 11731420 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 65.38 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 65.38 | 12773700 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | zoledronic acid | 65.38 | 17312309 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 7.63 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 7.63 | 19453300 | |
| MESH:D019767 | Maxillofacial Abnormalities | Folic Acid | 4.19 | 16832597 | |
| MESH:D008527 | Medulloblastoma | bortezomib | 3.88 | 19213072 | |
| MESH:D008527 | Medulloblastoma | Tretinoin | 3.88 | 17453147 | |
| MESH:D008545 | Melanoma | Carboplatin | 39.06 | 11712820 12040289 16225601 16342250 | |
| MESH:D008545 | Melanoma | Carmustine | 39.06 | 12393984 | |
| MESH:D008545 | Melanoma | Cisplatin | 39.06 | 17023156 12393984 12374674 12883367 16809738 11135225 18505091 18176117 16432458 15577323 16248763 18332650 17761969 | |
| MESH:D008545 | Melanoma | Curcumin | 39.06 | 17885582 18462866 | |
| MESH:D008545 | Melanoma | decitabine | 39.06 | 16505122 17785578 | |
| MESH:D008545 | Melanoma | Dinitrochlorobenzene | 39.06 | 17334785 12202904 | |
| MESH:D008545 | Melanoma | Doxorubicin | 39.06 | 16827129 | |
| MESH:D008545 | Melanoma | dracorhodin | 39.06 | 15684474 | |
| MESH:D008545 | Melanoma | epigallocatechin gallate | 39.06 | 11746506 17992120 | |
| MESH:D008545 | Melanoma | Fenretinide | 39.06 | 16270382 | |
| MESH:D008545 | Melanoma | Isotretinoin | 39.06 | 17237267 | |
| MESH:D008545 | Melanoma | LAQ824 | 39.06 | 17237267 | |
| MESH:D008545 | Melanoma | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 39.06 | 16487513 | |
| MESH:D008545 | Melanoma | Paclitaxel | 39.06 | 12025231 12040289 16342250 | |
| MESH:D008545 | Melanoma | resveratrol | 39.06 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 39.06 | 16487513 19082730 | |
| MESH:D008545 | Melanoma | Sulindac | 39.06 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 39.06 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Tretinoin | 39.06 | 16752155 | |
| MESH:D008545 | Melanoma | trichostatin A | 39.06 | 16505122 | |
| MESH:D008545 | Melanoma | TT 232 | 39.06 | 12556972 | |
| MESH:D008545 | Melanoma | Vitamin K 3 | 39.06 | 19082730 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 6.58 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 6.58 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 5.99 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 5.99 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 5.05 | 17263510 | |
| MESH:D008569 | Memory Disorders | Ethanol | 5.05 | 18411066 15451040 | |
| MESH:D008579 | Meningioma | Ethylnitrosourea | 4.46 | 17943659 | |
| MESH:D008591 | Meningomyelocele | Tretinoin | 2.95 | 16940565 | |
| MESH:D008607 | Mental Retardation | Phenytoin | 2.95 | 9212184 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 9.34 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 9.34 | 17638057 | |
| MESH:D008654 | Mesothelioma | hexamethylene bisacetamide | 9.34 | 15543656 | |
| MESH:D008654 | Mesothelioma | Selenium | 9.34 | 15107826 | |
| MESH:D008654 | Mesothelioma | zoledronic acid | 9.34 | 16675582 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 2.99 | 17112576 | |
| MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 3.07 | 17261469 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.26 | 16801185 | |
| MESH:D008679 | Metaplasia | Ozone | 3.59 | 10496685 | |
| MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.31 | 17358032 | |
| MESH:D008850 | Microphthalmos | ochratoxin A | 4.34 | 20036863 | |
| MESH:D053842 | Microsatellite Instability | Methylnitronitrosoguanidine | 4.39 | 17671175 | |
| MESH:D008881 | Migraine Disorders | Aspirin | 5.70 | 15240983 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 5.70 | 11903285 | |
| MESH:D008881 | Migraine Disorders | Valproic Acid | 5.70 | 18765137 18803445 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.10 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 4.03 | 15863610 | |
| MESH:D009006 | Monosomy | Azacitidine | 4.56 | 19299654 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 13.57 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Fenretinide | 13.57 | 16274795 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 13.57 | 18986760 16757204 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 13.57 | 12636206 | |
| MESH:D009062 | Mouth Neoplasms | Plant Preparations | 13.57 | 17418620 | |
| MESH:D052016 | Mucositis | Doxorubicin | 12.57 | 17415656 | |
| MESH:D052016 | Mucositis | irinotecan | 12.57 | 17159606 | |
| MESH:D052016 | Mucositis | Methotrexate | 12.57 | 17488658 | |
| MESH:D009101 | Multiple Myeloma | Am 80 | 44.51 | 17229644 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 44.51 | 14977855 11468182 15949261 19549372 19417148 | |
| MESH:D009101 | Multiple Myeloma | Azacitidine | 44.51 | 19549372 18443271 | |
| MESH:D009101 | Multiple Myeloma | Benzene | 44.51 | 17119195 | |
| MESH:D009101 | Multiple Myeloma | bortezomib | 44.51 | 19372569 19112817 19112201 | |
| MESH:D009101 | Multiple Myeloma | celecoxib | 44.51 | 16123214 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 44.51 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | decitabine | 44.51 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 44.51 | 15744524 15867202 16118317 | |
| MESH:D009101 | Multiple Myeloma | netoglitazone | 44.51 | 14977855 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 44.51 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 44.51 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 44.51 | 16490592 17164350 17049120 14749477 16267019 17935668 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 44.51 | 18172295 | |
| MESH:D009101 | Multiple Myeloma | zoledronic acid | 44.51 | 19621390 16996129 18089719 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 3.80 | 12879239 18160304 15213630 15241586 17724436 10479408 15834315 15259001 10890648 12130978 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 4.15 | 17086897 | |
| MESH:D019042 | Muscle Neoplasms | 2-nitrotoluene | 5.16 | 13678655 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 12.59 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 12.59 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 12.59 | 17962980 | |
| MESH:D009135 | Muscular Diseases | Glucocorticoids | 6.08 | 15946989 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 6.08 | 16239165 | |
| MESH:D020391 | Muscular Dystrophy, Facioscapulohumeral | marker/mechanism | 12868502 | ||
| MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 2.64 | 8888407 | |
| MESH:D009164 | Mycobacterium Infections | Ciprofloxacin | 4.08 | 10063276 | |
| MESH:D009181 | Mycoses | Iron | 3.95 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.16 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 17.89 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 17.89 | 17611569 19805378 18720364 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Ciprofloxacin | 17.89 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | decitabine | 17.89 | 16882708 19010910 19157545 18608210 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 17.89 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 17.89 | 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 17.89 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | Aspirin | 15.41 | 12692751 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 15.41 | 15857846 19429709 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 15.41 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 15.41 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | Pravastatin | 15.41 | 17188708 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 15.41 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 15.41 | 16525036 16456233 17188708 17015251 16317513 17125593 | |
| MESH:D009203 | Myocardial Infarction | SB 216763 | 15.41 | 16288908 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 11.28 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 11.28 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 11.28 | 17125593 17015251 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 11.28 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 13.29 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 13.29 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 13.29 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 13.29 | 16411023 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 13.29 | 19207477 | |
| MESH:D009205 | Myocarditis | Particulate Matter | 7.49 | 12563109 | |
| MESH:D009205 | Myocarditis | resveratrol | 7.49 | 17322642 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenobarbital | 7.55 | 17484760 | |
| MESH:D020191 | Myoclonic Epilepsies, Progressive | Phenytoin | 7.55 | 17484760 | |
| MESH:D009224 | Myotonia Congenita | Phenytoin | 3.92 | 1896199 | |
| MESH:D009232 | Myxoma | Raloxifene | 4.03 | 16343187 | |
| MESH:D009325 | Nausea | Aspirin | 7.23 | 15240983 | |
| MESH:D009325 | Nausea | vorinostat | 7.23 | 20479100 | |
| MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 9.39 | 18551238 | |
| MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 9.39 | 7678174 18551238 | |
| MESH:D009336 | Necrosis | 2-nitropropane | 9.39 | 12195237 | |
| MESH:D016870 | Neisseriaceae Infections | Ciprofloxacin | 4.85 | 20378725 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 5.57 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 5.57 | 18495463 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 21.61 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Diethylnitrosamine | 21.61 | 3581430 9029167 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 21.61 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 21.61 | 16537180 11239499 11053908 | |
| MESH:D009362 | Neoplasm Metastasis | irinotecan | 21.61 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 21.61 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | pentaacetyl geniposide | 21.61 | 19464279 | |
| MESH:D009362 | Neoplasm Metastasis | quinoline | 21.61 | 598648 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 21.61 | 19393235 | |
| MESH:D009362 | Neoplasm Metastasis | zoledronic acid | 21.61 | 17312309 19139120 15867366 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.81 | 19410462 | |
| MESH:D009369 | Neoplasms | 4-phenylbutyric acid | 58.74 | 19116145 | |
| MESH:D009369 | Neoplasms | alitretinoin | 58.74 | 16946489 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 58.74 | 11141357 | |
| MESH:D009369 | Neoplasms | Berberine | 58.74 | 12415430 | |
| MESH:D009369 | Neoplasms | Carboplatin | 58.74 | 17925555 18854779 | |
| MESH:D009369 | Neoplasms | Cisplatin | 58.74 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 58.74 | 18854779 | |
| MESH:D009369 | Neoplasms | decitabine | 58.74 | 19116145 17925555 19470736 | |
| MESH:D009369 | Neoplasms | deguelin | 58.74 | 17764071 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 58.74 | 15313581 | |
| MESH:D009369 | Neoplasms | Fenretinide | 58.74 | 17353921 15958647 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 58.74 | 18600527 16928823 18239605 | |
| MESH:D009369 | Neoplasms | Lindane | 58.74 | 16818664 12807735 | |
| MESH:D009369 | Neoplasms | lycopene | 58.74 | 17051425 | |
| MESH:D009369 | Neoplasms | Methylnitrosourea | 58.74 | 15533788 | |
| MESH:D009369 | Neoplasms | Nicotine | 58.74 | 16365874 | |
| MESH:D009369 | Neoplasms | Oleanolic Acid | 58.74 | 8847885 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 58.74 | 17405874 | |
| MESH:D009369 | Neoplasms | Quercetin | 58.74 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 58.74 | 11559025 | |
| MESH:D009369 | Neoplasms | TDP 521252 | 58.74 | 16432175 | |
| MESH:D009369 | Neoplasms | TDP 665759 | 58.74 | 16432175 | |
| MESH:D009369 | Neoplasms | Toxaphene | 58.74 | 8820588 | |
| MESH:D009369 | Neoplasms | Tretinoin | 58.74 | 16946489 16594593 | |
| MESH:D009369 | Neoplasms | Urethane | 58.74 | 15625555 | |
| MESH:D009374 | Neoplasms, Experimental | Ethylnitrosourea | 17.04 | 16707424 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 17.04 | 15625704 10663608 | |
| MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 17.04 | 12696579 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 17.04 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 17.04 | 20056578 | |
| MESH:D009374 | Neoplasms, Experimental | Urethane | 17.04 | 15582191 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | celecoxib | 9.79 | 19196722 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 9.79 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 9.79 | 19200415 19196722 19189210 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 8.64 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 8.64 | 17289903 | |
| MESH:D009389 | Neovascularization, Pathologic | Nicotine | 8.64 | 16365874 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 5.96 | 15464296 | |
| MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 5.96 | 6375363 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.30 | 16899518 16636307 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 2.92 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 8.08 | 19348381 18481113 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 8.08 | 16889571 15640375 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 8.08 | 17178036 | |
| MESH:D009410 | Nerve Degeneration | Ibuprofen | 6.89 | 10961664 | |
| MESH:D009410 | Nerve Degeneration | Paraquat | 6.89 | 16893418 | |
| MESH:D009410 | Nerve Degeneration | Rotenone | 6.89 | 17356569 18619942 15790535 | |
| MESH:D009421 | Nervous System Malformations | bisphenol A | 20.12 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 20.12 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 20.12 | 16427766 11399458 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 20.12 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 20.12 | 14600291 | |
| MESH:D009421 | Nervous System Malformations | Tretinoin | 20.12 | 9125849 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.11 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 30.52 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 30.52 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 30.52 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Benzene | 30.52 | 15643154 | |
| MESH:D009436 | Neural Tube Defects | Folic Acid | 30.52 | 17438019 | |
| MESH:D009436 | Neural Tube Defects | ochratoxin A | 30.52 | 20036863 | |
| MESH:D009436 | Neural Tube Defects | Phenytoin | 30.52 | 9118846 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 30.52 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Tetrahydrocannabinol | 30.52 | 19040278 | |
| MESH:D009436 | Neural Tube Defects | Tretinoin | 30.52 | 9142499 | |
| MESH:D009436 | Neural Tube Defects | Valproic Acid | 30.52 | 8888407 16359493 | |
| MESH:D009442 | Neurilemmoma | Ethylnitrosourea | 8.33 | 16003739 16651423 17160924 | |
| MESH:D009442 | Neurilemmoma | Methylnitrosourea | 8.33 | 11555667 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 3.72 | 17168769 | |
| MESH:D009447 | Neuroblastoma | 4-oxofenretinide | 16.15 | 16540676 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 16.15 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 16.15 | 8761367 15176712 16115947 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 16.15 | 15555623 | |
| MESH:D009447 | Neuroblastoma | irinotecan | 16.15 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Isotretinoin | 16.15 | 17368321 | |
| MESH:D009447 | Neuroblastoma | WP 744 | 16.15 | 15555623 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 16.10 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Diethylnitrosamine | 16.10 | 20387270 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 16.10 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 16.10 | 16604332 17296847 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 16.10 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 16.10 | 16850258 17266991 | |
| MESH:D017599 | Neuroectodermal Tumors | Carboplatin | 15.24 | 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 15.24 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 15.24 | 8761367 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | irinotecan | 15.24 | 8761367 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 9.68 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 9.68 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 9.68 | 17929310 | |
| MESH:D009461 | Neurologic Manifestations | Diethylnitrosamine | 3.59 | 20387270 | |
| MESH:D009472 | Neuronal Ceroid-Lipofuscinoses | Fenretinide | 4.18 | 16303764 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 4.61 | 16436463 | |
| MESH:D020258 | Neurotoxicity Syndromes | Methyl Parathion | 4.61 | 19784758 | |
| MESH:D009503 | Neutropenia | Ciprofloxacin | 10.74 | 17846019 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 10.74 | 8291058 | |
| MESH:D009503 | Neutropenia | Folic Acid | 10.74 | 16322990 | |
| MESH:D009503 | Neutropenia | Mustard Gas | 10.74 | 16761898 7688884 | |
| MESH:D052556 | Niemann-Pick Disease, Type C | perfluorooctanoic acid | 3.49 | 9802331 | |
| MESH:D009765 | Obesity | Ascorbic Acid | 6.43 | 17217161 | |
| MESH:D009765 | Obesity | Curcumin | 6.43 | 19297423 | |
| MESH:D009765 | Obesity | Dietary Fats | 6.43 | 19632207 21332399 20518802 17217161 18457598 11836018 18674790 20132043 16723640 | |
| MESH:D009765 | Obesity | pirinixic acid | 6.43 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 6.43 | 20132043 19056576 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.65 | 6374098 | |
| MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 7.36 | 12819281 16049721 | |
| MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 7.36 | 16049721 | |
| MESH:D009784 | Occupational Diseases | Benzene | 7.36 | 17479406 15935809 15913788 15612468 17178637 15727169 16737584 15576619 17119257 | |
| MESH:D009837 | Oligodendroglioma | Ethylnitrosourea | 4.46 | 17160924 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.25 | 16517039 | |
| MESH:D010003 | Osteoarthritis | Aspirin | 8.66 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Ibuprofen | 8.66 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 8.66 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 8.66 | 16640825 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 7.35 | 15867366 | |
| MESH:D010014 | Osteolysis | zoledronic acid | 7.35 | 15867366 | |
| MESH:D010018 | Osteomalacia | Phenobarbital | 7.14 | 17016548 | |
| MESH:D010018 | Osteomalacia | Phenytoin | 7.14 | 17016548 | |
| MESH:D010024 | Osteoporosis | Curcumin | 16.08 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 16.08 | 19401787 | |
| MESH:D010024 | Osteoporosis | Iron | 16.08 | 16648989 16640825 | |
| MESH:D010024 | Osteoporosis | Isoflavones | 16.08 | 16562857 | |
| MESH:D010024 | Osteoporosis | kaempferol | 16.08 | 16756079 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 16.08 | 17882678 19059307 15775268 | |
| MESH:D010024 | Osteoporosis | zoledronic acid | 16.08 | 17882678 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Dehydroepiandrosterone | 16.78 | 16397352 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 16.78 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 16.78 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 16.78 | 17893378 17823083 15579764 15758505 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 16.78 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 2.82 | 15930896 | |
| MESH:D010049 | Ovarian Diseases | bisphenol A | 3.49 | 11985600 | |
| MESH:D010051 | Ovarian Neoplasms | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 51.37 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | 4-oxofenretinide | 51.37 | 16540676 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 51.37 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 51.37 | 16624393 19769630 12452020 | |
| MESH:D010051 | Ovarian Neoplasms | Benzene | 51.37 | 12562636 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 51.37 | 17225452 15464296 6897625 19769630 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 51.37 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | decitabine | 51.37 | 19331143 19259094 | |
| MESH:D010051 | Ovarian Neoplasms | (E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide | 51.37 | 15528975 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 51.37 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Fenretinide | 51.37 | 16133793 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 51.37 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 51.37 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 51.37 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Progesterone | 51.37 | 16525653 17393432 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 51.37 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 51.37 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Tretinoin | 51.37 | 16936753 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 51.37 | 19331143 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 51.37 | 16211241 | |
| MESH:D010051 | Ovarian Neoplasms | Urethane | 51.37 | 16391232 | |
| MESH:D010146 | Pain | Acetaminophen | 18.08 | 16870215 | |
| MESH:D010146 | Pain | Aspirin | 18.08 | 6363464 6995502 | |
| MESH:D010146 | Pain | Cyclophosphamide | 18.08 | 18093676 12161096 | |
| MESH:D010146 | Pain | Ibuprofen | 18.08 | 3291741 | |
| MESH:D010146 | Pain | Indomethacin | 18.08 | 17627676 3291741 13679232 17440234 | |
| MESH:D010146 | Pain | Phenytoin | 18.08 | 15215642 | |
| MESH:D010146 | Pain | Sulindac | 18.08 | 3291741 | |
| MESH:D010146 | Pain | Tretinoin | 18.08 | 16870215 | |
| MESH:D010146 | Pain | zoledronic acid | 18.08 | 16475674 | |
| MESH:D010149 | Pain, Postoperative | Ibuprofen | 6.50 | 16678543 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 6.50 | 12538197 18702446 | |
| MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 55.25 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 55.25 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 55.25 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 55.25 | 17440100 19401701 19196508 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 55.25 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | decitabine | 55.25 | 19294695 | |
| MESH:D010190 | Pancreatic Neoplasms | Diethylnitrosamine | 55.25 | 16540662 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 55.25 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 55.25 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fenretinide | 55.25 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 55.25 | 16929163 19003803 15113037 16500647 | |
| MESH:D010190 | Pancreatic Neoplasms | gemcitabine | 55.25 | 11504793 16929163 18383843 18992248 17440100 | |
| MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 55.25 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 55.25 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 55.25 | 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Phenobarbital | 55.25 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 55.25 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 55.25 | 16820089 11504793 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 55.25 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 55.25 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 55.25 | 19294695 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 2.61 | 15028970 17883296 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.27 | 11578682 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 10.52 | 12065085 | |
| MESH:D010212 | Papilloma | Iron | 10.52 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 10.52 | 15173996 16517061 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 10.52 | 8330346 12065085 18404319 18922899 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 2.75 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.19 | 16537180 | |
| MESH:D020447 | Parasomnias | Iron | 4.49 | 17352947 | |
| MESH:D010300 | Parkinson Disease | Iron | 5.23 | 16640825 16563566 | |
| MESH:D010300 | Parkinson Disease | Paraquat | 5.23 | 11181820 15451049 12911755 11445065 15824117 16140633 11124998 16510128 | |
| MESH:D010300 | Parkinson Disease | Polychlorinated Biphenyls | 5.23 | 16702228 | |
| MESH:D010300 | Parkinson Disease | Rotenone | 5.23 | 19114014 16140633 11535288 18191903 15451049 16412576 11445065 18619942 19232380 | |
| MESH:D010302 | Parkinson Disease, Secondary | Paraquat | 2.98 | 16190885 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 4.90 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Rotenone | 4.90 | 15574749 15795934 18197244 15927086 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.19 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 2.73 | 12520081 | |
| MESH:D010391 | Pemphigoid, Bullous | Niacinamide | 4.93 | 11026799 | |
| MESH:D010409 | Penile Diseases | Antimony | 4.27 | 9643325 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.65 | 11148446 | |
| MESH:D010438 | Peptic Ulcer Hemorrhage | Aspirin | 4.04 | 11156591 | |
| MESH:D010493 | Pericarditis | Antimony | 4.61 | 20465667 | |
| MESH:D010518 | Periodontitis | Indomethacin | 3.41 | 17225004 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 5.33 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 5.33 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 8.14 | 16905509 6392382 15371236 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 8.14 | 15687053 | |
| MESH:D010538 | Peritonitis | Ozone | 5.61 | 16369182 | |
| MESH:D010538 | Peritonitis | Zymosan | 5.61 | 18977430 18760300 19641140 15979727 17826846 14761945 15259001 11985352 19088179 18557954 17371808 | |
| MESH:D020795 | Photophobia | Aspirin | 4.24 | 15240983 | |
| MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 3.99 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.64 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 9.04 | 14722030 | |
| MESH:D010900 | Pituitary Diseases | Iron | 9.04 | 16604332 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 7.26 | 15687265 16977796 | |
| MESH:D010911 | Pituitary Neoplasms | Urethane | 7.26 | 16391232 | |
| MESH:D010954 | Plasmacytoma | Selenium | 3.37 | 15087411 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 8.92 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 8.92 | 17638057 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 10.05 | 12224865 11605937 | |
| MESH:D011014 | Pneumonia | Ozone | 10.05 | 18381685 18929643 18007984 | |
| MESH:D011014 | Pneumonia | Paraquat | 10.05 | 12504350 | |
| MESH:D011041 | Poisoning | Iron | 6.74 | 16604332 | |
| MESH:D011041 | Poisoning | Methyl Parathion | 6.74 | 17603234 | |
| MESH:D011041 | Poisoning | Mustard Gas | 6.74 | 15727166 | |
| MESH:D011085 | Polycystic Ovary Syndrome | Simvastatin | 3.98 | 17105841 | |
| MESH:D017689 | Polydactyly | Phenytoin | 3.69 | 9212184 | |
| MESH:D017499 | Porokeratosis | alitretinoin | 4.48 | 16144296 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 6.24 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 6.24 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Azoxymethane | 18.70 | 14668109 12458338 19056647 | |
| MESH:D011230 | Precancerous Conditions | Corn Oil | 18.70 | 14668109 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 18.70 | 12371664 | |
| MESH:D011230 | Precancerous Conditions | Diethylnitrosamine | 18.70 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Phenobarbital | 18.70 | 2563599 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 18.70 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 6.31 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cytarabine | 6.31 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 6.31 | 21297632 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 5.29 | 16640825 | |
| MESH:D011225 | Pre-Eclampsia | Zinc | 5.29 | 17114810 | |
| MESH:D011248 | Pregnancy Complications | Toxaphene | 4.41 | 2087686 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.65 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 28.11 | 10548101 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 28.11 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 28.11 | 18769834 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | perfluorooctanoic acid | 28.11 | 17132714 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 28.11 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 28.11 | 11222880 11896295 11118676 11399792 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 28.11 | 20603192 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | vinclozolin | 28.11 | 18220299 18042343 19015723 | |
| MESH:D055728 | Primary Myelofibrosis | decitabine | 7.55 | 17616702 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 7.55 | 17616702 | |
| MESH:D011469 | Prostatic Diseases | vinclozolin | 3.43 | 18220299 | |
| MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 3.29 | 15572423 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 5.92 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 5.92 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | marker/mechanism | 12727815 15598783 | ||
| MESH:D011471 | Prostatic Neoplasms | (3-(4-(bis(2-chloroethyl)amino)phenyl)-3-propyl)carbamic acid 2-(6-(17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-11-yl)hexylamino)ethyl ester | 44.03 | 16039525 | |
| MESH:D011471 | Prostatic Neoplasms | Am 80 | 44.03 | 16289102 | |
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 44.03 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 44.03 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 44.03 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | Azacitidine | 44.03 | 18324645 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 44.03 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Berberine | 44.03 | 16505103 | |
| MESH:D011471 | Prostatic Neoplasms | bicalutamide | 44.03 | 17914592 19011039 19240160 18487222 15638997 | |
| MESH:D011471 | Prostatic Neoplasms | biochanin A | 44.03 | 12111696 | |
| MESH:D011471 | Prostatic Neoplasms | bisphenol A | 44.03 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 44.03 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | Calcitriol | 44.03 | 16644109 16289102 12479363 18247401 15754350 | |
| MESH:D011471 | Prostatic Neoplasms | celecoxib | 44.03 | 17908994 15570007 | |
| MESH:D011471 | Prostatic Neoplasms | Cholecalciferol | 44.03 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 44.03 | 12497104 10851300 11398177 18769126 15129424 18226269 18156803 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 44.03 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 44.03 | 15046698 15846301 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 44.03 | 15749863 15897917 16868541 18437689 16729912 16888761 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 44.03 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 44.03 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | Fenretinide | 44.03 | 17024972 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 44.03 | 18626508 19082440 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 44.03 | 15256057 16925846 15378649 | |
| MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 44.03 | 17409433 | |
| MESH:D011471 | Prostatic Neoplasms | Isoflavones | 44.03 | 16365062 17374662 17571952 17219775 | |
| MESH:D011471 | Prostatic Neoplasms | Ketoconazole | 44.03 | 17404083 | |
| MESH:D011471 | Prostatic Neoplasms | Lindane | 44.03 | 14688026 12661182 | |
| MESH:D011471 | Prostatic Neoplasms | lycopene | 44.03 | 15084515 17337101 | |
| MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 44.03 | 12376480 15682402 | |
| MESH:D011471 | Prostatic Neoplasms | methylselenic acid | 44.03 | 16205645 | |
| MESH:D011471 | Prostatic Neoplasms | N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide | 44.03 | 18798265 | |
| MESH:D011471 | Prostatic Neoplasms | netoglitazone | 44.03 | 14977855 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 44.03 | 16356831 17172428 16729912 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 44.03 | 14666653 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | Polychlorinated Biphenyls | 44.03 | 15721890 | |
| MESH:D011471 | Prostatic Neoplasms | Prednisone | 44.03 | 16888761 | |
| MESH:D011471 | Prostatic Neoplasms | pyrrolidine dithiocarbamic acid | 44.03 | 16139439 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 44.03 | 17292933 14715546 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 44.03 | 16220300 16536755 15731164 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 44.03 | 17636462 16731767 15767336 17718901 17804756 17675339 | |
| MESH:D011471 | Prostatic Neoplasms | roscovitine | 44.03 | 16140939 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 44.03 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | sulindac sulfone | 44.03 | 17908994 15570007 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 44.03 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 44.03 | 19789329 18798265 | |
| MESH:D011471 | Prostatic Neoplasms | vorinostat | 44.03 | 17218635 | |
| MESH:D011471 | Prostatic Neoplasms | Zinc | 44.03 | 16700911 16517595 16606632 12429649 | |
| MESH:D011471 | Prostatic Neoplasms | zoledronic acid | 44.03 | 19103299 12438248 | |
| MESH:D011472 | Prostatitis | vinclozolin | 3.43 | 18629315 | |
| MESH:D011507 | Proteinuria | Arsenic | 18.00 | 21343184 | |
| MESH:D011507 | Proteinuria | Ibuprofen | 18.00 | 6375363 | |
| MESH:D011507 | Proteinuria | Indomethacin | 18.00 | 11849393 | |
| MESH:D011507 | Proteinuria | pioglitazone | 18.00 | 16687628 | |
| MESH:D011507 | Proteinuria | Prednisone | 18.00 | 16636307 | |
| MESH:D011507 | Proteinuria | Tretinoin | 18.00 | 16636307 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.49 | 16640825 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 4.68 | 15861022 16919318 | |
| MESH:D011537 | Pruritus | Mustard Gas | 4.68 | 18058305 | |
| MESH:D019310 | Pseudolymphoma | Phenobarbital | 12.50 | 12752131 | |
| MESH:D019310 | Pseudolymphoma | Phenytoin | 12.50 | 12752131 8603615 1419762 | |
| MESH:D019310 | Pseudolymphoma | Valproic Acid | 12.50 | 12752131 11422049 | |
| MESH:D011565 | Psoriasis | Am 80 | 4.72 | 16819260 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 4.72 | 16882103 | |
| MESH:D011565 | Psoriasis | Methotrexate | 4.72 | 17410198 | |
| MESH:D011596 | Psychomotor Disorders | Isotretinoin | 4.42 | 18769834 | |
| MESH:D011625 | Pterygium | Tretinoin | 3.29 | 16723453 | |
| MESH:D011629 | Puberty, Precocious | bisphenol A | 3.29 | 10548101 | |
| MESH:D011645 | Puerperal Infection | Citric Acid | 5.23 | 1108409 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.15 | 19168576 | |
| MESH:D011657 | Pulmonary Eosinophilia | Ascorbic Acid | 3.82 | 14606601 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 10.13 | 16636934 | |
| MESH:D011658 | Pulmonary Fibrosis | methyl isocyanate | 10.13 | 7708994 | |
| MESH:D011658 | Pulmonary Fibrosis | Mustard Gas | 10.13 | 17266442 17720292 17894541 17620002 10334151 | |
| MESH:D011658 | Pulmonary Fibrosis | Paraquat | 10.13 | 17997886 16324872 | |
| MESH:D011658 | Pulmonary Fibrosis | Particulate Matter | 10.13 | 12475806 | |
| MESH:D011658 | Pulmonary Fibrosis | troglitazone | 10.13 | 18162602 | |
| MESH:D011693 | Purpura | Raloxifene | 4.03 | 15770314 | |
| MESH:D012003 | Rectal Fistula | Ciprofloxacin | 4.85 | 18371140 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.68 | 16160472 18286688 15538739 18722050 | |
| MESH:D012021 | Reflex, Abnormal | Pentobarbital | 4.52 | 10930210 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 12.66 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 12.66 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Folic Acid | 12.66 | 15728788 | |
| MESH:D051437 | Renal Insufficiency | Methotrexate | 12.66 | 17352296 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.06 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | marker/mechanism | 16968891 | ||
| MESH:D015427 | Reperfusion Injury | Leucovorin | 5.24 | 17295595 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 5.24 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 5.24 | 17520802 16314181 16317513 15827377 17058453 | |
| MESH:D012120 | Respiration Disorders | Chlorine | 3.70 | 18579056 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 17.32 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 17.32 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 17.32 | 11700416 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 17.32 | 17627322 18339021 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Paraquat | 17.32 | 11700416 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | pyrrolidine dithiocarbamic acid | 17.32 | 16129981 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 2.59 | 10835634 | |
| MESH:D012135 | Respiratory Sounds | Paraquat | 5.37 | 11874814 | |
| MESH:D012135 | Respiratory Sounds | Vehicle Emissions | 5.37 | 18950799 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.39 | 18990726 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.29 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | Fenretinide | 11.09 | 16303925 | |
| MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 11.09 | 18172121 18155124 | |
| MESH:D012162 | Retinal Degeneration | Paraquat | 11.09 | 16458197 | |
| MESH:D012162 | Retinal Degeneration | Zinc | 11.09 | 16584753 | |
| MESH:D012174 | Retinitis Pigmentosa | Ascorbic Acid | 2.70 | 16849425 | |
| MESH:D012175 | Retinoblastoma | Methylnitrosourea | 8.73 | 11555667 | |
| MESH:D012175 | Retinoblastoma | SN50 peptide | 8.73 | 12466137 | |
| MESH:D012206 | Rhabdomyolysis | Lamivudine | 4.04 | 9296927 | |
| MESH:D012208 | Rhabdomyosarcoma | decitabine | 10.36 | 19155313 | |
| MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 10.36 | 16283617 16116481 | |
| MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 10.36 | 19155313 | |
| MESH:D012220 | Rhinitis | Aspirin | 3.08 | 12372130 | |
| MESH:D012468 | Salivary Gland Neoplasms | Progesterone | 2.09 | 18045962 | |
| MESH:D012509 | Sarcoma | Curcumin | 5.07 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 5.07 | 18313854 17203757 15675481 17710206 15625365 16767912 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 27.00 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 27.00 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 27.00 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 27.00 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 27.00 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | roscovitine | 27.00 | 16230394 | |
| MESH:D012512 | Sarcoma, Ewing's | zoledronic acid | 27.00 | 16121404 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.30 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.02 | 16862918 | |
| MESH:D012559 | Schizophrenia | Folic Acid | 2.48 | 16641680 | |
| MESH:D012559 | Schizophrenia | Valproic Acid | 2.48 | 15737665 19110320 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.41 | 16636934 | |
| MESH:D012640 | Seizures | 2,4-dinitrotoluene | 17.73 | 18551238 | |
| MESH:D012640 | Seizures | 2,6-dinitrotoluene | 17.73 | 18551238 | |
| MESH:D012640 | Seizures | Acrylonitrile | 17.73 | 20127315 | |
| MESH:D012640 | Seizures | Ethanol | 17.73 | 9754883 | |
| MESH:D012640 | Seizures | Lindane | 17.73 | 7539098 15475178 12842176 | |
| MESH:D012640 | Seizures | Nicotine | 17.73 | 17873105 | |
| MESH:D012640 | Seizures | Pentobarbital | 17.73 | 10087439 9754883 | |
| MESH:D012640 | Seizures | Phenobarbital | 17.73 | 3137016 4039156 16876388 11442880 | |
| MESH:D012640 | Seizures | Phenytoin | 17.73 | 16876388 10029267 15946322 11044598 19919933 3691417 3137016 9844417 | |
| MESH:D012640 | Seizures | Valproic Acid | 17.73 | 11738929 17978042 16876388 15475178 1511512 11044598 14763951 3137016 | |
| MESH:D003294 | Seizures, Febrile | Phenobarbital | 3.32 | 6407741 | |
| MESH:D018805 | Sepsis | Curcumin | 5.32 | 18389075 | |
| MESH:D018805 | Sepsis | Zymosan | 5.32 | 11441115 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 3.23 | 7327846 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Aspirin | 3.80 | 12269725 | |
| MESH:D012871 | Skin Diseases | Arsenic | 7.11 | 17548696 19834688 17050553 15952646 17453740 17938729 16353154 16759981 18709164 16702368 6392382 | |
| MESH:D012871 | Skin Diseases | Ascorbic Acid | 7.11 | 18709164 | |
| MESH:D012871 | Skin Diseases | Folic Acid | 7.11 | 18709164 | |
| MESH:D012871 | Skin Diseases | monomethylarsonic acid | 7.11 | 21378128 | |
| MESH:D012871 | Skin Diseases | Mustard Gas | 7.11 | 12880345 15451306 16961503 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 35.70 | 19538983 16251483 15504454 17976673 17029826 17050553 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 35.70 | 10029692 19755658 | |
| MESH:D012878 | Skin Neoplasms | deguelin | 35.70 | 16041863 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 35.70 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Fenretinide | 35.70 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 35.70 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Iron | 35.70 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 35.70 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 35.70 | 8985016 15837718 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 35.70 | 18572023 19524636 | |
| MESH:D012878 | Skin Neoplasms | tert-Butylhydroperoxide | 35.70 | 8532709 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 35.70 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 35.70 | 11807781 8985016 18404319 12065085 8330346 | |
| MESH:D012878 | Skin Neoplasms | Tretinoin | 35.70 | 16467112 | |
| MESH:D012878 | Skin Neoplasms | Urethane | 35.70 | 11807781 | |
| MESH:D012893 | Sleep Disorders | Caffeine | 3.85 | 19395429 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Caffeine | 3.64 | 17225163 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 3.82 | 15464296 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.10 | 17203757 16767912 15625365 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 11.48 | 16709447 16002989 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 11.48 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 11.48 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 4.01 | 16517039 | |
| MESH:D013118 | Spinal Cord Diseases | Folic Acid | 4.00 | 16361298 | |
| MESH:D013119 | Spinal Cord Injuries | Progesterone | 5.96 | 15862959 16503802 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 5.96 | 19457130 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 5.27 | 12854658 | |
| MESH:D016135 | Spinal Dysraphism | Valproic Acid | 5.27 | 19490988 | |
| MESH:D013158 | Splenic Diseases | Dimethylnitrosamine | 3.75 | 12587719 | |
| MESH:D013226 | Status Epilepticus | Valproic Acid | 3.03 | 12833885 | |
| MESH:D013262 | Stevens-Johnson Syndrome | Phenytoin | 3.70 | 20235791 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 5.49 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 5.49 | 18209964 16113693 18545984 15472012 17160473 16184426 10192188 17207306 16280098 15038085 10486359 17638125 10215738 | |
| MESH:D013274 | Stomach Neoplasms | marker/mechanism | 14647439 | ||
| MESH:D013274 | Stomach Neoplasms | Acrylonitrile | 27.99 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 27.99 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Benzene | 27.99 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 27.99 | 2093021 20155912 | |
| MESH:D013274 | Stomach Neoplasms | celecoxib | 27.99 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 27.99 | 18396642 15958060 17522103 | |
| MESH:D013274 | Stomach Neoplasms | decitabine | 27.99 | 19037991 | |
| MESH:D013274 | Stomach Neoplasms | Diethylnitrosamine | 27.99 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Dimethylnitrosamine | 27.99 | 16033868 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 27.99 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 27.99 | 17522103 19015929 18396642 17172411 18567086 16951190 16424979 15786421 19084572 17498489 | |
| MESH:D013274 | Stomach Neoplasms | Folic Acid | 27.99 | 17171786 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 27.99 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | irinotecan | 27.99 | 15723263 | |
| MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 27.99 | 15930296 16257854 18593901 | |
| MESH:D013274 | Stomach Neoplasms | nitrosobenzylmethylamine | 27.99 | 12958204 17575124 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 27.99 | 18506536 18396642 | |
| MESH:D013274 | Stomach Neoplasms | styrene oxide | 27.99 | 12562636 | |
| MESH:D013274 | Stomach Neoplasms | Tretinoin | 27.99 | 17261132 | |
| MESH:D013274 | Stomach Neoplasms | troglitazone | 27.99 | 15930296 | |
| MESH:D013274 | Stomach Neoplasms | Zidovudine | 27.99 | 17696246 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 13.57 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | Ascorbic Acid | 13.57 | 18726076 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 13.57 | 16631530 19188055 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 13.57 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 13.57 | 17189318 16755016 9562338 17918041 9211565 11906479 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 13.57 | 16631530 18181030 10878458 18193104 18431645 17657623 15104355 18237397 17627676 11523592 17895592 15255614 18209962 18087811 17977527 18726076 1323529 17654042 17918041 12498302 15138204 11145282 12077510 18299717 11906479 11729361 16934674 14567935 10423059 16169175 16755016 12467913 11595431 12787963 12500499 16397915 10750652 18543354 11595415 16252198 17135157 16150113 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 13.57 | 17135157 18237397 18193104 15255614 12787963 | |
| MESH:D020521 | Stroke | Ascorbic Acid | 10.08 | 16517955 16403987 | |
| MESH:D020521 | Stroke | Aspirin | 10.08 | 16403987 | |
| MESH:D020521 | Stroke | Folic Acid | 10.08 | 16517955 | |
| MESH:D020521 | Stroke | Raloxifene | 10.08 | 16837676 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.11 | 16321402 | |
| MESH:D013345 | Subarachnoid Hemorrhage | pifithrin | 4.54 | 18364113 | |
| MESH:D019966 | Substance-Related Disorders | bisphenol A | 2.54 | 16684133 16045194 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 5.73 | 9754883 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Pentobarbital | 5.73 | 11529278 9754883 | |
| MESH:D013398 | Sudden Infant Death | Iron | 8.37 | 16640825 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 8.37 | 12563064 | |
| MESH:D015173 | Supratentorial Neoplasms | Carboplatin | 7.54 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 7.54 | 12837982 | |
| MESH:D013576 | Syndactyly | Methotrexate | 3.59 | 9562676 | |
| MESH:D024801 | Tauopathies | Camptothecin | 6.91 | 16930453 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 6.91 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 3.96 | 17997062 | |
| MESH:D013733 | Testicular Diseases | pyrazole | 3.36 | 6499806 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.22 | 15464296 17225452 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 5.61 | 15821434 | |
| MESH:D013921 | Thrombocytopenia | vorinostat | 5.61 | 20479100 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.21 | 11994571 | |
| MESH:D013927 | Thrombosis | Aspirin | 4.78 | 17672075 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 4.78 | 15669648 | |
| MESH:D013953 | Thymus Neoplasms | Benzene | 11.80 | 10850423 | |
| MESH:D013953 | Thymus Neoplasms | Ethylnitrosourea | 11.80 | 15790496 | |
| MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 11.80 | 11418001 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 7.37 | 12697716 | |
| MESH:D013959 | Thyroid Diseases | Thyroxine | 7.37 | 19910387 | |
| MESH:D013964 | Thyroid Neoplasms | 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine | 24.40 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 24.40 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Butyrates | 24.40 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | decitabine | 24.40 | 17967635 | |
| MESH:D013964 | Thyroid Neoplasms | Diethylnitrosamine | 24.40 | 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 24.40 | 17909728 16010429 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 24.40 | 18791128 11352223 14736730 | |
| MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 24.40 | 3078959 7505956 | |
| MESH:D013964 | Thyroid Neoplasms | Phenobarbital | 24.40 | 1399818 | |
| MESH:D013964 | Thyroid Neoplasms | Tretinoin | 24.40 | 16026305 17045167 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 8.69 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 8.69 | 19048282 | |
| OMIM:188890 | TOBACCO ADDICTION, SUSCEPTIBILITY TO | Nicotine | 3.50 | 16720336 11259349 16785264 | |
| MESH:D014029 | Tobacco Use Disorder | Nicotine | 3.98 | 18305452 18041664 15735609 17979512 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 12.55 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 12.55 | 16227395 | |
| MESH:D014062 | Tongue Neoplasms | Tretinoin | 12.55 | 16051514 | |
| MESH:D014062 | Tongue Neoplasms | Zinc | 12.55 | 16543248 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 2.50 | 15213294 | |
| MESH:D014123 | Toxoplasmosis | Ciprofloxacin | 4.51 | 20186551 | |
| MESH:D014178 | Translocation, Genetic | Valproic Acid | 3.71 | 17262798 | |
| MESH:D014352 | Trypanosomiasis | Antimony | 4.42 | 15220340 | |
| MESH:D014376 | Tuberculosis | Iron | 4.36 | 16597321 | |
| MESH:D014376 | Tuberculosis | Tretinoin | 4.36 | 16040207 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.41 | 17380554 10574470 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.03 | 3119515 | |
| MESH:D014511 | Uremia | methyl isocyanate | 5.42 | 8440870 | |
| MESH:D001749 | Urinary Bladder Neoplasms | marker/mechanism | 18640142 | ||
| MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 50.95 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 50.95 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 50.95 | 1399818 15289314 15867355 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 50.95 | 17306315 15987713 19429237 17976673 18640142 11144890 19322015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 50.95 | 20435036 11780464 12845720 12973940 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 50.95 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cacodylic Acid | 50.95 | 15537745 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Ciprofloxacin | 50.95 | 10741713 15028437 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 50.95 | 15464296 12973940 17225452 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 50.95 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 50.95 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | decitabine | 50.95 | 17616700 19087683 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 50.95 | 16712894 16452187 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 50.95 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Fenretinide | 50.95 | 16720286 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Plant Preparations | 50.95 | 11251952 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 50.95 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 50.95 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 50.95 | 17306315 11723127 16712894 16452187 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 50.95 | 16712894 17572228 8653321 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Vehicle Emissions | 50.95 | 11144890 | |
| MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.17 | 8888407 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 3.76 | 18462866 | |
| MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 7.05 | 10091137 | |
| MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 7.05 | 10091137 | |
| MESH:D014581 | Urticaria | Acetaminophen | 4.32 | 10982225 | |
| MESH:D014581 | Urticaria | Aspirin | 4.32 | 10982225 20485159 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 28.68 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 28.68 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fenretinide | 28.68 | 16154183 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 28.68 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 28.68 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 28.68 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 28.68 | 11813266 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 28.68 | 16129372 | |
| MESH:D014591 | Uterine Diseases | bisphenol A | 8.80 | 14652134 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 8.80 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Benzene | 23.50 | 12562636 | |
| MESH:D014594 | Uterine Neoplasms | celecoxib | 23.50 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 23.50 | 16690809 15809267 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 23.50 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 23.50 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 23.50 | 18645019 | |
| MESH:D014594 | Uterine Neoplasms | sulindac sulfide | 23.50 | 18645019 | |
| MESH:D014604 | Uveal Neoplasms | decitabine | 7.82 | 17785578 | |
| MESH:D014604 | Uveal Neoplasms | Tretinoin | 7.82 | 16752155 | |
| MESH:D014605 | Uveitis | Cyclosporine | 11.65 | 1336536 | |
| MESH:D014605 | Uveitis | Dexamethasone | 11.65 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 11.65 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 10.11 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 10.11 | 16002989 16513791 | |
| MESH:D014625 | Vaginal Neoplasms | Zidovudine | 10.11 | 12579204 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 6.91 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 6.91 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.07 | 12125929 | |
| MESH:D019043 | Vascular Neoplasms | Urethane | 4.39 | 10620525 | |
| MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 7.05 | 19057314 | |
| MESH:D020301 | Vasospasm, Intracranial | pifithrin | 7.05 | 18364113 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 3.69 | 16837676 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.15 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 8.88 | 17678736 16364871 17638931 17334414 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 8.88 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 8.88 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 3.82 | 18097624 | |
| MESH:D014820 | Vitiligo | Tretinoin | 2.62 | 16761959 | |
| MESH:D014839 | Vomiting | Cisplatin | 6.55 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 6.55 | 11897121 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 4.03 | 16343187 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 2.73 | 15886252 | |
| MESH:D015430 | Weight Gain | Dietary Fats | 2.41 | 16723640 | |
| MESH:D009396 | Wilms Tumor | Tretinoin | 2.62 | 16287080 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 3.00 | 20213670 19894650 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 2.92 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:05219 | Bladder cancer |
| KEGG:04110 | Cell cycle |
| REACT:1538 | Cell Cycle Checkpoints |
| REACT:152 | Cell Cycle, Mitotic |
| KEGG:05220 | Chronic myeloid leukemia |
| REACT:383 | DNA Replication |
| KEGG:04012 | ErbB signaling pathway |
| KEGG:05214 | Glioma |
| KEGG:05160 | Hepatitis C |
| KEGG:05218 | Melanoma |
| KEGG:04115 | p53 signaling pathway |
| KEGG:05200 | Pathways in cancer |
| KEGG:05215 | Prostate cancer |
| REACT:11061 | Signalling by NGF |
| No data |
| Releated disease ID | Related disease Name |
|---|---|
| PA447199 | Bipolar Disorder |
| PA443223 | Congenital Abnormalities |
| PA444065 | Epilepsy |
| PA444354 | Headache |
| PA447230 | HIV |
| PA447004 | Migraine with Aura |
| PA444949 | Migraine without Aura |
| PA445062 | Neoplasms |
| PA447216 | Schizophrenia |
| PA446284 | Spinal Dysraphism |
| PA164925725 | Toxic liver disease |
| PA446654 | Cholangiocarcinoma |
| PA443756 | Colonic Neoplasms |
| PA446155 | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| PA443560 | Breast Neoplasms |
| PA445742 | Stomach Neoplasms |
| Releated drug ID | Related drug Name |
|---|---|
| PA449167 | cyclosporine |
| PA451578 | tacrolimus |
| PA449957 | ibuprofen |
| PA448976 | choline |
| PA448478 | l-arginine |
| PA450635 | nitric oxide |
| PA451846 | valproic acid |
| PA448803 | carboplatin |
| PA450761 | paclitaxel |
| PA448871 | celecoxib |
| PA449165 | cyclophosphamide |
| PA128406956 | fluorouracil |
| PA450428 | methotrexate |
| PA449383 | docetaxel |
| PA449748 | gemcitabine |
| PA451743 | trastuzumab |
| PA451620 | teriparatide |
| PA450395 | metformin |
Drug Bank